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Section 2: Abstract  
 
Background: Personality Disorder treatment is a contentious subject in health care. 
Despite available research concerning the diagnosis itself and also available 
treatments, there is little research regarding treatment thresholds or defining how 
treatment decisions can be formulated. This problem has been identified by 
clinicians, patients, supervisors and specific organisations, particularly linked to 
recent healthcare changes associated with austerity measures.   
 
Research Question: How can mental health care staff use a formulated decision 
process concerning therapeutic interventions for people with PD, when considering 
the recent service changes and rationalisation of available treatments? 
   
Methods: An Action Research study has been conducted over a four year period, 
using predominantly qualitative methods including: a hermeneutic literature review 
(n=144 papers), patient questionnaires (n=15) and Interpretive Phenomenological 
Analysis (IPA) of clinician and supervisor semi-structured interviews (n=10). 
   
Results: Difficulties have been found when making decisions with people who either 
do not accept their diagnosis and/or do not accept the current evidence-based 
treatments for personality disorder. Other challenges have been identified regarding 
the patient/clinician relationship, the level of distress the patient presents with, and 
also the clinician view concerning the individual, the diagnosis, and the available 
treatments. The IPA produced five super-ordinate themes related to decision-making 
regarding treatment choices for people with personality disorder, including: 
difficulties with boundary management, diagnostic stigma, a focus upon time, 
metacognitive ability, and the potential for iatrogenic harm.  
 
Conclusions: Multiple factors require consideration when examining treatment 
choices for people with a personality disorder, concerning the patient's individual 
symptom profile, needs, attitude towards treatments; the clinician's profession, 
attitudes, opinions, and wellness on the day of the assessment, and also the 
treatments available within the locality. A diagram has been presented summarising 
these formulation factors. Recommendations have been made based upon the 
results, analysis, synthesis and discussion sections, indicating potential practice 
changes and areas for future research.  
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Section 1: Introduction  
 
1.1 Introduction and Motivation for undertaking this Research  
 
Professions1 working with people who have Personality Disorders2 (PD) have to 
make very difficult decisions within a frequently challenging therapeutic and 
changing clinical context. This research was developed in order to critically 
understand and develop a process for how professionals can be empowered and 
supported with making treatment decisions when they are working with patients3 who 
have a PD.   
 
The initial ideas for this innovative research evolved from actual experience of the 
challenges posed in both practice and supervision in this area of practice. It was 
evident in the context of locality teams4 that many of the clinicians were struggling 
with the Treatment Choice Encounter5. In order to provide the context for this 
research, a synthesis is developed within this Section. This synthesis brings together 
a coherent analysis of these personal experiences within UK research on Personality 
Disorder. This Section also provides an outline description of how the overall thesis 
is developed and presented. Finally, in order to conclude this chapter, the research 
aims and the specific research question are specified.  
1 - The use of the term "Professionals" within this research pertains to any member of health and social care staff whose role is  
to provide initial assessments and treatment decisions with people with a Personality Disorder. For example, Professionals who 
may fulfil these roles include: Psychiatrists, Psychotherapists, Nurses, Social Workers, or Occupational Therapists.  
 
2 – The use of the term Personality Disorder relates to people who fulfil the diagnostic criteria for the term Personality Disorder 
(PD), either as defined by the International Classification of Diseases 10
th
 Revision (ICD-10), or the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) (Appendix6). It is recognised that there are multiple subtypes of PD, the generic term PD 
will be used, however where specific subtypes are required, these will be specified.  
 
3 – The term “patient” will be used within this research to collectively refer to people who use mental health services. Other  
terms in the literature may include: service user, client, or patient, however within the author's employing organisation, users of 
the service have opted for the term patient when surveyed, and therefore this term will be used in respect of this.  
 
4 – The use of the term ‘Teams’ in this thesis relates to the specialist mental health, National Health Service (NHS) teams, that 
have been formed in the author's locality to deliver services for people with PD which may be the primary or co-morbid non-
psychotic mental health disorder.  
 
5 - The ‘Treatment Choice Encounter’ is defined as an encounter where a person with PD is engaged to discuss treatment 
choices. This is typically when they are first referred to specialist or secondary care mental health services, however it may 
pertain to a review of their treatment. In the service in which the author works, this encounter can be conducted by a number of 
professionals, including nurses, psychiatrists, psychologists, psychotherapists and/or occupational therapists. 
Student Number: 100104045 
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1.2 Thesis structure outline 
This thesis is structured within eleven sections. Each of these sections develop the 
central arguments cohesively within the thesis. This structure provides a clear flow 
that demonstrates critically how the research questions have been addressed and 
answered in a data driven unique form.  
 
Section One provides a brief introduction to the study area and research question. 
Section Two provides a comprehensive literature review, using a hermeneutic 
method of analysing and exploring published research contributing to this empirical 
study. Section Three explores the ontological, epistemological, methodological, and 
strategic approaches taken to gather information to answer the research question. 
Section Four reveals how, in conducting the research, practice changed, and a need 
emerged to develop a clinical heuristic that served the purpose of both re-engaging 
participants and stakeholders, and also structuring clinical interviews conducted in 
participant research.  
 
Section Five explores the participant study component, results of which are analysed 
within Section Six. Findings from the participant research are compared and 
contrasted with results from the literature review in Section Seven, to generate new 
information regarding formulating treatment decisions. Section Eight concludes the 
research, combined with a personal reflection regarding the author's experience, 
leading to the dissemination strategy provided in Section Nine. Sections Ten and 
Eleven provide references and appendices for the thesis. 
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1.3 Rationale for the focus of this enquiry. 
 
In current England and Wales NHS services, there are significant ongoing changes 
taking place within mental health care delivery. There are also enhanced 
expectations about worker productivity within this change context (DoH, 2014a,b; 
2011a,b,c,d, & 2009). The government introduced measures such as ‘New Ways of 
Working’ (DoH, 2007), in part to economically utilise existing resources to support 
development of specialist services.  
 
In many parts of the country, changes included moving away from generic 
community teams, with the creation of specialist Community Mental Health 
Treatment teams (e.g.: Psychosis or PD teams). This has meant that for many 
clinicians, their team context and caseloads have changed beyond all recognition. 
Thresholds for service provision within specialist services have also increased, with 
payments per treatment being evaluated (Monitor, 2014). Thus the overall strategic 
approach is aimed at the development of targeted specialised ‘cluster’ services, that 
it is envisaged will improve both effectiveness and efficiency. These aims, whilst 
many would consider them to be laudable, have been criticised. These criticisms 
mainly concern the impact on the clinicians delivering the services, such as 
potentially causing a negative impact on clinician wellbeing due to compassion 
fatigue from continuously working with patients with one set of symptoms (Schefer et 
al, 2007). 
 
The study presented here took place in the context of the above implementation of 
“New Ways of Working”. The locality services were subjected to a series of strategic 
organisational changes, the psychiatrist out-patients clinics and psychological 
Student Number: 100104045 
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therapy provision were integrated into community mental health treatment teams. 
Significant changes were also made to the form in which treatment and therapeutic 
interventions were delivered. This included a departure from primarily 1:1 patient 
sessions in a clinic-based setting, to increased group-based interventions. 
Additionally, psychological therapy staff became increasingly involved with team 
training, consultation, and supervision, for other (non-psychotherapeutically trained) 
multi-disciplinary team (MDT) members. The overall aim of these service changes 
was to try and deliver a more cost-effective service that is better able to cope with 
increased demand, with a more flexible and responsive workforce.  
 
Authorship and Agency 
This research has been approached from a Social Constructivist perspective, using 
an Action Research (AR) methodology. This enabled a ‘bottom-up’ approach, 
critically exploring and understanding the Treatment Choice Encounter from different 
perspectives. The following section describes the agency context and summarises 
the clinician, supervisor, and patient factors that influenced how the focus was 
constructed and how the case for change was created. 
 
Clinical context 
The study has been conducted as a research project associated with the author's 
post as a Consultant Psychotherapist and Advanced Nurse Consultant within an 
NHS trust. This post incorporates direct patient interaction, providing clinical 
supervision, clinical teaching, and service development with several service teams. 
Each team is comprised of multiple professionals, adults may be referred to the team 
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if they have a diagnosis or traits of PD, and often they present with comorbid mental 
health problems.  
 
The study was initially supported by the author's practice agency in respect of two 
aspects of their role. The first aspect concerned the delivery of brief 
psychotherapeutic training aimed at increasing the skills of the therapeutic 
workforce, the second concerned work conducted regarding trauma processing, after 
certain specific locality incidents related to self-harm and violence. Analysis of 
feedback from these two work strands prompted staff reflection and author curiosity 
in regards to the individual and systemic effects of incidents, and training concerning 
treatment choice, expanded upon in the following sections.  
 
Research Progress 
In 2012, the author conducted a pilot study, which delivered Cognitive Behavioural 
Therapy (CBT) education sessions to 179 staff members. This study enabled 
targeted CBT interventions to be delivered at different levels by a variety of staff, 
dependent upon patient need. This also enabled the increase of group level 
intervention, and subsequently decreased the demand for 1:1 CBT intervention 
delivered by a qualified psychotherapist. This mandate was necessary to enhance 
the skills of the existing workforce, prevent the development of increased waiting lists 
for 1:1 psychotherapeutic intervention, and make the most economic use of the 
scarce resource of registered psychotherapists.  
 
The study generated positive results in terms of staff feeling their knowledge and 
skills were increased, however it also revealed personal anxiety and traumatic 
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experiences connected with both their experience with service users who have a 
diagnosis of PD, and in terms of their redefined roles and changed way of working. 
The synthesis of training feedback combined with practice supervision data 
uncovered a need to (1) explore the effects of occupational trauma in this context; 
(2) explore how clinicians make treatment choices with people with PD, and; (3) 
develop a consistent approach to psychotherapeutic supervision of staff working 
where there may be value judgements connected with access to specialist 
treatments.  
 
To explore these themes further, the author conducted literature reviews concerning 
Occupational Trauma, which was published (Graham, 2012) and triangulated with a 
literature analysis regarding formulating treatment for PD. In researching this, the 
author discovered a gap in the research, in that there are currently no specific 
methods or tools to assist treatment choices for this patient group, and that although 
it is acknowledged that traumatic experiences can affect clinicians in different ways, 
there is no current multi-professional research which focuses upon the Treatment 
Choice Encounter. This disconnect is why this research provides an original 
contribution to the body of knowledge. 
 
As a part of the ongoing practice Action Research process, the author then 
conducted informal exploratory work with key locality professionals, to understand 
the problem better from their perspectives. Collaborative exploration enabled a shift 
for the author, from a researcher and reflective practitioner to a less detached and 
subjective position, understanding how the different beliefs and experiences of 
Student Number: 100104045 
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clinicians influence their thoughts, feelings, and behaviours, within their specific 
environmental context (Schunk and Bursuck, 2016:55). 
 
Professional’s perspectives and experiences: 
Through supervision and clinical discussion, four core themes were identified as 
influencing decision-making: firstly, through service reconfiguration: instead of being 
referred to three services (out-patient psychiatry, psychotherapy, and Community 
Mental Health Teams), patients are now referred to a care-coordinator, who can then 
access the team resources. Care coordinators (typically junior staff) stated that they 
struggled when deciding when to request additional input (i.e. psychotherapy).  
 
Secondly, through observation within supervision sessions, the author and other 
practice supervisors identified that there are many value-laden statements attached 
to PD patients, including: “deserving”, “manipulating”, and “attention-seeking”. These 
value judgements appear to influence objective decision-making, and can be 
connected to transferential processes related to the patient’s psychological defence 
mechanisms (Gedo, 2011; Dodwell, 2008). 
 
Thirdly, feedback showed that the patient’s mood and responses to formal mood 
ratings is often highly changeable. Clinicians suggested that they are often left 
unsure about whether to refer the person into the more intensive and costly 
therapeutic interventions that are available, due to the scarce resource, and doubts 
about whether it would be helpful to the patient. 
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Finally, a service framework issue theme was raised, concerning treatment teams, 
crisis teams, and in-patient staff, who all provide components of care for PD patients. 
The issue concerns the lack of a whole-system cohesiveness, which often leads to 
‘splitting’ and disagreements in teams and across services. This type of difficulty 
resulting from service configuration is not unique to this locality or patient group, and 
is one reason for piloting the current NHS Vanguard Sites, which focus upon the 
need for multiple care providers working to one single model (NHS England, 2015).  
 
The synthesis of these four themes suggested a need to critically understand how 
decision-making happens and is supported, when working with PD patients. Thus 
the views of supervisors were sought within the clinical practice area.  
 
Supervisor experiences: 
Locality professional leads consist of: psychiatrists, nurses, psychologists, 
psychotherapists, and managers, the author’s role is to provide specialist 
consultation with certain patients, and supervise these leads. Evidence from locality 
meetings, education sessions, and supervision sessions, showed that supervisors 
and senior clinicians are often not consulted by junior clinicians unless an incident 
has occurred, and they state that clinicians are often vague in what treatment they 
prefer.  
 
Therapists explained that although some referrals for group and 1:1 intervention are 
appropriate, other patients are ill-prepared for therapy, or unwilling to engage in 
talking-treatments, resulting in a disappointing therapy session for the patient, and 
an inappropriate resource use. Therapists reflected that this is often due to service 
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reconfiguration, resulting in non-therapists making treatment decisions. This raised 
issues in clinician's understanding of what they refer patients for, and how to prepare 
patients for certain treatments.  
 
In collating and critically analysing this supervisor feedback with the literature review 
findings and feedback from clinicians, it was identified that neither current published 
research or practice knowledge provided adequate descriptors of personal 
experiences in the Treatment Choice Encounter. This supports the need to better 
understand decision-making processes, and to develop a structure to aid decision-
making, not only for referral to different professionals in the team, but also for team 
supervision.  
 
Patient experiences: 
Locality data obtained through patient discussion forums and informally raised 
concerns suggested that PD patients are often unsure about why certain treatments 
were offered, not offered, or why specifically requested help was refused. Patients 
explained that they have felt confused about treatment, certain patients requested 
specific talking therapies or medication, and some rejected both treatments, 
requesting quicker, more practical help (i.e. housing applications).  
 
Themes raised by patients in clinical practice were compared by the author to 
feedback available in more public forums, in order to critically understand whether 
the issues are unique to the locality due to service configuration, or common for 
people with a PD diagnosis. Exploration revealed that locality patient feedback is 
echoed in online blogs and treatment feedback comments made upon websites 
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including NHS Choices, (NHS Choices, 2015a), and social media blogs, and 
personal experiences published on websites such as Emergence (Emergence, 
2016), and through twitter chat from patients discussing their experience of PD 
treatment. This informed how the research was shaped, as it suggested that 
relational aspects are also core to the personal interaction, rather than just the 
configuration of services.  
 
Difficulties raised in asking the question 
It was ethically important to be reflective and sensitive to the effects that simply 
asking the question had upon the researcher and other clinicians (Berger, 2015). 
People’s perceptions of their own practice, treatment decisions, and formulated 
decision-making, change through the process of enquiry, independently of whether 
any other outcomes are generated by the research. These impacts of “process” are 
fully congruent with the core tenets of AR. They will thus be commented upon 
throughout this thesis, to demonstrate reflection and the reflexive process.  
 
In asking the question about how treatment choices are made with PD patients, a 
degree of instability was witnessed with locality professionals and other decision-
makers, who started questioning their own actions. In response to this phenomenon, 
to attempt to stabilise clinicians and investigate what may help them, work was 
conducted with locality teams to develop a basic decision-making grid as a potential 
practice solution, discussed in Section Four. 
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Summary 
The focus of the research was identified after critical analysis of a training evaluation, 
contextualised through reflective information provided by clinicians in clinical 
supervision. The author’s curiosity about the subject, due to their previous research 
and clinical role, was influential in the study design. Exploration of published 
research, and clinician, supervisor, and patient experience, revealed some of their 
constructed realities and cultural narratives concerning the uncertainty of the 
Treatment Choice Encounter and treatment selection process. Literature review 
evidenced that this is an unexplored aspect of clinical practice warranting research 
exploration, whilst being ethically sensitive to the potential impact this may have in 
generating increased anxiety and uncertainty with more practice reflection and 
potentially practice changes.  
 
1.4 Research Question and Aims 
 
When all information is considered from Section 1.3, the current AR focus is to 
explore variables affecting consistent clinical decision-making concerning treatment 
choices for people with PD. The subject is approached from a CBT perspective, 
exploring how clinical decisions are made and articulated in practice. 
 
The study is presented, and thesis structured, using the 7 stages of an AR cycle 
(McNiff and Whitehead, 2006), presented in Figure 1. This demonstrates how the 
methodological approach answered the research question posed:  
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In AR, several subordinate iterations of a research cycle may underpin one problem. 
Within this thesis, three subordinate iterations are used to explore the focused issue: 
i) literature review, ii) grid development, and iii) field study. These three iterations 
enable the full AR study represented in Figure1 to be achieved. 
 
Research Question: How can mental health care staff use a pre-formulated guided 
decision process in the selection of therapeutic interventions for people with PD, 
within the context of rationalisation and service change?  
 
Purpose: To conduct an AR study in one NHS Mental Health Service site, using a 
newly developed ‘Treatment Choices Grid’ for patients, clinicians, and supervisors, 
then explore clinician's experiences of making treatment decisions using the grid.  
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Aims and Objectives:  
(1) To conduct a critical literature review, exploring variables and support 
strategies for the decision-making process for people with PD. 
(2) To use the newly developed heuristic: the ‘Treatment Choices Grid’, to focus 
practice exploration of the decision-making phenomena.  
(3) To use semi-structured interviews, analysed through an Interpretative 
Phenomenological Analysis (IPA) framework, to gain a better understanding 
of the difficulties clinicians face when making treatment choice decisions with 
PD patients, and identify support strategies that may assist the process.  
 
(4) To make practice recommendations considering the research results, which 
will then form the next AR practice cycle. 
 
Section One Summary 
When considering: ‘why this subject, and why now?’, the above section provides a 
rationale concerning the need to focus upon how clinicians are supported to make 
treatment decisions with PD patients.  
 
Waterman (1998) identifies three types of validity as essential when reflecting upon 
the purpose and outcomes of action research: dialectical validity, critical validity, and 
reflexive validity. The above section highlights how, in terms of ‘dialectical validity’, a 
disconnect exists between current practice evidence, and available research related 
to treatment choices. Considering ‘critical validity’, patient, clinician, and supervisor 
perspectives provide an insight into potentially emancipating elements of the 
research regarding improvement of patient and provider experiences, which require 
phenomenological exploration.  
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Lastly, in terms of ‘reflexive validity’, the author, as a researcher, clinician, and 
supervisor, has identified a need to approach the research considering the different 
perspectives, mindful of their own sense of personal agency. The next section 
focuses upon a literature review, providing an in-depth understanding of the current 
research concerning the research question. 
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Section 2: Literature Review  
 
Within the previous section, the research project has been introduced, defining the 
overall research question, aims, and objectives. An in-depth literature review is 
presented within this section, concerning treatment choices for people with PD. This 
section will concern subordinate AR cycle 1 (Figure 2), providing a critical analysis of 
current theory, using a hermeneutic approach to the concept of literature review.  
 
Figure 2: Subordinate Action Research Cycle 1: Literature Review within the study 
exploring treatment choices for people with Personality Disorder. 
  
 
 
Defining literature review parameters is challenging for two reasons: firstly, due to 
complex dynamics surrounding PD diagnosis, and secondly due to the vast amount 
of research conducted into variables influencing clinical decision-making.  
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To contextualise and focus the review, specific questions are asked of the literature 
sourced, and hermeneutic explorations were conducted, to critically analyse sources 
found, and link back to the overall research question.  
 
2.1: Theory review: Questions posed 
The scope of the literature will be specific to review questions posed, which link in to 
the overall research question: 
 
Literature Review Questions 
Q1. How is PD as a diagnostic construct interpreted? 
Q2. What guides clinical decision-making in mental health care regarding 
treatment for patients diagnosed with PD? 
Q3. Are there any clinical tools or heuristics to assist in decision-making 
concerning treatment options for a person presenting with PD? 
Q4. What helps or hinders clinician’s decision-making ability with PD patients? 
Q5. Are there any supervisory models which aid decision-making and practice 
reflection, when considering this patient group? 
Q6. Are there any research/sources detailing patient's experience of treatment 
selection regarding their PD? 
 
2.2: Scope of the literature 
Information was accepted from the following sources: research databases, 
primary/secondary research studies, books, professional narratives, and clinical 
opinions.  
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A literature search was conducted, using these electronic databases: 
PsycARTICLES, AMED, CINAHL, MEDLINE, PsycINFO. Search terms employed for 
the analysis are displayed in Figure 3: 
 
 
2.3: Inclusion/exclusion criteria: 
Clear parameters were set concerning inclusion and exclusion criteria for the 
literature review, aiding readers to understand potential bias, enabling repeatability 
should readers wish to check the review. Criteria set were: 
o Date inclusion: the date range was 2003-2015, as it captures data pertaining 
to the most recent treatment, from when ‘Not a diagnosis of exclusion’ (DoH, 
2003) was published. However, when searching the literature, other pertinent 
studies referenced were sourced and included. 
o No restrictions were set concerning country of publication, all pieces had to 
be in English. With non-UK sources, country of origin is specified, as 
although the results may apply to the population in focus, the context of the 
UK health agenda would make generalisability of non-UK studies 
questionable. 
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o The study generated both qualitative and quantitative research sources, also 
sources deriving from professional opinions. All of these were included in the 
review, due to the Constructivist approach taken.  
o Sources generated were limited to: mental health care and PD, as defined in 
the introduction.  
o Literature that primarily focused upon children was not included. 
o A search completion date was set for: 1/05/2015, as pertinent6 studies may 
be published after this time, and should this be the case, the literature review 
outcome could be altered.  
 
A summary of study characteristics is presented in Appendix1. For consistency in 
data analysis and exploration, the data extraction and review tool by Benton and 
Cormack (2004) was applied to all research sourced, enabling identification of 
potential strengths and weaknesses. 
 
In any literature review, there is a degree of subjectivity in the analysis performed 
(Bowling, 1997:389), however the above framework was used to minimise result 
variability if the analysis were repeated.  
 
2.4: Literature Review Method 
Hermeneutics is the theory of interpretation derived from the works of 
Schleiermacher, Heidegger, and Gadamer (Smith et al, 2009:54). The rationale for 
this choice of method is explained within Section three. 
 
6 The term ‘Pertinent’ refers to any studies that predate the stated range, but include information 
relevant to the research questions, specifically if they refer to making treatment choices with adults with 
a Personality Disorder.  
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2.5: Ethical Issues of the Literature Review 
This part of the study does not concern human participants, however certain ethical 
considerations must be adhered to in any literature review (Vergnes et al, 2010). The 
following ethical considerations were made:  
 
 The researcher’s philosophical approach to data interpretation is presented, 
allowing readers to understand any potential bias (Girden, 2001) – (See 
Section 3).  
 The researcher declares a personal bias connected with her role as a mental 
health nurse and psychotherapist. This bias is declared, as it will affect the 
literature reviewed and may influence the perception of treatment cited.  
 This study is not funded, therefore has no sponsorship implications.  
 Respecting the literature, analysing each source with a balanced critique so 
as not to skew findings (McLeod, 1998).  
 Searching a wide range of sources to answer questions posed, rather than a 
narrow range selected to adhere to the researcher's viewpoint (Barker, 1994). 
 All sources are accurately referenced, enabling repeatability (Lewis and 
Barnes, 1997)  
 No plagiarism (Scanlan, 2006). 
 Full results are presented (Welsh and Dickson, 2005). 
 
2.6: Study selection process 
A search was conducted, search findings were refined using the restriction criteria 
set. The refinement process is detailed in Figures 4&5: 
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Figure 4: Diagrammatic representation of the literature review search refinement 
within the study exploring treatment choices for people with Personality Disorder. 
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2.7: Study Demographics  
The appendices provide study demographics for research, including a table 
concerning journal sources (Appendix 2). This demonstrates that information was 
gained from a wide range of journals; the age range of the literature (Appendix 3); 
country of origin (Appendix 4); and PD type focused upon by the paper (Appendix 5). 
These appendices will be referred to from within the subsequent literature review 
discussion. 
 
2.8: Literature Review Findings 
The literature review findings are presented using the six questions posed in Section 
2.1. Q1 commences by providing a historical overview related to the diagnostic 
construct itself, identifying moral, social, cultural, and legal factors that influenced the 
definition of the disorder itself, and impacted upon the notion of treatability. 
 
Q1: How is PD as a diagnostic construct treated? 
 
History & Diagnostic Categorisation 
The psychiatric construct of having a disordered personality as a part of mental 
health problems dates back thousands of years, with 3,000 year-old records 
describing symptomatology (Antoniadis et al, 2012). The two current main diagnostic 
coding systems used are DSM and ICD (Reed, 2010), the ICD criteria being the 
main criteria used in the UK, however the DSM is also used in some areas. The 
diagnostic systems differ slightly, the DSM has 10 subcategories of PD, the ICD has 
8, (Appendix 7). 
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The diagnostic conceptualisation and categorisation of PD in relation to other mental 
health disorders differs slightly between ICD and DSM. Since the 3rd DSM in 1980, 
PD is placed on a separate axis from other mental health problems, due to the 
disorder's course and likelihood of comorbidity (Krueger et al, 2010), whilst the ICD-
10 retains PD in the main rubric of mental disorder categorisation (Moran, 2007).   
 
ICD-10 and DSM PD classifications are currently debated due to conceptual 
complexity, with proposals that a hybridized, multi-dimensional model may be more 
suitable for PD categorisation. The introduction of DSM-5 (APA, 2013) has changed 
PD conceptualisation, but recommended further research. PD classification changes 
are likely to be expanded further in ICD-11, which will impact on UK treatment 
choices, and the overall research question posed concerning formulated treatment 
choice. 
 
The new DSM-5 conceptualisation provides two specific PD criteria: impairment of 
personality functioning (i.e. interpersonal functioning and identity), and one or more 
pathological personality traits (i.e. detachment and empathy). This model proposes 
that personality pathology cannot be defined by trait elevation alone. This important 
differentiation should reduce the number of people meeting PD diagnostic criteria, 
however people previously diagnosed may no longer meet criteria.  
 
Theories concerning PD aetiology appear to remain stable, however amorphous and 
changing diagnostic definitions are intrinsically linked with difficulties diagnosing PD, 
resulting in devalued validity of PD diagnosis itself, discussed in the next section. 
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Major Mental Illness or Not?  
Although the defining characteristics of PD as a concept are still debated (reflected 
above), what is no longer debatable is that PD is now one of the most recognised 
mental disorders. The inclusion of PD as a major and enduring mental illness has 
changed the focus of the research conducted, and also the notion of its ‘treatability’. 
Most studies that focus upon generic ‘major mental illness’ therefore include PD, 
however some researchers still exclude people with PD (i.e. Martin et al 2012). In 
terms of answering Q1, the author proposes that it is conceptually important as, if 
there is a right to provide a diagnostic label, there is a corresponding responsibility to 
treat. This research focuses upon the full range of PD diagnosis. 
 
Pickersgill (2012) suggests that PD diagnostic labels are particularly controversial 
when associated with criminal or antisocial behaviour, posing a medical, political, 
and public concern, specifically focused upon constructs of Antisocial PD (APD) or 
Psychopathy. Categorising this particular set of traits is ethically debated in terms of 
treatability (Eastman et al, 2006). As a consequence, there have been alterations in 
mental health law, prompting policy changes and reformulated care provision for 
people with PD (Pilgrim, 2007). All of these factors influence PD treatment choice.  
 
Despite the multiple PD categories, two specific PD categories have received a 
specific focus by researchers and policy makers. These are Borderline Personality 
Disorder (BPD) and Antisocial PD (APD). This focus has led to increasing service 
recognition of these categories; however other categories which arguably may 
require more treatment resources (i.e. Dependant Personality Disorder) do not 
currently have treatment guidelines (Bornstein, 2005). This polarised research focus 
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is reflected by the literature sourced in this review, which primarily concentrated on 
APD or BPD, or referenced PD as a generic category, without specifying the PD 
type. The more significant association with risk to self and/or others, requiring mental 
health service intervention, appears to be one of the main reasons that PD 
guidance/legislation is particularly focused on BPD and APD (Budge et al, 2012).  
 
How do diagnostic labels influence attitudes and treatment decisions? 
It can be argued that mental health diagnosis are socially constructed, meaning that 
social and cultural opinions on what is normal and abnormal are core to 
conceptualisation of PD. Descriptions of  disorder can take one of two forms, i) the 
prototype view, meaning mental representation of a concept is gained by a list of 
defining and separating features (i.e. ICD-10 criteria), or ii) through taxonomies, 
which often consist of hierarchically-connected structures (i.e. the multi-axial system 
used by the DSM) (South et al, 2013). 
 
There are strengths and limitations to either type of description and organisation, 
central to Q1.  One difficulty with the prototypal view of PD conceptualisation, like 
other mental health problems including anxiety, is that symptoms are subjectively 
rated and 'norm-governed' (i.e. what is impulse control?), and therefore influenced by 
factors other than diagnostic symptoms, including emotionally-laden factors 
connected with race, gender, and socio-economic status, which influence clinician 
decision-making.   
 
Several examples of this difficulty were found in the literature review. For brevity, just 
the topic of gender will be provided as an example: when considering PD, some 
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research states gender stereotypes significantly impact upon diagnosis (Jørgensen 
et al 2009). BPD is diagnosed more in females than males, debated in the literature 
concerning whether it is a gender-specific ‘illness’, or whether there is gender bias 
due to societal expectations and cultural ‘norms’ (Grant et al, 2008). Additional 
research found that in violent criminals, PD is diagnosed more in women than men, 
because violence is contrary to female stereotypes (Liebman et al, 2013). Research 
also suggests specific cultural ‘norms’ governing the provision of a diagnosis, 
specific to western societies (Leichsenring et al, 2011; Nysæter et al, 2008). 
 
Considering the taxonomic conceptualisation of PD used in DSM, one strength is 
that diagnosis is not seen as merely a list of symptoms (as with prototypal 
categorisations), instead it is accepted that PD patients may present differently 
dependent upon issues in the other axis (i.e. homelessness, or IQ level). This is 
important when formulating, as research links allocation of diagnosis with value-
laden treatment decisions, with clinicians categorising or clustering symptoms, 
including: “things I refer out”, “diagnosis I like or dislike” and “things I treat” (Flanagan 
et al, 2007).   
 
Whether prototype or taxonomical categorisations are used, criticisms concern the 
categorical approach to PD. Moray et al (2014) state that criticism surrounds: 
heterogeneity of symptoms; temporal instability of PD diagnosis, and complications 
raised by co-occurrence of PD, suggesting: “arbitrary diagnostic thresholds in 
polythetic criterion sets, with little or no empirical basis”.  Categorisation is important 
when considering treatment choice, and other diagnostic models were considered in 
the debate (i.e. Personality Trait model, Krueger et al 2010; Five-Factor Model, 
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Piedmont et al, 2009). The APA rejected proposals for model change in PD 
conceptualisation, however placed suggestions in DSM-5 Section 3, as “constructs 
requiring further study”.  
 
Ongoing research debates (Rottman et al, 2009; Widiger et al, 2011; Mullins-Sweatt 
et al 2012) parallel the research locality clinical practice debates defined in Section 
1. Various research tools are defined as useful when diagnosing PD (i.e. SCID-5-PD, 
First et al, 2016), however due to the ongoing changes proposed in terms of 
diagnostic construction, this results in a lack of a single validated test for PD. In 
practice, PD diagnostic testing remains subjective, meaning that, dependent upon 
whether traits are recognised, or a full diagnosis is provided, this affects the person’s 
right to access a particular treatment. This matter is core to the overall research 
question, and is expanded upon in the following section. 
 
Diagnosis or traits 
A point identified through literature reviewed affecting PD conceptualisation, is linked 
with notions of diagnostic and treatment thresholds, underpinned by concepts of; 
disease, dysfunction, and disability. Clark and Ro (2014) explain that it is 
conceptually important that ‘functioning’ and ‘traits’ are distinguished, as a person 
may have ‘extreme traits’, but this may not necessarily be pathological. This 
represents an empirical challenge to clinicians selecting treatments, because the 
constructs conceptually interact and overlap. They additionally introduce a further 
debate concerning whether, for a PD diagnosis, it merely requires symptoms to be 
present, or whether these must be accompanied by a degree of disability or distress, 
to warrant treatment?  
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The question of assessing levels of distress and disability is complex. The ICD-10 
distinguishes “disease” from disability, considering disability as a consequence of 
disease. This influences clinical decision-making, meaning that disability does not 
influence the diagnosis of the disease itself, which is solely based on dysfunction. 
 
When considering Q1, PD diagnoses are considered differently from other diagnosis, 
for example physical health problems. Physical health diagnoses have clearer 
distinctions between intrinsic factors of the disorder, and extrinsic consequences of 
the disability (i.e. arthritis is not defined by restriction of movement, that is a 
consequence that affects treatment). This is therefore a contentious difference 
between mental and physical health problem conceptualisation and treatment 
allocation, considering whether psycho-social impairment should be included as part 
of the PD diagnosis, or as a consequence of PD. DSM-5 does not include the clinical 
significance criterion, prompting the opportunity and challenge of separating and 
measuring levels of functioning and disability. 
 
Personality Development 
European and USA epidemiological studies estimate that the prevalence of PD is 
between 4%-13% of the adult population (Coid, 2006; Lenzenweger, 2008; Samuels, 
2011). PD aetiology is closely connected to unstable attachment patterns in 
childhood (Eagle, 2006), and most commonly linked to trauma and/or abuse 
(Kanninen, 2003). Chaikin et al (2004) explain that early life abuse of any kind 
predisposes a person to physical health problems, other mental health problems, 
financial and occupational problems, and impaired interpersonal functioning (Chard, 
2005; Owen, 2011).  
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Kruger et al (2010) explain that a personality profile of any person may find traits of 
dysfunction, the debate surrounds the degree of intensity and number of facets that 
would warrant a diagnostic pathology. This is particularly important when considering 
the research question as, when assessing a distressed person (i.e. one who has 
recently experienced trauma), or a person with diagnostic comorbidity (i.e. severe 
depression), symptom assessment may be skewed by transient difficulties the 
person experiences, potentially exacerbating underlying traits.  
 
When considering the research focus, the research in this section is influential, as it 
is not the diagnostic traits that are most important regarding treatment choice for a 
PD patient, but contextual variables which may adjust the presentation of these 
traits; this is often termed the “big picture” of personality variation (Clark, 2007), 
which is significant when considering treatment formulation.  
 
This “big picture” focus means that two people with PD could have few overlapping 
personality features, providing diagnostic heterogeneity, posing conceptual 
conundrums, obviated by use of multidimensional models of personality. Practically, 
this would mean that diagnosis would not be defined by potentially dichotomous 
variables (i.e. above/below diagnostic thresholds), instead assessed in multiple 
dimensions, related to trait extremities rather than traits themselves. Difficulties 
include the notion of objectivity, when not only symptom-nature is clinician rated, but 
also degree and/or severity, which cannot be adjudicated with value-free objective 
judgements. It is a matter of societal and professional opinion whether the diagnosis 
is made, and in terms of the nature of the presentation, whether a treatment is 
provided.  
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Certain clinicians suggest that “Global Assessment of Functioning” from Axis-V of 
the DSM be used to justify clinical judgements regarding diagnostic and treatment 
thresholds (Mullins-Sweatt et al 2012), linking back to the point about whether 
‘disability’ or ‘distress’ must be present alongside the PD symptoms criteria, in order 
for the diagnosis to be recognised and treated. DSM-5 preparations debated the 
need for a “paradigm-shift” in relation to PD, however this debate was not concluded, 
but there is opportunity to now empirically research this, to influence future 
diagnostic changes, which will influence treatment choice (Skodol et al, 2013). 
 
Semantics, Linguistics, and Negative Perceptions  
Patients with PD have long been researched as eliciting more negative emotional 
responses (i.e. disdain, frustration) than other mental health disorders (Markham et 
al, 2003). This negative perception is changing, with the improvements in 
symptomatic prognosis being increasingly recognised (Zanarini et al, 2003) and the 
gradual shift in terminology associated with PD to focus upon ‘trauma related 
difficulties’, improving hope (Smith et al, 2016).  
 
Stigma is highly linked with terminology/language and is particularly important when 
considering PD conceptual construction. There are many different terms used in the 
literature when referring to PD, which are important to explore, to understand the 
conceptual context of the disorder, including exploration about which behaviours 
attract different responses concerning treatment, core to this research.  
 
One example concerns Bowers (2003a), who identifies social "boundaries" (deriving 
from ‘respect’) that a “normal” person (one without a PD) would not cross, or if they 
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did, would evoke guilt. Bowers (2003a) represents the PD patient as a Machiavellian 
schemer (Machiavelli and Bull, 2003:64), echoed in other papers which use the term 
'psychopathy', and explores a particular set of traits or symptoms within the PD 
spectrum. Other key words from seminal texts used to describe PD are: “general 
unreliability and untrustworthiness” (Cleckley, 1982:338), “ingenious 
misrepresentations”,  “apparent repentance in order to escape consequences” (Hare, 
1991:27), these types of viewpoints affect treatment choices.  
 
The stigma associated with PD was recognised in the UK approximately 10-15 years 
ago, and had significant implication upon its conceptualisation in healthcare, the 
criminal justice system, and wider society. Arguably, the two main shifts were: the 
introduction of “Not a Diagnosis of Exclusion” (DoH, 2003), and the shift in health 
policy with the introduction of the concept of ‘Dangerous and Severe Personality 
Disorder’ (DSPD) (Straw, 1999). DSPD patients are defined as severely PD, from 
whom the public must be protected, emphasising that although these patients only 
represent a small proportion of people with PD diagnosis, the label influences the 
way that generic PD is conceptually perceived, due to notions of ‘collective identity’ 
(Frick et al, 2014). 
 
DSPD as a concept appeared from Whitehall, rather than a medical diagnostic 
manual (Pickersgill, 2012). It altered the notion of state responsibility, risk regulation, 
and ‘treatability’, advancing certain recommendations from the Fallon Report related 
to PD treatment (Bartlett, 2003); and was revisited after the Bradley Report 
(Ruszczynski, 2010). In terms of indeterminate confinement and specified treatment 
in the UK, units were built either in special hospitals or prison hospitals, where 
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people with DSPD could receive treatment (DoH, 1999), the UK was not alone in this 
approach (de Boer et al, 2008).  
 
This movement not only affected the image of PD, but also provoked mixed 
responses from mental health professionals concerning ‘treatability’ of PD, prompting 
a review of the Mental Health Act (MHA) (DoH, 1983&2007) (Glover-Thomas,2006). 
The ‘treatability’ test in the MHA was reviewed and revised to an ‘appropriate 
treatment test’, which impacts upon treatment decisions made by clinicians. 
Positively, this shift prompted research into pharmacological and psychotherapeutic 
treatments for people with PD (Wilson et al, 2014). Specific studies found that: 
psychotherapeutic techniques evidenced for BPD may not be transferable to other 
parts of the PD spectrum (Crawford, 2007), and that insight and acceptance of the 
diagnosis has a significant part to play in regards to whether treatment is accepted 
(Bartlett, 2003). However, no research currently identifies how clinicians can be 
supported with treatment decisions. 
 
Levels of ‘dangerousness’ and ‘risk management’ obligations  
Associated with treatability, research also provided a heightened focus upon levels 
of ‘dangerousness’ posed by people with PD (DoH, 2000a&b, 2004a&b, 2006a&b), 
which affects treatment and risk management decisions. Stigma and antipathy 
associated with PD diagnosis affects both professional and social opinions (NIMHE 
2003a&b). This links back to the notion of treatability, suggestions made by the MHA 
review emphasised the necessity to ‘remove obstacles to practitioners’, and 
challenge the false presumption that PD or certain PD diagnosis are ‘untreatable’ 
(DoH, 2006b).  
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Despite this recommendation, levels of disapproval still remain about the revisions 
made to law and policy (Prins, 2007). The USA followed UK PD treatment 
guidelines, but there is still bias in the way that PD is responded to. One example, 
sourced from research, showed a higher likelihood of defendants being found “Not 
Guilty by Reason of Insanity” with a diagnosis of psychosis, compared with a 
diagnosis of PD (Neal et al, 2014), meaning that there is no consistent global legal 
definition of PD, this affects public perceptions and approaches in healthcare 
settings.  
 
The literature links the issue of risk back to the stigmatised terminology associated 
with PD. The most commonly associated term with PD in the literature is 
‘psychopathy’, as a symptom, a disorder, and also used interchangeably with the 
term PD in some literature. This association affects conceptualisation of PD.  
 
The term ‘psychopath’ is considered a derogatory term used in popular culture and 
fiction, typically associated with displays of egocentricity, deceitfulness, and 
externalisation of blame (Donahue et al, 2004). Eden (2006) emphasises that “few 
disorders elicit such a visceral reaction” from health professionals as psychopathy. 
He suggests influences for this are the connections of ‘psychopathy’ and PD with 
high-profile criminals, including Ted Bundy, Charles Manson, and Charles Bronson, 
linking this to negative public opinion and perceptions of ‘untreatability’. A Google 
search was conducted using the term ‘psychopath’, Figure 6 shows the 3 images 
identified, emphasising that stigma is still present: 
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Figure 6 - images gained using the search term ‘Psychopath’ (date: 10.1.14). 
Image removed for copyright 
reasons 
Image removed for copyright 
reasons 
Image removed for copyright 
reasons 
Character: Jack Torrance 
Reference:The Shining (1980) 
Directed by Stanley Kubrick 
[Film]. USA: Warner Brothers. 
 
Character: Patrick Bateman 
Reference: American Psycho (2000) 
Directed by Mary Harron [Film] 
USA: Lions Gate Films. 
Character: Hannibal Lecter 
Reference: Silence of the Lambs 
(1991) Directed by Jonathan Demme 
[Film]. USA: Orion Pictures 
Corporation. 
 
Cleckley (1964:14), differentiated psychopathy from PD, stating that psychopathy is 
not merely a ‘PD’, but a “constructed dissimulation of a personality”. Evans (2011) 
suggests that one reason why professionals and others are repelled by APD patients 
is because APD is interchangeably used with ‘psychopathy’, and due to the often 
callous things that patients do. He explained that APD patients have a typical history 
of abuse, meaning that they adopt a position of defensiveness to protect themselves: 
“idealisation of the self as predator, and a denigration of the other as prey”. The 
stigma associated with APD affects the whole concept of PD. 
 
The ‘challenging’/‘difficult’ patient 
The concept of “difficult patient” in UK literature is repeatedly applied to people with a 
PD (Friedman, 2008). In the literature, it is a theme raised in in-patient, community, 
and A&E settings. The “difficulty” is often associated with behaviours associated with 
PD diagnosis, such as self-harm, drug/alcohol misuse, and threatening behaviour 
(Bland et al 2007; Westwood et al 2010; Woollaston and Hixenbaugh 2008).  
 
The label of “difficult patient” is problematic for patients, staff, and organisations; it 
affects judgements concerning treatment allocation and the relational encounter. 
Research demonstrates that both mental and physical health providers feel ill-
equipped to effectively treat or assess PD individuals (Kopala-Sibley et al, 2012). 
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This occasionally prompts unsympathetic attitudes (Lequesne, 2004), and a default 
to stereotypical labels concerning lack of treatability and dangerousness, which can 
then warrant denial of treatment (Schulze, 2007), or minimisation of threats (i.e. self-
harm), which then poses risks to patient safety (James et al, 2007). Higher stress 
and burnout is also evident in staff working long-term with these patients (Bowers, 
2002). 
 
Stigma and treatability 
‘Personality Disorder: no longer a diagnosis of exclusion' was introduced to highlight 
stigma and focus treatment (DoH, 2003). However, Duggan et al (2007) describe 
how boundary issues in mainstream services (i.e.: rules applied to intoxication) make 
PD engagement for treatment difficult, and prompt certain reasons for exclusion 
related to behaviours that may be associated with PD, rather than the diagnosis of 
PD itself.  
 
These rules in themselves are understandable considering safety, but when 
considering certain symptoms of PD (i.e.: affect instability, boundary management 
issues, (Kopala-Sibley et al, 2012)), the question must be posed that: does including 
PD treatment within mainstream services still result in excluding them, due to the 
service parameters in place?  
 
Magnavita et al, (2003) emphasise a significant need for public and professional 
education regarding PD, to reduce stigma when accessing health and social care 
treatment, as despite receiving a diagnosis, most patients worldwide will receive no 
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treatment (Reed,2011). It is estimated that dependent upon the disorder, the gap 
between diagnosis and treatment is between 32%-78% (Kohn et al, 2004). 
 
In the UK, two treatment guidelines are published by the National Institute for Health 
and Care Excellence (NICE) concerning PD: BPD and APD (NICE,2009a&b). No 
other guidance is published for any of the 6 other PD diagnostic categories 
recognised in the ICD-10. UK treatment for PD is via three treatments: supportive 
talking treatments, social support, and medication for comorbid mental health 
problems, with targeted specific forms of these interventions, dependent upon PD-
type (i.e. DBT for BPD). There is also guidance regarding hospitalisation as a 
treatment for PD.  
 
The current NICE Guidance for PD is considered as limited by the researcher, not 
only due to its focus upon two subcategories rather than the whole range of 
Personality Disorder, but also due to its lack of focus upon guiding how decisions are 
made for treatment.   
 
Recent UK mental health care reform 
The shift of many health thresholds changed following current UK austerity 
measures. Rather than PD-specific, this issue now concerns how society views 
illness generally. The NHS has undergone radical transformation since the early 
1990’s, certain papers suggest that the way reforms have been translated and 
implemented may have compromised core NHS principles of universality, public 
accountability, solidarity, and comprehensiveness (Mandelstram, 2007). Chiesa 
(2008) suggests that the changes are fundamentally introducing a business mentality 
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within the NHS, resulting in a publically owned system being replaced by a 
healthcare marketplace, with legal contracts and external regulation replacing public 
accountability.  
 
The impact of this in terms of treatment provision and conceptualisation of illnesses 
such as PD, is that there are often differences in opinion between commissioner, 
provider, and patient, regarding ‘best treatment’, and whether resources are 
commissioned at different thresholds, connected with the diagnostic debates 
discussed.  
 
Due to austerity measures, increased demand, and lengthy waiting times, threshold 
changes concerning treatment provision for PD were introduced. Clarke et al (2013), 
identify this as a problem for patients, as their receptiveness and preparedness for 
treatment may change within the timescales that they have to wait, which in some 
cases can be several years. 
 
Q1 Conclusion 
The discussion outlined in Q1 demonstrates that the concept of PD is dynamic and 
complex, with changing diagnostic and legal criteria. PD is a collective description of 
phenomena with subordinate diagnostic categories that vary significantly in their 
individual presentations, complicating both assessment and treatment choice, when 
considering the overall research question:  
 
How can mental health care staff use a pre formulated guided decision 
process in the selection of  therapeutic interventions for people with PD, within 
the context of rationalisation and service change?  
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Risk behaviours associated with certain PDs attract stigma which affects the 
Treatment Choice Encounter and subsequent treatment decisions, as risks posed 
are often generalised over the whole PD spectrum. The answer to Q1 provides a 
context to anchor debates concerning assessment and clinical decision-making, 
these debates are funnelled and explored further in Q2 when specifically exploring 
treatment choice.    
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Q2: What guides clinical decision-making in mental health care regarding 
treatment for PD patients? 
 
Social and cultural themes raised in Q1 concerning development of PD diagnostic 
constructs link to notions and obligations to make decisions about treatability for 
patients.  
 
Clinical Decision-Making 
Clinical decision-making in healthcare is well-researched. For Q2, reference is made 
to certain clinical decision-making strategies; however this will not be the sole focus. 
Instead, a micro-focus concerns what guides clinical decision-making in relation to 
treatment for PD patients, linked to the Research Question. 
 
The literature search did not generate a specific model or framework for decision-
making for treatment with PD patients, however multiple themes were identified 
regarding the decision-making process, and dynamics that influence this. Themes 
are explored under three headings: evidence bases for decision-making, risk factors, 
and factors pertaining to the therapeutic relationship: 
 
 
Evidence for decision-making: does research and policy guide decision-
making? 
 
Research typically guides treatment selection in healthcare. There are treatments 
suggested for certain PD types (NICE, 2009a&b), however there is a paucity of 
decision-making frameworks for these.   
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One difficulty concerns the underpinning research-base regarding talking treatments, 
where there is a lack of ‘clinically syntonic’ studies involving tasks intrinsically linked 
to clinical practice (Castonguay, 2013). Constantino et al (2012), suggest that 
despite research exploring common/pantheoretical treatments, factors such as 
patient's treatment expectations have more influence upon efficacy of the treatment 
than the model used. This type of research implies that decision-making for 
treatment is complex, as it must consider treatment, patient variables, and 
therapeutic relationships.  
 
Cukrowicz et al (2005) suggest that the heterogeneous symptom profiles PD patients 
may present with means treatment choice varies dependent upon the person's 
individual characteristics, implying that you can have a standard model, but internal 
variables need adjusting to the idiosyncratic need. This study additionally reinforces 
the need to treat patients in a timely manner, otherwise they are highly likely to 
discontinue interventions if they do not perceive immediate gains, due to their 
difficulties regarding toleration of frustration and maintaining motivation.  
 
Changeable Idiosyncratic Symptoms 
Another difficulty is anchored to the varied symptoms PD patients present with, 
meaning that it is difficult to have a ‘one size fits all’ approach (Ebner-Priemer et al, 
2009). Smith (2009:56) suggests that interacting relational and bio-psychosocial 
factors presented by a person with PD complicates treatment selection for them, 
introducing the question concerning: ‘what requires treatment?’, and recommends 
use of a rhetorical/hermeneutic model for PD, which considers the complexity of a 
person’s presentation, and what constitutes ‘normal’ for them. This is contextually 
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important, as many people live with symptoms of disorders without accessing 
treatment. This adds another dimension to the question of treatment choice: if the 
aim is not cure, then what is “good enough”?  
 
Polarised evidence-base 
Another issue raised by the review is that despite the range of PD diagnosis, 
research tends to be polarised, mainly focusing upon BPD and APD (Crawford, 
2007; Krueger et al, 2010). What is useful for a person with APD may be unhelpful 
for a person with Avoidant PD. This is not a new challenge for mental disorder policy, 
it was evident in the development of research into Anxiety Disorders, meaning that 
there is one policy guiding practice, with 6 subcategories for the separate anxiety 
disorders (NICE, 2014a). The author of this thesis suggests that future PD treatment 
policy take a similar approach; one PD framework, with 8 treatment strands for the 
separate PD diagnosis.  
 
Clinician factors 
Much of the literature discussed clinical factors when assessing and treating people 
with PD. Flores et al (2014) explored how clinicians make treatment decisions, 
finding that they do so by recognition of symptomatology, matching this to the range 
of treatments provided. This appears a simple process, however they found that 
different treatment decisions are made dependent upon different factors, (i.e. the 
stress in the therapeutic encounter, the clinician's experience and knowledge-base, 
and the range of available treatments and waiting lists), rather than necessarily all of 
the treatments that national policy recommend.  
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Although generic research for clinical decision-making will not be fully explored due 
to the focus of the research question, certain related concepts are discussed in brief: 
reliance upon representational heuristics in diagnostic treatment decisions (Maj, 
2011; Westen, 2012), and reliance upon prototypical theory based on causative 
factors (outlined in Q1). 
 
PD treatment decisions are complex (Magnavita et al, 2010), requiring specialist 
knowledge, rather than the ability to fit a person into the available treatments. 
Magnavita highlights the current dearth of empirical evidence upon which clinicians 
can base clinical decisions about PD treatment, further complicated with the vast 
range of recommended treatment options, all having different implications for both 
patient and provider (Stone, 2009).  
 
A final point regarding evidence-based psychotherapeutic interventions concerns the 
notion of what the research describes as the ‘Dodo Bird verdict’ (Luborsky et al, 
2002). It refers to Lewis Carroll's 'Alice's Adventures in Wonderland' character, and 
suggests that all PD-focused psychotherapies have a similar efficacy, “no matter 
what model or theoretical stance they are derived from”, implying that they all have a 
similar outcome for the patient (Beutler et al, 2012).This supports the need for further 
research, but suggests a requirement to target patient and clinician variables, rather 
than the treatment modality itself. 
 
The notion of ‘Scientist-Practitioner’ 
The notion of ‘scientist-practitioner’ underpins the formulated approaches to PD 
patient treatment, as patient needs are not clearly covered by a single health/social 
policy. Scientist-practitioners use their knowledge of different policy guidance, 
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research, local resources, and patient factors, to make treatment decisions. The 
challenge for clinicians is to warrant how they discriminate between available options 
(Castonguay, 2013). 
 
Krueger et al (2010) explain that it is the “inconvenient truth” that many PD patients 
do not precisely compare with subjects in PD research, explaining that in the 
zeitgeist of Evidence-Based Practice (EBP) this is problematic to the “scientist-
practitioner”. Dozois (2013) explained that the DSM-5 review triggered an impetus 
for diagnostic guidance to focus upon the widening scientist-practitioner gap. They 
explained that there are opportunities and barriers when considering empirically 
supported treatments, firstly to question what constitutes best ‘evidence’, and 
secondly, highlighting that, at times, clinicians do not offer EBP due to the opinions 
they hold about the evidence (Hunsley, 2007; Kazdin, 2008; Shafran et al, 2009), or 
attitudes towards EBP concepts (Baker et al, 2008).  
 
One argument against EBP is that it detracts from individualised case formulation 
(ideographic), which is advocated for PD (NICE, 2009a&b), leaning towards group 
approaches of treatment (nomethetic). This type of research approach and evidence-
based prescribed intervention is typically an approach used for medication trials.  
 
What this means in practice is that the scientist-practitioner can always identify some 
elements of a patient presentation that may/may not respond to a certain treatment 
(i.e.: psychotherapy and, or medication). It is ultimately the clinician’s choice, why 
they either offer or withhold a certain treatment.  
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The question of who is assessing for treatment? 
Flores et al (2014) found that individual clinician decision-making is often anchored 
in personal and professional experience of what works for ‘this type of person in 
practice’. This means that the same patient presenting to two different clinicians may 
receive different treatments dependent upon the clinician's intuition, reliant on the 
clinician's personal cognitive heuristic, rather than necessarily the patient's individual 
needs or evidence-base. 
 
Local mental health team configuration comprises of nurses, doctors, occupational 
therapists, psychotherapists, etc, any of whom may conduct Treatment Choice 
Encounters. These clinicians have different levels of qualification, and differing 
knowledge bases concerning the treatments NICE guidance proposes, therefore it is 
easy to understand where differences occur, potentially resulting in a lack of 
continuity for both patient and team regarding treatment provision.  
 
Magnavita et al (2010) emphasise the importance of an MDT when making treatment 
decisions pertaining to PD. She explains that single clinicians may become “stuck” 
with such complex disorders, specifically where a risk/benefit analysis is required, 
regarding whether to offer treatment.  
 
The literature not only details the assessor as a treatment choice variable, but 
highlights assessment time as an additional factor for consideration. Yates et al 
(2013) advocate extended assessment for PD patients, suggesting this improves 
treatment outcomes, as one encounter may not accurately represent the patient. 
This poses difficulties concerning cost and service configuration regarding ‘Payment 
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by Results’ (PbR) (DoH, 2011e), which suggests 1-2 assessments only, before 
transfer for treatment.  
 
The notion of ‘Expert Patient’ 
The notion of ‘expert patient’ is not new, and now high on UK health agendas, 
specifically concerning people with longer-term conditions, including PD (NHS 
Choices, 2015b). Castonguay (2013) explains that a difficulty in decision-making 
may be; what one patient may feel is effective, may not be when considering the 
research. Patient choice is a large factor concerning treatment efficacy in PD, 
however there are other factors: the perceived challenge of treatment, the degree of 
belief a person has in the treatment, and the ‘placebo-effect’ of purely being engaged 
with care services (Lambert, 2005).  
 
Cook (2004) researched problems concerning PD treatment choices, finding that 
clinicians may select treatment choices that are less anxiety-provoking for them and 
the patient, which may not be evidence-based. A challenge when analysing decision-
making is to understand whether there is no specific evidence-base for this patient's 
unique presentation, or whether their decision is based upon avoidance of 
distressing encounters. 
 
Goodman et al, (2014) suggest that clinicians must balance knowledge of treatments 
with the patient's perception of what may help them, to make collaborative decisions. 
Hershenberg et al (2012) expand, suggesting clinicians must overcome patient 
barriers connected to their previous health encounters, encouraging realistic 
treatment expectations and choices. This could be conducted via a formulated 
Student Number: 100104045 
45 
 
approach, attempting to understand the problem “as the patient sees it”, including 
attitudes, values, and preferences (Spring, 2007).  
 
Magidson et al (2012) suggest there may be narcissistic struggles in some PD 
encounters, manifesting in patients undervaluing clinician's knowledge and role 
(Dimaggio et al, 2006). In these situations, patients present as experts, only agreeing 
with clinicians who agree with their own perception of treatments (Kernberg,2009). 
This can cause difficulty if the patient's perception of problems/treatment conflicts 
with organisational provisions.  
 
Rofe (2010) suggests that PD patients are often preoccupied with circumstances or 
behaviours associated with current distress (i.e. relationship breakdown), rather than 
the triggers that caused them to have difficulty problem-solving. They then seek a 
‘quick-fix’, rather than develop longer-term coping strategies. Rose (2007) explains 
that this may be linked to impulse control issues, a core component of PD. 
 
A final issue raised in this section concerns patients mandated to attend for 
treatment (i.e. detained under the MHA). Difficulties are encountered, as patients 
have not necessarily chosen to access treatment, instead it has been imposed.  
 
Manchak et al (2014) explain that threats of incarceration (i.e.: in hospital or prison) 
can alter patient's engagement either positively or negatively, meaning they are 
either more likely to attend for treatment than those not mandated, or when 
attending, the person adopts treatment-interfering behaviours which ignore, attack, 
blame, or control clinician’s interpreting them, as another agent of control. The 
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treatment that can be offered for patients exhibiting problematic behaviours is 
limited, as most treatment evidenced for PD relies upon ‘informed consent’ from 
patients regarding participation (Norton et al, 2005; Rudd et al 2009).  
 
The notion of ‘prescribed’ treatments: which treatment, and why? 
Prescribed treatment may be compulsory (i.e. Court mandated), or link to treatments 
prescribed by a clinician. The notion of ‘prescribing’ treatments may conflict with a 
collaborative approach. This is further complicated, as PD patients tend to present 
with relatively polymorphous co-morbidity (i.e. PD patients simultaneously meeting 
criteria for several other mental health disorders) (Krueger et al, 2010). This poses 
questions for prescribing clinicians concerning what treatment is offered, for which 
disorder, and why?  
 
Levine et al (2006) discuss the complications of clinician autonomy and prescribed 
treatments, explaining that multi-professional debates can occur between 
psychiatrists and psychologists or psychotherapists, due to their different theoretical 
standpoints, raising a further question: whose right is it to prescribe a particular 
treatment?  
 
There is a simple answer for certain treatments (i.e. medications require legally 
registered prescribers), however it is not simple when considering 'prescription' of 
social support, or ‘talking-treatments’, where any team member may 'prescribe' these 
treatments, potentially conflicting with other team member's views.  
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A further dynamic concerns the cost of prescribed treatment. Cost varies 
considerably when considering different treatments (i.e. medication may cost pence 
per dose, however talking therapy could cost several hundred pounds per session). 
Conflict may additionally arise if patients express a wish to have a treatment that is 
not provided due to high cost. Multiple recent media healthcare controversies 
concern access to high-cost treatments, (Osley, 2014), and ‘postcode-lotteries’ 
(Chiesa, 2008), which impact upon treatment provision in times of austerity. 
 
This issue is not new: Paul (1969:44) asked the question: “What treatment, by 
whom, is most effective for this individual with that specific problem, under which 
sets of circumstances, and how does this come about?”, but research supporting 
clinicians is sparse. Nelson-Gray (2003) suggests that understanding how clinicians 
process and interpret assessment data to inform clinical judgements remains one of 
the least-researched topics in psychiatry and psychotherapy. This is one of the core 
rationales for conducting this study.  
 
Stiles et al (2008) suggests an added factor concerning: ‘dose and effect’, which 
explores the intensity of input, and the potential longevity of treatment. As described 
above, this can be a problem with PD patients, who may perceive that treatment 
needs to continue when they get to the point of discharge, due to childhood 
attachment difficulties, linking back to notions of what is ‘enough’ and in whose 
perspective: the patient, clinician, or organisation.  
 
Risk factors  
Risk assessment and management factors are central to PD treatment regimes, 
therefore when considering treatment choices, risk management must be a core 
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feature. The potential for the person to cause harm to others was discussed in Q1, 
therefore will not be repeated here. However, concerns surround the potential for PD 
treatments to cause patient harm, which affects decision-making regarding 
treatment. 
 
Castonguay et al (2010) suggest that psychotherapy can be harmful to certain PD 
patients, detailing that if “therapists are honest”, they will admit that they have 
potentially harmed certain patients. The harm referenced is: the patient not making 
progress in treatment, or mentally declining due to the process of treatment 
(Shimokawa et al, 2010). There is a sparse amount of research in this area, as 
authors suggest that clinicians are not always as reflective as they may be, related to 
professional ethical guidance, whose first principle is ‘to do no harm’ (NMC, 2015; 
BABCP, 2010).  
 
Castonguay et al (2010) suggest that it may not be the psychotherapy itself that 
causes harm, but lack of skill in some 'therapists', or lack of engagement in some 
patients. Adversely, research also suggests that denial of psychotherapeutic 
intervention may equally cause iatrogenic harm to patients with PD and related 
conditions (Brand et al, 2014). Assessing clinicians must have knowledge of all 
potential costs and benefits of treatment sessions. 
 
This raises a further difficulty, concerning who makes treatment decisions, and are 
they informed on all factors influencing a person’s ability to engage in talking 
treatments. Within the research, various formulation structures are presented 
(Goodman et al, 2014; Clarkin et al, 2006:139; Bateman et al, 2004; Young et al, 
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2003), but no specific PD formulation model prompting specific treatment selection is 
identified. The model sources are tools used in psychotherapeutic treatment, rather 
than something prompting selection of psychotherapeutic treatment over, for 
example: medication.  
 
Heilbron et al (2010) identify the paucity of research concerning how clinicians make 
decisions, specifically relating to whether or not to allocate a talking treatment. 
Dimidjian et al (2010) propose five complications concerning risk and the notion of 
treatment choice: (1) treatment may have harmful and beneficial effects, (2) there 
may be different perspectives on treatment outcome, (3) the nature of PD patient's 
presentation may change, (4) a treatment can be universally harmful in its effects, 
dependent upon the person's co-morbid characteristics, (5) a treatment may have 
harmful side-effects.   
 
With many therapeutic strategies, people often have to either face past trauma or 
address distress, potentially causing discomfort for the patient; this will subside and 
is an unfortunate side-effect of certain treatments (i.e.: CBT for PTSD). However, the 
risk that a person may disengage, as they feel the treatment is temporarily harmful 
for them, is higher in PD patients (Pascual-Leone, 2009). 
 
The therapeutic relationship 
Factors connected to therapeutic relationships were one of the most highlighted 
areas found within the review concerning treatment decision-making processes. This 
is linked to a core PD symptom concerning relationship difficulties (Kopala-Sibley et 
al, 2012). Patient and clinician variables are focused upon more intensely in Q3 & 6, 
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however in the remainder of this section, an overview of specific relationship 
variables is presented:  
 
Clinician’s authenticity 
Chatziandreou, Tsani, Lamnidis et al (2005) suggest that authenticity is the skill that 
a clinician has, to interact and understand the patient as a unique person, whilst 
creating an environment fostering support and encouraging progress. They list 
authenticity as the most important factor in engaging PD patients, over any particular 
therapy model or technique. Clarke et al (2013) emphasise that this is connected to 
the clinician's honesty and realism within Treatment Choice Encounters.  
 
Clinician’s explanation/formulation of difficulties 
Formulating therapeutic treatment decisions is researched as complex, and linked to 
the clinician delivering the session (Lane and Corrie, 2012:128). This may be 
because certain clinicians are trained in different formulation techniques; i.e. medical 
formulation is not typically as collaborative as psychotherapy/psychology 
formulations.  
 
Within the research reviewed, information concerning formulated approaches is 
confined to psychology/psychotherapy literature. This is an important practice 
consideration, as initial consultations are conducted by a range of different 
professionals, rarely a psychologist or psychiatrist. Hunsley et al (2005) explain a 
formulated approach to difficulties aids integration of the patient’s perspective with 
the clinician’s perspective, emphasising that PD patients specifically benefit from 
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either written or visual formulation structures, as they are often unable to fully recall 
what was discussed in-session.  
 
Müller (2011) explains that traditional case-formulation models are in written 
narrative form, tailored dependent upon which model of therapy is used, however 
advocating diagrammatic representations as opposed to narrative, as many people 
have a better memory for diagrammatic cues, and diagrams can link complex 
interacting/interrelation variables which may maintain problems.  
 
Empathy  
Angus et al (2007) suggest that empathy and therapeutic alliance are key factors in 
engagement and treatment. This implies that decision-making is relationship-
dependent, considering the patient's relationship with services, and the clinician’s 
relationship with the patient. Awareness of the difference these factors make when a 
person presents with a PD (i.e. rather than a broken leg), is an important aspect 
when considering what guides clinical decision-making (Smith, 2015).  
 
Bennett et al (2006) emphasize that empathy and clinical alliance are central to 
balanced decision-making, however highlight that if difficulties are present in either 
the patient/therapist's affective state within the session, then decision-making may 
be altered.  
 
Early writers emphasise the need for empathy when engaging patients with 
psychological problems (e.g.: Rogers, 1951). Empathetic ruptures can occur due to 
counter-transferential and/or transferential dynamics within the therapeutic encounter 
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(Bennett et al, 2006). Rogers' (1951;1957) viewpoint contrasted with writers such as 
Skinner, due to his concentration on a person’s self-actualising potential, suggesting 
that the clinician's approach in the therapeutic encounter changes the interaction 
itself (Rogers and Skinner, 1956). This is particularly important in the Treatment 
Choice Encounter, as a clinician's approach may influence engagement or 
disengagement (Morris, et al, 1974).  
 
Goldfried et al (2005) advocate Rogers' theory for people with PD, however Lazarus 
(2007) criticises Rogers' simplification of the core premise of the therapeutic 
encounter, stating that patient's needs are diverse. He suggests that some patients 
may respond well to a warm empathetic relationship, however some prefer a 
'business' relationship. This balance between empathy and directedness is a key 
theme in literature concerning provision of intervention for PD.  
 
Magidson et al (2012) explain that some personality profiles present as more 
challenging in therapeutic encounters than others, patients may display arrogance, 
be patronising, and occasionally malicious, in Treatment Choice Encounters, to 
influence the clinician’s decision-making. McMurran (2012) suggests that patients 
with antisocial or narcissistic beliefs anchored in early-life experience of 
powerlessness, may develop compensatory behavioural strategies of relational 
aggression and intimidation, complicating empathetic formulation and balanced 
decision-making.  
 
Ruszczynski (2010) reinforces this, explaining that different PDs can prompt clinician 
emotions influencing treatment selection, including feeling frightened, disgusted, 
corrupted, abused, or seduced, which may mean that they allocate a treatment 
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influenced by this, or feel complete empathetic rejection towards the patient. DPD is 
differentiated in the research from other PDs, Kopala-Sibley et al (2012) explain that 
DPD patients are characterised by feelings of weakness and fear of abandonment, 
which may trigger treatment prolongation, and/or a sense of duty to provide care in 
clinicians. 
 
Knowledge and perception of treatments  
The research reviewed generated a number of different treatments (e.g. DBT) for PD 
(Berrino et al, 2011). However, results failed to identify when treatments should be 
initiated and with who, complicating decision-making. Chard et al (2005) emphasize 
the need for psycho-education concerning treatment-choices, however the pace of 
education and clinician's ability to understand and adapt information must be 
monitored (Hershenberg et al, 2012). 
 
Ulvenes et al (2014) suggest that clinicians will hold beliefs and personal bias about 
which different treatments work, and this will influence their decision-making. This 
bias is important, because it may not consider variables required to ensure the 
treatment is appropriate for the patient. Magnavita et al (2003) suggest that 
clinician's beliefs about different treatments must be regularly explored in 
supervision, as otherwise the patient could be allocated “the same as usual”, rather 
than something appropriate for their new presenting need.  
 
Patients presenting with multiple comorbidities 
Leichsenring et al (2011) highlight the importance of recognizing that the presence of 
a PD makes a person highly susceptible to other potentially more transient mental 
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disorders. There have been instances where people with PD have not been provided 
treatment for other physical health and mental health disorders, due to clinicians 
misdirecting treatment, attributing all symptoms to the presence of a PD diagnosis 
(Krueger et al, 2010; Gregory et al, 2006).  
 
A further difficulty is that research and UK policy often only guides intervention for 
single-diagnostic presentations (Cukrowicz et al, 2005). Evidence which presumes 
that treatments for common mental health problems (i.e. depression) may be 
ineffective if the person has a PD, mean some treatments are excluded by clinicians 
(McMurran et al, 2010), despite research demonstrating the presence of PD not 
interfering with treatment efficacy (Weertman et al, 2005). If the facilitating clinician 
has seen non-adherence or poor treatment efficacy before, they may block this 
treatment for the patient unnecessarily (Kelly et al, 2007). 
 
Chaikin et al (2004) recognize this, stating that presence of a PD may obscure the 
presentation of the other mental health issue, meaning that patients present as 
typically disordered in multiple aspects of their life. It is therefore not only a problem 
for the decision-maker to decipher which problem requires treatment, but further 
complicated by the presence of information either disclosed or withheld in-session by 
the patient.  
 
When is enough, enough? 
The concept of ‘enough’, is linked with the notions of ‘recovery’ and ‘cure’. Bryan et 
al (2012) explain that there is limited research concerning this question, specifically 
when considering treatment termination for people with PD, as much recovery-
Student Number: 100104045 
55 
 
focused research pertains to treatment of psychosis. This poses an additional 
challenge for clinicians assessing patients who have had multiple treatments, yet still 
feel they need more. Warner (2010) suggests that this is one of the reasons 
prompting development of the “Recovery” model in mental health care, which 
focuses upon patients maintaining or rebuilding satisfying lives, accepting the 
presence of a mental illness, rather than necessarily attempting to remove it, or be 
‘cured’.  
 
Clinicians must encourage a sense of ‘optimism’ in patients, enabling them to self-
manage their residual symptoms, and integrate them as a part of their being (Repper 
and Perkins, 2003:12). Unfortunately, no specific guidance was found in the 
literature review concerning how clinicians may be supported to operationalise this 
with PD patients, and also how the concept of “enough” is measured (Gudjonsson et 
al, 2011).  
 
A final and underpinning theme identified in the review concerns the concept of 
motivation. Valbak et al (2003) asked: “how you make the 'unsuitable for treatment', 
suitable?” when considering PD, suggesting that motivation work, and work 
concerning realistic expectations, should be the focus. Younggren (2011) explained 
that treatment choices in this sense are ethically fraught, and the reality is that some 
patients are kept in treatment who should be discharged, resulting in damaging 
consequences, and correspondingly, some patients are discharged rather than 
‘allowed’ treatment, because it is felt to be non-productive or clinically inappropriate. 
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Increasing efficacy by targeting resources 
The ‘New Horizons’ document (DoH, 2010) was published to encourage everyone, 
including other government departments, to engage with mental health concerns. It 
placed a greater emphasis upon evaluating interventions and increasing innovations, 
and also focused upon reducing costs, in line with the current financial climate of 
austerity. PD services are included within the ‘New Horizon’ focus; there is an 
emphasis upon increasing the research base underpinning the rationale for services 
with differing levels of cost.   
 
Costs do not merely relate to community treatments provided, but also high-cost 
long-term placements, and high-cost short-term services (i.e.: PICUs). Both of these 
are nationally and locally in focus as part of austerity measures, and are a core part 
of treatment pathways for PD. 
 
Hunsley (2003) suggests that a common framework is required to estimate the 
personal and societal cost of an illness or disease, considering both direct costs of 
treating the disorder, and also indirect costs of not treating the disorder. Indirect 
costs do not just imply wider demand on public health costs (i.e. repeated crisis 
contacts, criminal justice contacts), but also include 'loss' costs (i.e. loss of 
productivity through unemployment).  
 
BPD is named specifically as one of the most problematic disorders in this sense, 
due to high levels of A&E and GP use, erratic attendance, non-adherence, and/or 
abuse of prescribed medications, meaning that the debilitating part of the illness that 
often prompts the chaotic nature can mean that the illness may not be able to be 
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analysed in the framework of other debilitating illnesses, where chaotic 
disengagement may not be a central feature.  
 
Evidence shows that not only is BPD treatable (Moran, 2007), but following 
successful treatment, the chaotic nature of the person is reduced, and therefore the 
wider use of public services is reduced, and the person's personal productivity  
increases (Mendelberg, 2014). The issue of cost is therefore not only about the 
direct cost of treatment at this time, however needs to consider future costs if 
proactive interventions are not provided (i.e. high-cost placements). 
 
Q2 Conclusion 
The discussion presented in Q2 builds upon Q1, demonstrating that not only is the 
concept of PD assessment complex, diagnostic features mean there is a higher 
likelihood of conflict or turbulence in therapeutic encounters. Q2 also emphasises 
that there may be difficulties within decision-making processes when considering PD 
treatment choices, due to the multiple co-morbidities people present with, the gap 
between research and practice, and increasing cost pressures placed upon health 
services. Q3 expands upon this, exploring whether there are any frameworks which 
may assist decision-making in this complicated therapeutic encounter.  
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Q3. Are there any clinical tools4 or heuristics to assist clinicians to make 
decisions concerning which treatment should be selected for PD patients? 
 
Although several algorithms were found in the literature review, these only related to 
treatment direction after the initial decision-making process takes place, rather than 
addressing issues regarding initial suitability for treatment. Despite this, certain 
themes were raised connected to this question, either related to treatment selection 
in mental health generally, or specific aspects explored below.  
 
Decision-Making 
Widiger et al (2010) suggest that PD is a diagnosis at the forefront of a psychiatric 
paradigm-shift, associated with the DSM reclassification. Mental health problems are 
currently considered as qualitatively different from physical health disorders 
generally (Regier et al, 2009), as in physical health disorders, there is more often an 
expectation of a cure, whereas with PD, as discussed in Q2 regarding the “Recovery 
model” principles, a cure is not always possible, however symptom education and 
reduction is. This affects decision-making with PD, and may also suggest that 
models for decision-making developed for physical conditions which had an endpoint 
‘cure’, are irrelevant when aiding decision-making for PD. 
 
 
 
4- The term ‘Tools’ is used to describe any clinical guidelines or frameworks that clinicians 
use in the Treatment Choice Encounter. Examples of tools include: algorithms, care 
pathways, formulation models, and decision-making frameworks. In this thesis, the use of the 
word ‘tool’ does not apply to a person who makes the decision.  
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Millon et al (1993) extensively researched PD, providing evidence that the reason 
clinical decisions are difficult is that the disorder itself affects internal and external 
systems. Magnavita et al (2003) explained that in understanding this, when 
assessing a person with PD for treatment, biological factors, intrapersonal factors, 
interpersonal factors, and social factors, all contribute to treatment choice. Zeldow 
(2009) suggests decision-making is complicated, due to treatments not being well-
defined (i.e. social care parameters changing with the introduction of the Care Act 
2014). Therefore, Hollon (2006) explains that peculiarities of human experience 
inevitably lead to individualised clinical 'judgements' concerning decision-making.  
 
Schön (1983) proposed two models of decision-making in professional practice: the 
“instrumental problem-solver”, who applies their own knowledge and applied science 
to real-world patient encounters, and the "reflective practitioner” who addresses 
indeterminate real-life problems that are not typically amenable to the application of 
technical rationality. Schon (1983:89) provides 3 reasons for uncertainty in clinical 
decision-making: (1) uncertainty about ‘what is going on?’, meaning the clinician 
must act, (2) what questions within the encounter would add value to the decision-
making progress?, and (3) the uniqueness of each encounter, meaning that no 
researched formula could provide a direct guide for clinicians to define the actual 
outcome of the treatment session. This builds on the work of Meehl (1954:46): 
“When Shall We Use Our Heads Instead of the Formula?”  
 
Van Manen et al (2008) propose various considerations when decision-making: 
treatment efficacy, non-evidence-based factors (i.e: treatment availability), personal 
experience, and personal belief in treatment models, suggesting that these possibly 
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lead to inefficient use of available resources and treatment selection, which may be 
ineffective, and potentially harmful. They explain that there are some emerging 
thoughts about clinical decision models for PD, however they are in their infancy.  
 
Ma et al (2008) researched nurse’s decision-making in Taiwan regarding PD 
treatments. They found 5 themes: “(a) shifting from the 'honeymoon' to 'chaos' stage, 
(b) nurse's expectations for positive vs. negative outcomes, (c) practicing routine vs. 
individualised nursing care, (d) adequate or inadequate support from healthcare 
team members, and (e) differences in care outcomes (satisfactory experiences, and 
superficial relationships)”.  
 
Extrapolating from these themes, they developed a conceptual framework 
concerning a ‘two-stage care process’, suggesting that nurses develop positive 
coaching skills, rather than ‘give up' on their patients, to motivate them to engage in 
treatment, whilst monitoring their own beliefs about whether their personal 
expectations of potential treatment outcomes are influencing their decision-making. 
Key themes concerning: ‘caring less’ and ‘keeping a distance’ to avoid anticipated 
‘treatment failure’ were important. This study does not give a framework for decision-
making regarding treatment choice for PD, but does reinforce that attitudes towards 
patient outcomes are central to decision-making processes.  
 
In practice, there is often an initial need to make certain immediate treatment 
decisions with PD patients (typically linked with risk), then a need to make longer-
term treatment decisions. Short-term or immediate treatments often have clear 
frameworks for decision-making (i.e. treatment following self-harm), however longer-
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term treatment decisions are typically the most complicated, with the least research 
in terms of decision-making (NICE, 2011).  
 
Jasper et al (2014) discussed decision-making where there is uncertainty, testing 
three heuristics concerning: treatment availability, representativeness, and anchoring 
heuristics based upon personal experience. The use of a heuristic approach may be 
proposed as beneficial when considering PD treatment choices, as it would provide 
an anchor (or reference point), and enable increased consistency.  
 
Motivation and Psycho-education 
Patient motivation is a recurrent theme in the literature, assisting in treatment 
selection (Clarke et al, 2012), and also as a treatment technique required for the 
person (Motivational Interviewing (MI)). Angus et al (2009) suggest that until a 
relationship is built, it is difficult to assess motivation, as there are relational 
dynamics that interfere with motivational processing. Westra (2004) explained that in 
therapeutic approaches such as CBT, it is not uncommon to use MI techniques to 
enhance engagement and manage treatment resistance, pre-treatment.  
 
McMurren (2012) emphasizes that pre-treatment preparation significantly reduces 
non-adherence, particularly when making referrals for talking-treatments. A question 
therefore must be posed concerning whether the first treatment that should be 
selected concerning PD patients is MI? If so, is this then considered as treatment or 
pre-treatment?  
 
Student Number: 100104045 
62 
 
Three potential pre-treatment strategies are presented in the research as options: 
open-ended groups (Birtle et al 2007), MI techniques, and a ‘patient-buddy system’ 
(Chiesa et al 2003). Simonsen et al (2014) suggest that the heterogeneity of PD 
must be accounted for when decision-making, disagreements between theorists is 
one factor to consider, and also differences between clustered symptoms defining 
disorders, linked with the patient's environmental, relational, and resilience factors.  
 
Clinically relevant tools 
Despite the problem of not finding a model specifically focused upon treatment 
selection for PD patients, research generated results for certain tools which may be 
potentially helpful when making choices with people with PD, briefly outlined below: 
 
Barry (2007) suggests the Clinical Evaluation of Risk and Functioning Scale—
Revised (CERF-R) model to aid clinical decision-making, he does not state that it is 
for PD specifically, instead states it is for all mental health problems. He suggests 
that the mental health diagnosis ‘is irrelevant to some extent’ concerning treatment 
allocation, arguing that it is the degree of risk and functional impairment attached to 
a person’s presentation which influences whether  health and social services allocate 
treatment resources. Beutler et al (2012) also support the assessment of functional 
impairment when considering treatment allocation, advocating use of the Systematic 
Treatment Selection Clinician Rating Form (STS-CRF) rather than the CERF-R 
model. 
 
Although no specific PD tools were found, Pulleyblank et al (2013) presented a case 
for treatment decisions in psychosis, which may aid in the development of a PD 
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treatment selection tool. They explored the conditions considered ‘useful’ in making 
a decision to treat or not, finding that ‘decision curve analysis’ is a framework 
whereby inclusion of certain assessment tools may be useful in guiding clinical 
decision-making. The difficulty with this model is that treatment choices may only be 
made by people trained to use and interpret the tools, however the positives are that 
they are useful in outlining potential benefits and harms resulting from a treatment.  
 
Choice between treatments 
Beutler et al (2012) explain that a natural tension is present with clinicians 
concerning their preference for particular therapeutic models when making treatment 
choices, and that this tension will influence the particular intervention they select, 
and preferences between talking treatments (i.e. Dynamic or CBT).  
 
Krueger et al (2010) explain that the value placed on different treatments by both 
patients and clinicians influences decision-making, when there is conflict between 
either what diagnosis or presenting symptom requires treatment. Larsson et al 
(2009) explain that techniques for PD treatments are often similar, though known by 
different terms, dependent upon which school the treatment derived from. Lazarus 
(2007) identifies manualised treatments that are evidence-based for PD; however 
there are divergent opinions about the sustainable effect of these treatments. 
Salkovskis (2002) usefully summarises conflicts between different schools of 
thought, suggesting that clinicians must recognise the need to individualise treatment 
approaches, whilst being responsive to clinical science, using empirically supported 
approaches, without becoming fixated upon a single theory.  
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Medication vs psychotherapy  
Boswell et al (2010) explored what influenced clinician's approaches to patients 
within sessions, finding that patient's ‘comfort zones’, and their willingness to flex 
boundaries of these, was a strong factor affecting treatment selection. This is linked 
to respecting patient choice, but serves as a way of understanding why those who 
would not move from their comfort zone were not allocated an active treatment 
requiring participation (such as CBT).  
 
This is important, as the patient may want something that is more collaborative, 
however may need something that they have to work at. This proposes a potential 
heading for this section as: “who knows what is good for them?” This is a difficult 
point when considering ‘expert patients’, patient choice, and patient collaboration. An 
example may be why some patients buy illegal diazepam, rather than use problem-
solving treatments. Clarke et al (2012) explained that patient and clinician 
assertiveness and negotiation are significant factors in the Treatment Choice 
Encounter. 
 
Engagement skills as a tool 
Some clinicians have a difficulty working with people with PD, due to the nature of 
patient symptoms. Castonguay et al (2010) explain that due to past encounters, 
some clinician's approaches are linked with poor outcomes concerning engagement 
and treatment choices, due to: hostile control in-session, pre-set agendas due to 
knowledge of the patient's history (demonstrated by hostile separation in-session, 
ignoring or neglecting the patient's point of view), and conveying contradictory 
information that may be confusing for the patient, all of which can lead to toxic 
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therapeutic encounters. Each factor influences clinician's decision-making, and the 
patient's willingness to engage with any treatment offered. It also influences ways in 
which patients engage, if they return to services in the future.  
 
Constantino et al (2012) suggest clinicians must assess patient’s prognostic 
outcome beliefs informally through discussion, prior to treatment selection. They 
suggest some outcome measures which can achieve this (i.e. The 
Credibility/Expectancy Questionnaire, (Devilly et al 2000) and the Milwaukee 
Psychotherapy Expectations Questionnaire (MPEQ) (Norberg et al., 2011)). These 
are not decision-making models, but models where clinicians assess factors 
influencing clinical decision-making. Defife et al (2011) also support this approach, 
suggesting it fosters collaborative goal-formation, positive yet realistic expectations 
of treatments, and engenders role preparation prior to allocating expensive treatment 
resources.  
 
Assessment of patient readiness  
Harakas (2013) identifies three key concepts in terms of readiness as motivation, 
resistance, and efficacy, particularly when considering talking-treatments. In 
contrast, psychodynamic and humanistic approaches may consider motivation as 
part of the therapeutic process. Additionally, research suggests that ambivalence is a 
core part of the unconscious conflict analysed by psychoanalytic and psychodynamic 
therapies, whereas humanistic approaches assume all have motivation, as long as 
the therapeutic environment and relationship is geared to remove barriers to 
engagement. Motivational enhancement, solution-focused interventions, executive 
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coaching, and goal setting, are all strategies which may be considered pre-therapy, 
to reduce resistance in people with PD.  
 
In the literature review, a model was sourced concerning analysis of a person’s 
readiness to engage, presented in Figure7: 
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McMurran (2012) emphasises the need for respect, mutuality, and consideration 
when assessing PD patients, emphasising that barriers to engagement must be a 
central focus of the Treatment Choice Encounter. This model is helpful when 
considering what may aid the clinician to assess readiness, however fails to address 
the research question concerning how clinicians can be supported to make 
decisions.  
 
Q3 Conclusion 
Q3 revealed that although several algorithms were found in the literature review, 
these only related to treatment direction after the initial decision-making process 
rather than addressing issues regarding initial suitability for treatment, and selection 
of appropriate treatment choices for people with PD, which is core to the focus of this 
research. The literature has however revealed several components pertaining to the 
therapeutic relationship, and the complexities affecting this encounter, which may be 
useful when considering how people can be supported in the decision-making 
process. Q4 expands upon this, exploring clinician factors in the Treatment Choice 
Encounter. 
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Q4: What helps or hinders clinician’s clinical decision-making ability with PD 
patients?  
Q1, 2, and 3 have all detailed factors raised within the literature reviewed that help or 
hinder clinician's decision-making. This section refines this, identifying pertinent 
clinician factors. 
 
Empathetic engagement  
Angus and Kagan (2009) suggest that empathetic engagement significantly impacts 
upon patient engagement with the treatment planning process, stating it is 
particularly problematic for PD patients, because their predominantly negative 
experiences of early relationships affect how they engage with current service 
providers.  
 
The experience of disclosing feelings of understanding and acceptance for a person 
with PD may form a part of a new corrective interpersonal experience (Castonguay, 
2005). Clinician modelling via empathy and understanding is extremely important 
when making treatment choices, as it models for the patient, and attempts to build 
upon their capacity to emotionally regulate, self-sooth, and relationally interact (Elliott 
et al, 2004:47). 
 
Linked with this concept is therapeutic alliance. Falkenström et al (2013) identify 
conflict among authors about the extent to which the therapeutic alliance affects 
treatment outcomes. Bordin (1979) felt that the alliance in itself may be curative, 
rather than a pre-therapy task.  
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The therapeutic alliance as a concept could be proposed as a more complex 
consideration with PD patients, due to the frequent relational difficulties encountered. 
Gadassi et al (2014) focused on social proximity, specifically where there were 
affective components of the patient’s presentation. They found that if social reactions 
are positive and signal rewards (i.e. safety), then they are often responded to 
positively. However, if they are threatening and signal danger or punishment, this will 
engender avoidance tactics. Others authors reinforce this notion (Gilbert et al, 2008; 
Kashdan et al 2010).  
 
When analysing this phenomena in the light of the research question, clinicians must 
be aware of the impact of empathic engagement on the therapeutic alliance, as it 
shows that it is not just what they say, but also how they present themselves and 
their information, that impacts upon the decision-making process. 
 
Working with insight and resistance 
Baiden et al (2013) conducted research regarding a person’s willingness to engage 
in treatment or treatment selection, and found that insight into diagnosis and mental 
health problems was one of the largest variables concerning engagement.  
 
Castonguay et al (2011) suggest that MI may assist in improving insight, and 
reducing ambivalence (which often sustains sub-therapeutic engagement in 
treatment for people with PD). They suggest that MI encourages a ‘no blame 
approach’, explores a person’s motivation to change, and reduces the potential for 
the clinician's transferential and counter-transferential interfering behaviours, as 
described earlier. 
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Baiden et al (2013) discuss the shift in mental health care over the past 50 years, 
aimed at empowering patients to make treatment choices, explaining the many 
positives to this, however there are also challenges. Beutler et al (2012) expand, 
explaining that low levels of patient resistance, and high distress with low 
impairment, are collectively the best combination a person can present with to gain 
the most from a session, explaining that this should correspond to a comparable 
match of clinician factors, including high directedness with low session intensity, for 
the optimum engagement in a Treatment Choice Encounter.  
 
Rationalisation and adherence 
Treatment rationalisation is a contentious area in healthcare, linked with austerity 
measures. Corrigan et al (2014) explain that much world-health research focuses 
upon the cost implications (personally and financially) concerning non-adherence, 
and the impact upon the allocation of different treatments. They produced a table 
highlighting adherence across different diagnosis: 
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This chart does not individualise PD as a diagnosis, but requires consideration, as it 
demonstrates that if there are comparable adherence rates for very different 
disorders (i.e. schizophrenia, cancer), taking this into account, the question then 
must be raised concerning: why is a similar model not  adopted for PD?  
 
Many health decisions concern the impact of cost/benefit analysis on treatment 
allocation. There can be harm in commencing a treatment which is then not adhered 
to or suddenly discontinued, whether that is medication or talking-treatment (Russell 
et al 2007). Cook et al (2014) explain that when allocating treatment, clinicians must 
consider the potential of adherence by the patient, as sometimes there is more risk 
in starting and stopping than completely withholding a treatment.  
 
In terms of hindrance factors, Harakas (2013) explains that a patient’s motivation to 
engage can change, from amotivation and unwillingness, to personal commitment. 
McMurran et al (2010) explain that different personality types are associated with 
non-completion, having a Dependant PD diagnosis was connected with non-
completion in one study sourced but not another, but having a diagnosis of Avoidant 
PD was more connected to treatment completion.  
 
Traits of narcissism and impulsivity were connected to non-completion, independent 
of the specific PD diagnosis. For people with any diagnosis of PD, the following trait 
variables had an effect regarding treatment completion: people who completed were 
rated as less depressed or had no mood disorder, non-completers also had fewer 
suicide attempts, and lower levels of interpersonal distress. Finally, non-completion 
was compared to being in the ‘pre-contemplation’ stage of change, linked with lower 
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levels of persistence, higher levels of avoidance, and poor relational and social 
problem-solving skills. Co-occurring problems shown to reduce treatment completion 
and engagement include: psychoactive substance misuse, and the presence of 
aggressive behaviours.  
 
Clinician ‘wellness’. 
Barnett et al (2007) identify ‘clinician wellness’ as a central component in health 
treatment decisions and ethically balanced patient assessment and care. They 
expand, explaining that professionals accessing training and supervision ‘insulate’ 
themselves from ‘destructive effects’ that may be encountered.  
 
This research identifies that in clinical practice, there is a need to explore the 
vulnerability of workers who support decision-making, who may not have access to 
this type of training or supervision.  
 
Bowers (2003a) explains that contact with people with PD can affect clinicians, 
causing them to adopt ‘interpretational schema’ towards certain types of behaviours 
such as manipulation, both inside and outside of work, it can be displayed as 
cynicism. This can result in a reduced capacity for compassion and a reduced ability 
to care. Barnett et al, (2007) explain that indicators of personal risk factors may 
include: increased frustration, impatience, decreased motivation, and increased 
fatigue. 
 
Liebman et al (2013) describe other variables connected to wellness that are 
researched as affecting treatment choices and any therapeutic encounter: clinician's 
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age, training level, experience level, ability to recognise and manage transference 
and counter-transference, degree of burnout, attitude towards mental 
illness/wellness, and attitudes held toward the diagnosis of PD.  
 
Clinician directedness as a theme  
Directedness is raised in several papers, however with different recommendations. 
Chatziandreou et al (2005) explain that one problem evoking a negative response 
from patients in-session is the thought that the clinician has a pre-set agenda or 
outcome in mind, it is researched as prompting feelings in the patient that they are: 
not understood, that the clinician is there just to “get the job done”, and also feelings 
that the clinician is dishonest, all of these variables can then affect the patient's 
future engagement with services.  
 
Conversely, Goodman et al (2014) emphasise that optimal treatment occurs when 
clinicians are empathetic, yet gently challenging of patient’s implicit emotional-
regulatory expectations. Directedness must therefore be considered as a variable, 
concerning the overall research question posed: what helps or hinders decision-
making, which requires more consideration/research, specifically when considering 
the points made in Q2&3 regarding collaboration. 
 
Financial and resource pressures  
Connected with the degree of directedness, balanced against patient choice, is an 
added component concerning financial and resource pressures for the clinician. This 
is not only an awareness of wider NHS pressures, but also the micro-pressures 
within the service in which they work. They will be aware of the waiting times for 
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particular treatments, however they also need to be aware of the wider cost 
implication, if people with PD are left untreated (Leichsenring et al, 2010). 
 
Cost pressures come into focus particularly when considering psychotherapeutic 
intervention. Beutler and Forrester (2014) explain that difficulties occur when 
evaluating the efficacy of certain psychotherapeutic techniques. They explain that 
sometimes the time required for the healing process within therapy does not meet 
expectations of fund-holders and commissioners, who expect certain results within 
short timeframes, which they feel is not possible with the most complex mental 
health patients.  
 
Barry et al (2007) expand, explaining that insufficient support for complex patients 
can result in ‘unwanted outcomes’, including exacerbation of risk. Berrino et al 
(2011) explain that this is particularly important for PD patients, as cost-saving by 
denying treatment in one health sphere can often result in the patient overusing 
other health services, such as A&E, in-patient mental health, and crisis services. In 
contrast, we do know that for people with PD who engage in treatment, their overall 
healthcare cost is reduced (Cedereke et al, 2005; Brown et al 2005; Tyrer et al 
2003). 
 
The funding discussion is presented in papers sourced from both inside and outside 
the UK. The reason to make this point is that different countries such as the USA 
and Canada have insurance-funded access to treatments, rather than an NHS 
(Mendelberg, 2014). Chiesa et al (2009) suggest that often less costly interventions 
are opted for in the first instance, even though this may lead to treatment failure and 
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a need to opt for the costly intervention on top of the initial outlay, arguments are 
made for considering longer-term health benefits rather than shorter-term costs, to 
treat the severe and “treatment refractory” end of the PD spectrum. Clarke et al 
(2013) agree with Chiesa (2008) regarding treatment delays due to waiting lists and 
funding issues.  
 
Mendelberg (2014) highlights that market forces and cost considerations have 
penetrated the clinical encounter, which has prompted criticism that a Treatment 
Choice Encounter may feel “factory-like” and driven by bureaucratization, potentially 
eroding person-centred care and clinician's independence.  
 
This phenomena is central to this research question, however little evidence was 
found concerning how a practical rather than idealistic outcome for Treatment 
Choices Sessions may be achieved in a sensitive manner.  
 
Clinician belief in or understanding of treatment 
Within the literature reviewed, a recurrent theme revolved around clinician belief in 
the treatment. This may be because, in PD, there are so many different treatments 
(specifically talking treatments) which may be beneficial, or it may be reflective of the 
fact that certain treatments are under-researched.  
 
Functional impairments that often accompany PD require joint health and social care 
provision, some interventions may concern stress reduction by focusing upon 
relapse triggers (i.e. debt, loss of employment etc.), and for these interventions, 
there can be equal treatment efficacy compared with medication and psychotherapy, 
Student Number: 100104045 
77 
 
however they lie outside the realm of what are researched as interventions in the 
literature review (Beutler and Forrester, 2014). Bornstein (2005) suggests that 
especially with people with PD, the most effective treatment packages are not sole 
interventions, but combined bio-psycho-social treatment strategies. 
 
This links into one of the clear challenges clinicians face, of linking EBP into 
treatment choices for people with PD. How do they translate an evidence-base for 
what they know works (i.e. social care and occupational support), when the NICE 
guidance etc focuses upon other treatments such as DBT? Cook et al (2004) explain 
that empirically supported treatments often do not consider individual patient's 
symptoms and current problems.  
 
Mendelberg (2014) suggests that clinicians, concerned regarding limitations to 
treatment and restrictions on 'paid for' services, are in a paradoxical predicament, 
potentially feeling that the treatment that would be best for the patient may be 
unavailable.   
 
Presence of manipulation/manipulative behaviours 
Bowers (2003a) states “social behaviour is doubly ambiguous with respect to 
judgements of manipulation”, suggesting a moral component, where people make 
decisions with patients who have a PD based on the presumption of deception and a 
globalised response to it, rather than a contextualised theme. In a second paper, 
Bowers (2003b) suggests that the presence of manipulation is integral to PD 
patient's interpersonal style and the disorder itself, emphasising that if rejection is the 
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response, it will result in therapeutic failure and potential discrimination against 
treatment provided to others.  
 
Evans (2011) and Naso (2006) suggest that clinicians working solely with APD 
and/or Narcissistic PD can have their capacity to decision-make interfered with by 
the mental states and behaviours of the patients, particularly if the patients use 
intimidation or manipulative tactics.  
 
The presence of self-harm 
As with manipulation, the presence of self-harming behaviour, particularly in 
response to decision-making that conflicts with the patient’s belief system, can result 
in staff members feeling bullied or coerced into making different decisions. Chaikin et 
al (2004) build upon this, suggesting that self-harming in this way is typically 
anchored in past trauma, leading to ethical dilemmas for the clinician regarding 
treatment provision. Principles of beneficence, non-maleficence, and autonomy are 
considered, specifically when making judgements about whether and when to 
intervene, considering patient's risks and clinician's duty (Royal College of 
Psychiatrists, 2008).  
 
Brown et al (2012) explain that engaging with people with a disorganised attachment 
style, as in PD, can lead to significant problems for clinicians concerning ‘boundary 
management’, suggesting that clinicians must consider risks, strengths, resilience, 
and resources for recovery, when they are decision-making about treatment, 
resilience here is a core term repeated in several papers, with a caution against 
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commencing in-depth work if resilience is low, due to the likelihood of increased risk 
associated with an increased sense the person is ‘losing control’.  
 
This research demonstrates that resilience is a separate theme from the PD 
pathology, which should be considered in treatment decisions. Some PD patients will 
never need long-term therapy, as it would be too risky and self-destructive, however 
some do, and it is how clinicians define this that is one of the core components of 
this research. Clinicians must evaluate whether therapy or certain treatments would 
be tolerated by the patient, to improve functionality without compromising resilience, 
particularly when considering trauma exposure work. Living a ‘split-existence’ is 
advocated by some (Brown et al, 2012), as this enables a person to 
compartmentalise their distress, and still conduct everyday life (i.e. work etc). 
 
Q4. Summary 
Q4 has outlined several clinician factors which influence the Treatment Choice 
Encounter with a patient with Personality Disorder. These factors include the 
clinician's ability to:- empathetically engage; build therapeutic alliance; assess the 
level of insight, resistance and motivation for treatment; and conduct a cost/benefit 
analysis considering treatment adherence and treatment rationalisation in this 
financial climate. This is central to analysing the decision-making phenomena. Q5 
explores potential supervisory models, and Q6 explores patient variables.  
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Q5: Are there any supervisory models which aid decision-making and practice 
reflection? 
 
A significant amount of literature focuses upon providing supervision for people who 
work intensively or psychotherapeutically with PD patients, however this is mostly 
focused upon ‘in-treatment’ issues only, rather than decision-making for treatment, 
e.g:  
 
 Magnavita et al (2010) explain that without adequate supervision, clinicians 
may be at risk when treating people with PD, because of the increased risk to 
self and others.  
 
 Perseius et al (2007) suggest that clinicians who are not supported with 
supervision are more likely to burn out and become emotionally exhausted by 
the demands put on them by their patients.  
 
 Ruszczynski (2010) explained that this may lead to dislike of the patient and 
any patient representing this group, in turn leading to negative patient 
experience and unbalanced decision-making.  
 
 Hershenberg et al (2012) emphasise that supervision sessions should be 
where learning and reflection can occur. When working with people with PD, 
group supervision is essential, for a team model for consistent approaches to 
be provided, which gives stable and boundaried support for people with PD.  
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In the research reviewed, there were no PD supervision models which focused upon 
how to support therapeutic decision-making for all MDT members. Instead, research 
generally supports the need to develop training and supervision models for all 
clinicians working with people who have a PD (Castonguay et al, 2010). This would 
be a useful and important area for future research.  
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Q6: Are there any research/sources that detail patients’ experience of 
treatment selection regarding their PD? 
 
The research generated information pertaining to patient experience of treatment 
selection, however much of this was presented from a service/clinician perspective, 
rather than detailing patient’s actual responses. As accounts are described by the 
clinician, bias may be present due to misinterpretation (Lilliengren et al 2005). 
Additionally, those few which were gained from patient perspectives typically used 
retrospective analysis, which can create difficulties, as there will be a filtered 
biographical reflection on retrospectively recalled events (Ebner-Priemer et al, 2009).  
 
The following themes were raised concerning patient experiences of treatment 
selection: 
 
Meta-cognitive ability 
Bandura (2006) reflected that a patient’s meta-cognitive ability to engage in 
reflection, analysing their feelings, behaviours, and actions, is a core part of 
‘personal agency’. This ability is posited to be a core requirement in regards to 
treatment selection, specifically concerning talking therapy approaches, as it is 
central to engagement and ability to change (Williams et al, 2007). There is 
substantial research linking the concept of meta-cognitive ability with the ability to 
adaptively problem-solve and have insight into problems, for PD patients.  
 
Fertuck et al (2009) explain that PD patients often predict abandonment in Treatment 
Choice Encounters, affecting how they engage. This may mean that they 
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inappropriately interact on an interpersonal level (Clarkin et al, 2006:143), have 
altered judgements concerning what they feel may/may not help (Linehan, 1999:18), 
and become hyper-alert to emotional expressions demonstrated by clinicians (Flury 
et al, 2008).  
 
Does the patient know best? 
Certain PD patients can accept control over their treatments, however research has 
identified that some struggle, and present with misguided treatment requests for a 
variety of reasons. The first researched reason is that certain patients are seeking 
treatment for a different disorder, rejecting their PD diagnosis (Antoniadis et al, 2012; 
Paris et al, 2007; Benvenuti et al, 2005). The second reason sourced was that, if 
accepting the PD diagnosis, some patients request treatments that may be 
evidence-based, but could cause iatrogenic harm due to their personal 
circumstances (Brand et al, 2014) 
 
Diagnostic stigma  
Pickersgill (2012) highlights the long history of PD diagnostic stigma expressed 
within tabloid media and health research (elaborated upon in Q1). In the literature 
review for this research, one way in which this was demonstrated was via an 
influential paper entitled: “Personality Disorder: The patients psychiatrists dislike” 
(Lewis and Appleby, 1988). It is also clear that many services in the 1990’s and early 
2000’s were focused more upon psychosis as a ‘real’ and ‘enduring’ mental illness, 
meaning PD services were very limited (Snowden et al, 2003), increasing stigma 
through marginalisation and lack of health priority. 
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The literature reviewed demonstrated that although stigma is reducing (Aguirre, 
2016), and people's diagnosis are connected more compassionately to a complex 
trauma spectrum (Feliu-Soler et al, 2016), there is still discrimination (Guy et al, 
2008).  
 
Heilbron et al (2010) explain that social ‘norms’ and ‘values’ are changing in relation 
to PD, enhancing stigma reduction. However, despite this, Liebman et al (2013) 
explain that clinicians experience difficulty admitting any negative attitudes towards 
people with PD, as they feel ‘unsafe’ in doing so, making this a difficult area to 
explore, even through the supervisory process, echoed in the process issues 
witnessed when planning this research.  
 
Quinn et al (2009) explain that stigma is a socially constructed phenomenon, finding 
that with stigmatised concealed illnesses, (i.e. PD, rather than physical deformity), 
shame can often be a central component affecting the treatment selection process, 
as the person's experience may become "unspeakable" (Moses, 2009). This is 
similar to other concealable stigmas such as: HIV, rape victims, and other mental 
illnesses (Pachankis, 2007). Anticipated stigma refers to the degree in which people 
feel that they will be stigmatised by others if they disclose their difficulties, and what 
a person feels about the negative stereotypes attached to their diagnosis (discussed 
in Q1). 
 
In contrast, Moran (2007) explains that care must be taken when analysing 
diagnostic stigma, to ensure that the person has a PD, and is not misdiagnosed. He 
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explains that the following mistakes have been made when behaviour is out of 
character for the patient:  
 Affective disorders can be mistaken for Dependant PD,  
 Histrionic PD can be mistaken for hypomania,  
 Anxious PD can be difficult to separate from a disorder on the anxiety 
spectrum.  
 Dependant PD can be difficult to separate,  
 Paranoid and Schizoid PD can be mistaken for a psychotic illness or 
delusional disorder,  
 Acute personality changes may present as part of an organic illness, rather 
than being a part of a PD.  
 
Treatment beliefs 
Patients have different treatment beliefs, affected by different factors (i.e. faith, 
personal values, health beliefs, family influence), this can also be linked with notions 
of personal stigma discussed previously. The literature review identified that a 
person’s treatment beliefs will affect their engagement in the Treatment Choices 
Encounter, and their subsequent adherence to treatment. Defife et al (2012) explain 
that part of any treatment choice is engendering faith in that treatment, by the 
provision of psycho-education, and the explicit explanation of the degree of patient 
participation required for treatment success.  
 
One issue concerning PD patient’s beliefs about treatment is connected to 
intolerance of heightened affect, and difficulty in longer-term planning. Friendman 
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(2008) explains that it is understandable for a PD treatment process to progress by 
“one step forward-half a step backward”. 
 
Green et al (2004) explain that if patients are asked to choose between treatments 
with delayed or uncertain outcomes, patients often discount the value of these 
outcomes on the basis of the expected time, which poses a problem in terms of 
informed treatment choice. 
 
This is a core difficulty for people with PD, when the treatments are uncertain and 
unspecific in terms of benefit, however the issue is primarily linked to the clinical 
decision-making part of treatment. McMurran et al (2010) explain that decision-
making may be complicated further if “practitioners are seeking inherent deficits in 
the patient as explanations for treatment non-completion, rather than factors 
concerning the service and the patient's opinions of the service”.  
 
Insight 
Insight is another factor linked to PD patient’s low tolerance to stress and high 
likelihood of disengagement. Baiden et al (2013) researched in-patient psychiatric 
settings, focusing upon self-discharge against medical advice, and found that people 
with a diagnosis of PD do this with higher frequency than people with other mental 
health problems, due to lack of insight into their treatment needs. This research 
focused upon an in-patient setting, however similar levels of disengagement from 
treatment are found in papers concerning community treatment (Brook et al, 2006; 
Tyrer et al 2003; Karterud et al 2003), indicating that insight and disengagement are 
important when considering treatment choice. 
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Clarke et al (2013) found that patient factors concerning treatment disengagement 
included: personal protective factors rejecting close treatment relationships, fears 
about personal safety, prompted by therapy raising difficult emotions, lack of trust in 
clinicians related to patient's past abusive relationships, and factors pertaining to an 
inability to attend/engage with appointments (i.e. homelessness). They also found 
therapy barriers concerning overuse of prescribed medication to numb emotions, or 
illicit substance/alcohol misuse, and slowed cognitive processing associated with 
this, and finally, service barriers including lack of access and inconsistency with 
certain treatments, and long waiting times between treatment decisions and 
commencement. 
 
Patient distress levels  
Many papers cited patient distress levels as central to treatment decisions. Beutler et 
al (2012) explain that distress has motivational properties which affect treatment 
engagement, as well as treatment apathy, suggesting that research has typically not 
included distress as a key factor in the type of treatment or interventions provided for 
people with mental health problems. 
 
Cook et al (2004) explained; patients are often excluded from certain treatments due 
to the presence of suicidal behaviour, substance misuse, and differing neurological 
difficulties. This exclusion affects the research which considers treatment efficacy for 
people with PD, which then poses a challenge for clinicians making treatment 
choices for real-life patients, who typically present with co-morbidities excluding them 
from research trials, meaning that a further challenge is posed to clinicians: what 
about when there is little evidence to guide practice decisions?  
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Gadassi et al (2014) found that distress levels are predominantly higher in people 
with PD than the general population; Kopala-Sibley et al (2012) explain that this 
affects clinical encounters. Levy et al (2006) explain that distressed people with a PD 
often find difficulty in mentalising during appointments, however, McMurran et al 
(2010) suggest that distress is considered as a motivator for engaging in treatment, 
as patients often wish to ‘treatment-seek’ to reduce distress. When considering the 
PD categories, this means: Anxious, Dependant, Anankastic, and Histrionic, 
whereas treatment-rejecting personality types are typically: Dissocial, Paranoid, and 
Schizoid.  
 
In terms of distress, some patients may demonstrate their stress by taking a “one-up” 
position. Owen (2011) connects this type of behaviour with the 'treatment rejecting' 
personality types. The way these patients are likely to interact is that they approach 
then recoil, they dominate then submit.  
 
Patient symptom profiles  
Beutler et al (2012) suggest PD patients can be divided into two symptom profiles: 
‘externalisers’ and ‘internalisers’, suggesting that ‘internalisers’ respond better to 
insight-orientated treatments rather than behaviourally-orientated ones, and are 
more responsive to treatment than ‘externalisers’. This is interesting when examining 
treatment choices, as within the PD spectrum, there are certain personality types 
associated with internalised responses (i.e. Obsessive-Compulsive), and others who 
tend to be more externalised (i.e. Antisocial/Borderline) showing the highest 
prevalence for treatment, but also the most likely to disengage.  
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Correspondingly, Bornstein (2005) explains that dependency is often as problematic 
as treatment disengagement, stating that dependant traits are associated with 
cooperativeness and compliance. They explain that dependency can be a preferable 
factor at the start of treatment, but becomes more problematic at discharge.  
 
Widiger et al (2010) highlight the different constellations of symptoms observed with 
different PDs, meaning that standardising treatment choice is difficult. Kopala-Sibley 
et al (2012) explain that despite the core features, symptom profiles vary, meaning 
different treatments may be more efficient. This, combined with the shame or 
embarrassment associated with treatment-seeking, may mean that treatment 
selection is difficult (Owen, 2011). The difficulty with varied symptom profiles is 
associated with construct validity (Teglasi et al, 2012), linked with diagnostic debates 
presented in Q1, and also linked with the overall research question concerning 
treatment choice.  
 
Responses to rejection 
Bowers (2003b) suggests that PD patient's demands and perceptions of increased 
levels of care is often difficult for clinicians. Castonguay et al (2010) explain that 
difficulties are associated with fluctuating patient motivation and ‘split states’, 
meaning patient presentation varies, anchored to the relationship that they are in. 
This factor needs consideration in Treatment Choice Encounters, as it differs from 
other treatment choices for disorders that have a greater degree of stability in 
symptoms (whether this is: stable-severe, or stable-well). 
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Discharge often evokes feelings of rejection. PD patients often experience 
autonomic hyperarousal if they perceive rejection and abandonment in the encounter 
(Kopala-Sibley et al, 2012). Friedman (2008) explains that discharge plans for 
people with PD often fail to incorporate potential decompensating factors, which then 
may result in re-referral due to relapse shortly post-discharge. They explain that 
issues that may be linked with this include: denial, resistance, divergent opinions 
concerning care needs, and indifference regarding crisis plans or follow-up 
arrangements. Other research connects perceived rejection as related to clinician 
‘aloofness’, which can result in reduced confidence in delivering information to 
emotionally aroused people (Goodman et al, 2014).  
 
Transference and Countertransference 
Transferential responses are well-researched when considering therapeutic 
treatments for people with PD, but lack research regarding the Treatment Choice 
Encounter. Chaikin et al (2004) state that PD patient’s capacity for trust is often 
damaged, due to early-life abuse. In therapeutic relationships, patients are often 
vigilant concerning the reoccurrence of trauma generated from relationships where 
there is a power imbalance (i.e. healthcare relationships). This can then result in the 
patient consciously or unconsciously behaving in a way that either rejects the 
clinician, (because of anticipation of threat), or pressures the clinician to re-enact the 
early life trauma in some way.  
 
Either behaviour will affect the Treatment Choice Encounter, due to potential 
confusion or disconnectedness as a reaction from the clinician (Chatziandreou et al, 
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2005), or potentially negative counter-transferential patient reactions (Friedman, 
2008; Liebman et al, 2013).  
 
Patient’s perception of treatment  
Constantino et al (2012) explain that patient's ‘outcome expectations’ are important, 
representing the person's ‘prognostic beliefs’ about personal resilience, treatment 
efficacy, and personal efficacy, which may mean a pessimistically low or 
unrealistically high expectation of treatment. Therefore, if clinicians commence 
encounters with an inflexible pre-set criteria which does not assess these factors, the 
patient may feel rejected and demoralised, and so have a greater likelihood of 
disengagement with any treatment offered (Perseius et al, 2007).  
 
Disengagement of PDs from treatment has further knock-on consequences, 
including: more frequent emergency attendance, increased amounts of in-patient use 
(Karterud et al, 2003), and overall higher treatment costs (Webb and McMurran, 
2009). DeFife et al (2011) suggest that negative expectations after an initial 
Treatment Choice Encounter will affect a patient’s choice to return for treatment, and 
future treatment efficacy.  
 
Gudjonsson et al (2011) suggest that a key factor in the recovery process is 
engendering a sense of empowerment and control in the patient, whilst assessing 
levels of optimism, and exploring the person’s capacity to engage in treatment. 
Lilliengren et al (2005) suggest that the patient’s perspective on what works 
concerning treatment choices is evidently missing from research.  
 
Student Number: 100104045 
92 
 
The study by Lilliengren et al (2005) took a grounded approach to exploring patient's 
feelings about selecting talking treatments, generating the following thematic results:  
 
(1) talking about oneself rather than others,  
(2) talking being difficult,  
(3) having a ‘special’ place and a ‘special’ relationship,  
(4) new relational experiences,  
(5) exploring together,  
(6) expanded self-awareness,  
(7) self-knowledge is not always enough,  
(8) something was missing,  
(9) experiencing mismatch.  
 
Although the Treatment Choices Encounter is not necessarily a therapy session, all 
of these issues are helpful to understand in terms of potential patient feelings within 
the encounter. The study also revealed that the patient wanted the clinician to adopt 
the role of the ‘expert’ in regards to all treatments, to trust the clinician, and also be 
guided into what may benefit them and make them ‘feel well’, which may contradict 
other previous research pertaining to ‘expert patients’.  
 
Psychological reluctance and resistance 
Therapeutic reluctance and resistance was a theme that arose pertaining to 
treatment choices. Goldfried et al (2005) identify that some patients have a higher 
‘locus of control’ than others, and clinicians should adjust their position and approach 
to respond to this, even though they may be reviewing other patients with the same 
Student Number: 100104045 
93 
 
diagnosis. They explain that when selecting treatments, some patients may wish to 
be advised what to do, and some not, and this may change within sessions with the 
same individual, due to the nature of altering affective states often observed in PD. 
Harakas (2013) discusses resistance, when examining people with PD. He explains 
that it is a obstructive phenomenon in the change process, and may mean that 
treatment is not possible. He adds that there is a related concept of reactance, which 
can decrease the effect of behavioural change.  
 
Q6 conclusion 
Findings for Q6 explore specific patient factors that can affect the Treatment Choice 
Encounter. Much research focused upon patient's relationships generally or whilst 
involved with specific talking treatments. This demonstrates that there is a paucity of 
research for PD treatments in other fields such as social, nursing, or medical care.  
 
There is also insufficient literature published from a patient’s perspective in terms of 
being assessed, receiving treatment, and exiting treatment (Dimaggio et al, 2006). 
Within the research found, for those pieces which did focus upon patient experience, 
it has been from a perceived perspective rather than first-person perspective. The 
literature review has identified this as a research gap for future study.  
 
Patient thought processes, symptom profile, values, insight, and treatment beliefs, all 
impact upon the therapeutic encounter. To support clinicians to make decisions, it is 
therefore essential that clinicians are not only aware of potential effects, but also 
pitfalls of counter-transferential responses, and ways of overcoming certain negative 
factors.  
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2.9: Literature review conclusion 
A significant amount of literature was reviewed and analysed to explore the research 
question. Unfortunately, little pertained directly to making treatment choices for 
people with PD, meaning that the research question cannot be fully answered by a 
literature review alone, justifying the need for an additional field study as a part of 
this project.  
 
The literature sourced for the review came primarily from psychology and 
psychotherapy literature (Appendix 2), and was generally derived from clinician 
opinion, lacking the patient voice.  
 
This research analysis was useful in exploring the 6 questions posed, however due 
to the origins of the research sources, cannot be considered as representative for 
treatment in the locality researched. The predominant clinicians are not 
psychotherapists or psychologists, however work in a way which is psychologically 
informed. Because no research could be found which studied a sample 
representative of the research locality make-up, the result's cross-applicability must 
be questioned.  
 
In terms of the specific questions posed for the review, interesting insights were 
obtained regarding: the effect of history and stigma on treatment choices, therapeutic 
relationships, patient factors, and clinician factors, however no model was sourced 
concerning decision-making, and no supervision framework was obtained which 
adequately supported the decision-making process.  
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In summary, the following issues are raised by the literature review concerning the 
overall research question: 
 
 PD as a diagnostic construct has a changing nature, making it difficult to 
define prevalence rates, and therefore also treatment rates. 
 There is a separation of the diagnosis from other mental health problems, 
despite its comorbidity, which makes it exclusive, and appears to devalue it. 
 The notions pertaining to treatability have been debated for a number of 
years, which means that there is exclusion. 
 APD and BPD are the main PD diagnosis that are focused upon or treated in 
the literature, meaning that there is insufficient research to support the 
treatment of other PD diagnosis. 
 People can present with traits, or full PD diagnosis, complicating whether they 
are eligible for a treatment or not. 
 Aetiology linked to trauma appears to be a major factor and unchanged in 
terms of the rest of the diagnostic debates, however the transient nature of 
the intense distress is often representative of a person seeking treatment, 
resulting in patients often demanding to focus upon immediate stressors and 
requesting others to solve things for them, conflicting with service wishes to 
focus upon longer-term/‘bigger picture’ solutions. 
 The presence of distress or disability is most important in terms of treatment 
choice, rather than just identifying the symptoms required to fulfil the 
diagnosis to justify treatment. 
 Terminology surrounding the diagnostic label evokes stigma, particularly 
when considering the commonly associated and interchangeable terms used 
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for PD in the literature (i.e. "psychopath"). This is reinforced in research and 
popular media, meaning that empathy for PD is difficult, as exclusion is 
reinforced, and clinicians in patient encounters must be mindful of this.  
 PD is often symbolically recognised by antisocial behaviours (i.e. violence or 
self-harm), which can evoke fear and exclusion. These risks can be 
distracting in Treatment Choice Encounters, and influence decision-making.  
 The available research is considered as incomplete, as people with this 
diagnosis often have multiple co-morbidities in clinical practice (i.e. alcohol 
misuse), but people with co-morbidities are typically excluded from research 
trials, meaning that applicability of the results may be questioned.  
 Standardised approaches or decision-making structures are difficult for people 
with PD, linked to their variable symptom presentations. 
 Clinician factors significantly affect decisions that are made, which must be 
considered in the therapeutic encounter (i.e. Clinician wellness, directedness, 
belief in and knowledge concerning particular treatments, clinician's 
authenticity, ability to clinically formulate).  
 Patient symptoms may vary dependent upon their reaction to the clinician 
conducting the encounter, linked to early attachment patterns and reinforced 
relational difficulties, meaning it may take more than one session to formulate 
treatment choices, which is at odds with the current UK payment system. 
 The notion of 'expert patient' is significantly reinforced in all aspects of care, 
people's viewpoints must be considered in the Treatment Choice Encounter. 
Unfortunately, due to PD patient's difficulties with power-relations, their ability 
to be an ‘expert’ when they are significantly distressed may be limited. They 
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will often request immediate solutions, which then helps them regulate their 
affect, otherwise impulse control is destabilised. 
 The question of treatment prescription is raised in several pieces, with certain 
prescribed treatments (i.e. medications), having clear definitions in who may 
prescribe, however with other treatments (i.e. talking treatments), the 
prescriber's remit and roles are less clearly defined, causing problems. 
 There are risks associated with either prescribing or withholding treatment, 
this is not fully researched, which then impacts upon defensible decision-
making. 
 Treatment termination, notions of recovery, and treatment thresholds, are 
difficult to define, meaning discharge and dependency are major issues which 
influence treatment decisions.  
 Many tools have been identified for use when a person has been accepted for 
treatment for PD, or to assess patient readiness, but no structures or tools 
have been used to define how a person is accepted for treatment, or what 
thresholds or symptoms make them more suitable for treatment than others, 
however certain tools were identified which may be adaptable. 
 The decision-making process for acceptance into treatment is subjective, and 
subject to influence by many factors (i.e.: clinician bias, and reflectivity).  
 Patient motivation is a factor when considering treatment choices, however 
the importance of psychoeducation for PD does not seem to be as 
appropriately emphasised as it is with other mental health disorders. 
 There is a lack of a structure to support specific treatment selection. There are 
disagreements between whether different treatments have different levels of 
treatment efficacy or not. 
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 The ability to empathise and empathetically engage with people who have a 
PD is difficult, and reciprocally, the ability of the PD patient to empathise is 
researched as challenging, and influential concerning decision-making. 
 Insight and resistance are often challenging factors affecting the Treatment 
Choices Encounter. 
 Cost and treatment rationalisation must also be considered when 
contemplating adherence and possibility of successful treatment outcomes.  
 Research cost considerations often take a narrow view (i.e. 'what the cost of 
providing this treatment means for the team?' - Rather than 'does it reduce the 
cost for the wider health and social care system?'), this micro-focus often 
prompts 'revolving-door' patients, which is why new health 'Vanguard Sites' 
are having to consider more of the wider effects than segregated services do.  
 Treatment beliefs held by the patient affect treatment choice, as does insight, 
distress levels, responses to rejection, countertransference and transference, 
reluctance, and resistance. 
 
The literature review informs phenomenological analysis by enabling a presentation 
of current knowledge regarding the treatment choice encounter. However, it also 
identifies research gaps concerning the phenomena of making treatment decisions. 
In the following section, a methodology plan is presented, concerning data from the 
practice setting, which helps to further answer the research question posed. 
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Section 3: Methodology  
  
3.1 Introduction to the Research Design 
In this chapter, the methods used and overall strategy for exploring the research 
question will be described and critically considered. Within the description, analysis 
of different approaches will provide a rationale concerning why specific approaches 
were chosen, within the context of this study and its aims. 
 
3.2 Methodology Background 
Cohen et al (2011) suggest that there is no ‘blueprint’ for research planning; instead 
they suggest governance for research design must be made through the notion of 
‘fitness for purpose’. To analyse this research design for ‘fitness for purpose’, it is 
important to revisit the research question: 
 
How can mental health care staff use a pre formulated guided decision 
process in the selection of  therapeutic interventions for people with PD, within 
the context of rationalisation and service change?  
 
 
Creswell (2014:15) suggests that research approaches are procedures spanning 
broad assumptions to detailed methods concerning methodologies for data 
collection, analysis, and interpretation. Informing the research design has been the 
philosophical standpoint from which this researcher has approached the problem, 
the method proposed and methodology governs this selection, the theory 
underpinning the methodology, and an analysis of the epistemology that underpins 
the theoretical perspective (Crotty, 1998:54).   
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To answer the research question posed, a robust design capable of fulfilling the 
research aim and objectives follows. The research aims were described in Section 1 
along with the overall Action Research staged plan (Figure 1).  
  
3.3 Research Strategy  
A diagrammatic representation of the overall research strategy for this study is 
presented below in figure 9:  
Figure 9: Research Strategy Diagram concerning the research study exploring 
treatment choices for people with Personality Disorder. 
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A good research strategy transforms the research questions and aims into a 
credible, legitimate, and practicable plan which can be operationalised (Dawson, 
2009:110). When planning research, Cohen et al (2011) identify two phases: the 
'divergent' phase, and the 'convergent' phase. The divergent phase opens up a 
range of options facing the researcher; this was considered in the literature review 
stage of this thesis. The convergent stage analyses the options for researching a 
phenomena, understanding which are compatible, desirable, practical, realistic, or  
even unachievable. This strategy is the anchor in achieving research justification. 
The research strategy chosen not only guides the methodology selected, but also 
the approach taken towards research ethics.  
 
When considering a research strategy such as this, this researcher takes into 
account four important philosophical assumptions within social science: 
epistemology, different theoretical perspectives, methodology, and method (Burrell 
and Morgan, 1979). There are many philosophical stand-points and approaches 
applicable to health and social research, however only a brief account of 
methodological approaches relevant to this research study is presented in the 
following sections, to define the researcher’s approach and the related important 
concepts.  
 
3.3.1 Epistemology  
Epistemology concerns theories of ‘knowledge’ (Turri, 2014:24). It underpins how 
knowledge generation processes are understood, and specifically how the person as 
subject of research is theorised (Hollway, 2008). Objectivism, Constructionism, 
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Subjectivism, (and their variants) are considered as three core epistemological 
stand-points within psychotherapeutic research (Crotty, 1998:56).  
 
The standpoints identify this researcher’s perception of ‘human nature’, and 
therefore the relationship between humans and their environment (Cook, 2009:6). 
This is of particular importance when considering the research question, as it 
focuses upon the support provided for an interactional dynamic between clinician 
and patient in the Treatment Choice Encounter. The interaction between individual 
philosophical viewpoints defines the researcher’s subjective interpretation of reality 
(Danvers, 1995).  
 
Explicit declaration of viewpoints and approaches enables readers to understand 
potential subjective bias, constitutes a core part of ethical research, and may 
influence a researcher’s methodological preference, associated with their view of the 
world (Gray, 2004:24). This study is approached from a Constructivist perspective. 
Brief discussions concerning the Objectivist's perspective (Appendix 7) and the 
Subjectivist's perspective (Appendix 8) are provided, but do not form the core part of 
this study, therefore only the Constructivist perspective is considered and 
synthesised below:  
 
3.3.1.1 Constructivism 
When considering the research question, aims, and objectives, this approach is 
more compatible, realistic, and practicable, in terms of problem analysis. The 
justification of utilising a Constructivist approach is on the basis that the research 
focuses on analysing existing influences concerning treatment selection with PD 
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patients, examining different possible aids to treatment selection, which may assist 
the patient journey and care provider's ability to make consistent evidence-based 
decisions.  
 
Constructivism is described as more closely aligned to Subjectivism than 
Objectivism, as it also often adopts an Interpretivist approach. However, rather than 
placing value solely on an individual’s subjective meaning, Constructivists construct 
meaning and value by analysing the researched subject’s interaction with the world 
(Gray, 2004:16). The origins of Constructivism are cited back to Greek philosophers 
such as Heraclitus and Protagoras, more recently it has become a legitimate 
research approach in the psychotherapeutic research arena, since the work of 
Piaget (Phillips, 1995). 
 
Constructivism has two main sub-paradigms: i) Constructivism and ii) Social 
Constructionism. Constructivists focus upon individual meaning-making processes, 
assuming a personal and private component to the process, whereas Social 
Constructivists examine the relationships among people, rejecting isolated 
individualism, prizing a more shared psychological meaning (Twomey-Fosnot, 
2005:4).  
A Social Constructivist approach is the most suitable for this study, on the basis that 
the research question explores the interaction between clinicians, supervisors, and 
patients, and the interaction within and between the opinions of all, rather than solely 
being concerned with a deep understanding of one perspective. 
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Glasersfeld (1995:17), detailed two principles which encapsulate a Constructivist 
approach: firstly, that the purpose of human constructions is not representational, but 
adaptive, and secondly, that knowledge is actively constructed, rather than passively 
received. This means that the Constructivist approach takes the view that people are 
‘active meaning-makers’, who formulate their experiential world “for the sake of 
survival, rather than to represent ontological reality” (Raskin, 2011:224). 
Constructivists typically accommodate and assimilate new knowledge connected to 
their research experience in order to reframe their perception of reality, and advance 
their knowledge base (Wadsworth, 2004:46). 
 
There are a number of criticisms of the Constructivist approach, such as an overly 
subjective researcher perspective (bias), with the researcher's own assumptions and 
construction of events affecting the outcome of the research. This is critical, as it 
views Constructivists as ‘dangerous’, because they deny external realities, meaning 
that an antirealist (‘anything goes’) perspective may be adopted, contradicting any 
‘essentialist truth’ claims (Gill, 1996). Guston (2001:93) challenges this, suggesting 
that ‘serviceable truths’ are possible, which satisfy scientific testing without 
compromising individual viewpoints. 
 
Supporters of the Constructivist viewpoint argue strongly that Social Constructivists 
accept the reality that society provides a structure to conduct research within, 
however view the lack of restraint that Constructivist theory provides as liberating, 
meaning that researchers can understand and reveal new realities within the 
dynamic of a social world. In this sense, arguments concern the conceptualisation of 
how Constructivism is perceived. Raskin (2011:224) suggests that it should be 
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conceived as an epistemological theory as opposed to an ontological theory, 
meaning that it is concerned with “What people can know and how they know it”, 
rather than how something existed and its nature or being.  
 
3.3.2 Theoretical perspectives  
As explained above, Interpretivism is a philosophical stance that informs a 
methodology, and provides a logical context for the research process.  
 
Interpretivism is a theoretical perspective linked to Social Constructivism, because 
Constructivists argue that ‘truth and meaning do not exist in an external world, but 
are created by the subject's interaction with the world’ (Gray, 2014:20). Aligned with 
this, the researcher considers that, for the research question concerning the 
phenomena of treatment choice to be understood, individual perceptions and 
constructed meanings for reality must also be explored, to generate a collective 
understanding of the phenomena, or bring together opposing realities, which means 
the complexities of the phenomena can be revealed.  
 
The researcher considers the adoption of an interpretavist approach as essential, as 
the literature review demonstrated, there are multiple different opinions about why 
Treatment Choice Encounters are difficult with PD patients, but there is a polarised 
research base for decision-making, primarily restricted to psychology/psychotherapy 
encounters. Understanding why this may be, by exploring practitioner's viewpoints, 
allows the participant interpretations to be revealed, enabling co-constructed results 
which contribute essential new insights into the phenomena, aligned with social 
constructivist principles.     
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3.3.3 Selecting a Methodology  
Interpretivism is a major anti-positivist stance, and commonly draws upon different 
theoretical perspectives of inquiry, such as: symbolic interactionism, phenomenology, 
and hermeneutics. It typically draws upon situational-specific, historical, and culturally 
derived interpretations of the social world (Crotty, 1998:72).  
 
Due to the Social Constructivist nature of the study, a hermeneutical approach was 
taken regarding the literature review. This is because constructivists view knowledge 
as created not discovered, meaning that when conducting a literature review, the 
information from all sources is analysed, interpreted, and in so generates a different 
outcome as a whole rather than individual parts, hermeneutic approaches embody 
this, rejecting positivist standpoints, allowing an in-depth search for meaning within 
literature reviews.  
 
The literature review generated insufficient knowledge to answer the research 
question asked, and lacked depth regarding clinician’s perspectives in the NHS.  
When considering the AR Methodology used, this then identified a need to consider a 
further AR iteration, asking questions of clinicians in practice, rather than gaining 
information from written sources. An IPA Method was selected, as this method has 
origins in hermeneutics, and is researched to enable exploration of people’s 
experiences of a given phenomenon, in this study: how treatment decisions are made 
with people who have PD.  
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3.3.4 Methodology  
‘Methodology’ is a set of methods, rules, and principles for regulating an approach, 
which in reality governs the relationship between the researcher and what is being 
researched, concerned with the principles and procedures of the research inquiry 
itself (Creswell, 2013:22). It justifies the plan of action behind a particular method 
used, associated with the desired outcome generated by the research question. The 
issue in focus is significantly complex, developed from previous research in this 
practice setting, detailed in Section 1.  
 
There are many different types of methodologies, some of which are more allied with 
Social Constructivist Interpretative paradigms, including Phenomenological 
Research, Grounded Theory, and AR. An AR approach is taken for this study. The 
argument for this approach is that the aim of the study is to analyse a practice issue, 
and change an element of practice in response to the results generated. This 
decision was not only selected by the researcher, but also the validation group who 
were consulted as part of this research.  
 
Three reasons are provided regarding the choice of an AR methodology. Firstly, AR 
is described as ‘responsive’ in order to achieve the ‘action’, the issue is practice 
generated and problematic for clinicians, patients, and supervisors, therefore 
requires actions to analyse. Secondly, AR is emergent, meaning that potential 
answers and results are not available for ‘testing’, this is the case with the problem 
focussed upon in the study. And finally it is ‘not impersonal’ (Brydon-Miller, 
Greenwood and Maguire, 2003), meaning that the researcher and all others involved 
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in the research process have respected opinions, enabling a socially constructed 
outcome.   
 
Reason et al (2014) identified the importance of moving beyond grand narratives to 
understanding micro-perspectives that may influence local practice, enabled by AR. 
Tacit knowledge is the embodied know-how that is the foundation of action in 
practice, this is different from knowing what should happen based in theory regarding 
a certain situation. This is key to the research question posed; NICE guidance 
describes treatments for PD, but it is clinicians in practice who make the decision 
about whether to or not to provide treatment.  
 
The research question posed can therefore only be partially answered by conducting 
the literature review (Section 2), the remainder of the question requires discussion 
with people who currently ‘know how’, or conduct the Treatment Choice Encounter. 
In conducting this research and analysing the outcome, practice development can 
occur, which is a reason why an AR methodology was selected.  
 
Action Research 
McNiff et al (2006) suggest that AR is a powerful tool to facilitate change at a local 
level, developed by Lewin (Lewin, 1946). Cohen et al (2011) expand, explaining that 
AR methodology is not restrictive, and is beneficial in a variety of areas, for example: 
teaching methods, learning strategies, evaluative procedures, for analysis of values 
and attitudes, management, and administration. This research focuses upon the 
practice procedure of selecting treatments, and requires analysis of values and 
attitudes from the patient, clinician, and organisation, which may influence the 
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outcome of this encounter. AR enables participant research, which explores personal 
and social perspectives to understand the different values and attitudes which 
influence the decision-making process.  
 
To gather clinician opinion, various methods exist that may be used within AR 
methodology. Participatory research of this kind has a double objective; firstly to 
produce knowledge and action directly useful to a group of people, and secondly to 
empower people through the research process, where research participants 
construct and use their own knowledge to change practice, making improvements for 
clinician, service, and patient (Coghlan et al, 2014:54).  
 
AR as a methodology does not mean that a specific method is prescribed, in the 
same way as it is not selected from a specific epistemology. The method required 
within the AR process must be phenomenological, to focus upon the subject matter 
and participatory research methods.  
 
3.3.5 Methods  
Various methods were considered when developing the research strategy for this 
study associated with the Interpretivist paradigm, including narrative analysis, use of 
focus groups, and clinician interviews. The method selected was clinician interviews, 
analysed using an IPA framework, on balance it is the best method for providing an 
insight into individual clinician’s interpretations of the Treatment Choice Encounter, 
whilst allowing exploration of variables influencing the encounter.  
 
Student Number: 100104045 
110 
 
IPA can be considered as either a methodology in its own right, or a method used to 
analyse transcripts within another methodology, such as AR (Biggerstaff et al, 2008). 
As a method, IPA typically has five goals: (1) to generate qualitative data concerning 
lived experiences, (2) to employ IPA to the qualitative data, (3) identify key themes 
within and across different data sources, (4) interpret and describe the lived 
experience, and (5) provide recommendations for change, maintenance, or 
discontinuation of a phenomena, based upon research results (Cooper et al, 2012).  
These five goals are consistent with the research aims of this study, and justify why 
IPA is the method rather than the methodology, as the results of the IPA will 
constitute a part of answering the AR question, rather than the whole. It is also 
consistent with the Social Constructivist approach, as it enables the interpretation of 
multiple personal perspectives, incorporating results generated from a shared reality 
of the focused issue.  
 
A research study which has elements of both quantitative and qualitative data 
gathering and analysis is considered as a ‘mixed-methods’ study (Venkatesh et al, 
2013). Despite the majority of this study employing qualitative analysis, it does 
employ aspects of quantitative analysis, and therefore is considered as mixed 
methods. When considering complex human phenomena, Doyle et al (2016) stated 
that the use of mixed-methods allows a deeper and broader understanding. Creswell 
(2014:2) expands, explaining that through the collective strength analysis, a better 
understanding is gained of the researched problem than with either type of data 
alone. 
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3.3.5.1 IPA approach  
Smith et al (2014:63) provide an IPA framework which was employed for this 
research (Appendix 9). They emphasise that this approach involves detailed 
exploration of the participant's lived experience and account of an encounter, rather 
than feeling the need to produce an objective statement of the event itself. The use 
of IPA in this study is justified, as it enables the ‘Treatment Choice Encounter’ to be 
fully explored from a clinician perspective. 
 
Within the IPA process, the researcher has an active role, in a two-stage (or double-
hermeneutic) interpretive process: the participant is trying to make sense of their 
world; the researcher is trying to make sense of the participant's 'making sense' of 
their world (West, 2013). IPA is therefore proposed as being intellectually connected 
to hermeneutics and theories of interpretation (Tomkins et al, 2010), which is why it 
is linked in this research strategy. IPA may combine different interpretative stances, 
such as empathic hermeneutics with questioning hermeneutics. The way in which 
interviews were designed and data gathered are expanded upon in Section 4 in 
order to understand the complexities of asking the specific research question. 
 
3.3.5.2 Questionnaires 
The second method used within the AR process is data gathering through patient 
questionnaires. The questionnaires will enable patient data to be obtained regarding 
the Treatment Choices Encounter, which will help enhance support strategies 
provided for clinicians in the decision-making process.  
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The reason that questionnaires are used to gain patient data, rather than using the 
interview format that is used with clinicians and supervisors, is that firstly, the patient 
information is more unique concerning their individual encounter, rather than 
providing examples of multiple encounters, which is the case for clinicians, and 
secondly, because of the ‘effect’ an interview may have in influencing patient's 
expression of their thoughts. It is accepted that interviews may be intimidating for 
some participants, and may therefore be subject to more bias than anonymised 
questionnaires (Kitzinger, 1995). As is the nature of AR, the researcher clinically 
works in the area where the research was conducted, and therefore would influence 
an interview more than a questionnaire.  
 
Lastly, consideration was made regarding gaining support for interviews, similar to 
the ones planned with clinicians and supervisors, with patients, using an interviewer 
that is either a peer support worker or external from the practice area. Although this 
was considered as an option, it was decided that this would alter the data gained, as 
there is a strength connected with the Constructivist and Interpretivist epistemologies 
that may be compromised by an external researcher. 
 
3.4 Ethical Considerations 
Ethical principles are central to any research and practice-based study, the main two 
ethical principles are beneficence and non-maleficence (NMC, 2015; BABCP, 2010). 
There are multiple areas to consider when drawing attention to and expressing the 
ethics of this study, therefore the ethical considerations are presented under 
separate headings below: 
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3.4.1 Consent 
Consent was required within each stage of the research process:  
 
Patient Feedback Questionnaires 
Each patient who entered treatment was provided with a questionnaire to complete 
(Appendix 30). Completion of this questionnaire was voluntary, the questionnaire 
contained a summary outlining the research being conducted. A stamped addressed 
envelope was provided for returning the questionnaire; no patient identifying data 
was contained within the questionnaire, to ensure anonymous feedback for the 
patient. 
 
Clinician and Supervisor Interviews 
Written consent was obtained from each person participating within the semi-
structured interview process. A consent form was devised, to ensure participants 
were aware of study aims and objectives and consent and confidentiality issues 
pertaining to the study (Appendix 31). 
 
Validation Groups 
Minutes were taken at each validation group, detailing a summary of discussions. It 
was appreciated that attendance at the validation group was voluntary, and therefore 
attendance varied. Consent to participate in this group was discussed at the start of 
each group.  
 
  
Student Number: 100104045 
114 
 
3.4.2 Deception  
All semi-structured interview questions were provided to the interviewees in advance 
of their interview, enabling transparency for all participants. This study does not use 
deception; therefore there are no considerations in this area. 
 
3.4.3 Debriefing  
There was not considered to be a need to provide a specific debrief within this study, 
due to the nature of the investigation. As this is an AR study, debrief was provided 
on an ongoing basis through the validation groups. The study outcomes were 
available to all participants following study completion. 
 
If clinicians or supervisors had required support due to any issues raised by 
participating in the research, the service managers agreed to provide this. Should 
patients have required support or advice due to the research study, the NHS Trust 
Patient Advice and Liaison Service agreed to provide this support.  
 
3.4.4 Withdrawal from the investigation 
 Once the anonymous patient questionnaires were received, they could not be 
withdrawn from the study. This was made clear within each participant letter. 
Following each semi-structured interview, transcription took place. After participant 
validation concerning accuracy, the transcript was provided with a study number, 
meaning it was anonymised, and candidates were unable to withdraw from the 
investigation. This was specified in each participant consent letter. 
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3.4.5 Confidentiality 
Confidentiality issues concern: the organisation, the patient, and the interviewees. All 
information gained within the research will become public, due to the intention to 
disseminate findings within teams post-study, to publish findings within peer-
reviewed academic journals, and also present findings at relevant conferences. 
 
Questionnaires (Appendix 30): The questionnaires were structured so that they had 
no identifying information upon them, ensuring confidentiality. Participants could 
either choose to hand-deliver or post them back, and were provided with a stamped 
addressed envelope to do so. Participants who had literacy difficulties could choose 
to answer the questions when read by the clinician. 
 
Audiotaped Interviews: prior to consenting to the interview, it was made explicit that 
the interview content would be used for research purposes. Interviewees were 
requested to complete a demographic questionnaire prior to the interview (Appendix 
32). Completion of this form was optional, and it was separated from the interview 
transcripts once they were anonymised. Audiotaped sessions were securely 
encrypted as per NHS Trust policy, conforming with terms of confidentiality. 
 
Interview Transcripts: With regard to confidentiality, the following precautions were 
taken: 
 Removal of subject identity from final transcript. Each transcript was 
referred to by number only. 
 It was recognised that due to the small number of clinicians and 
supervisors in the NHS Trust sites involved, anonymity could not be fully 
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assured, however the right to withdraw was explicitly stated, until the point 
the transcript was anonymised. 
 Basic data is kept identified by a number/code, which ensures 
anonymization, all notes will be kept for a period of 5 years after the study 
is completed, then destroyed. 
 Secure storage of transcription data was assured. 
 
3.4.6 Protection of participants   
All questionnaires had to remain anonymous, therefore participants were fully 
protected. Written consent was obtained from each person participating within the 
interview part of the research, the consent form was designed to ensure participants 
are protected by being aware of their rights, study aims and objectives, and consent 
and confidentiality issues pertaining to the study. 
 
3.4.7 Giving advice  
Advice letters (Appendix 33) were prepared for this research project, and provided to 
each interviewee who agreed to participate. The letter provided a brief study 
rationale, and consent and confidentiality information, including the right to withdraw 
from the study, with boundaries about when the right to withdraw would be removed. 
 
3.4.8 Data protection 
Data protection issues considered in this study include: anonymity of research 
participants, described in the consent and confidentiality sections above. All 
questionnaires and audiotapes were securely encrypted using NHS Trust approved 
software, data is securely locked in Trust filing cabinets. Once transcriptions were 
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validated by participants, the encrypted files were destroyed. Transcriptions will be 
kept securely for 5 years after the study is completed, then destroyed.  
 
3.5 Ethics approval 
Ethics approval for this study was gained from: 
 
 The UK National Health Service Ethics Committee  
 The University of Derby Ethics Committee  
 Regional Research and Development Committee 
 
Approval letters are provided in Appendix 34, 35 & 36. The reason that it is important 
to gain approval is to adhere to policy and also to provide an external analysis of the 
study structure which checks the ethical validity of approaches to protect all.  
 
3.6 Subjects and Sampling 
Patient Questionnaire: Questionnaires (Appendix 30) were provided to all patients 
with a diagnosis of PD, attending sessions over a 4-month period. The number of 
questionnaires supplied was recorded by clinicians. Research suggests that 
approximately 50% response rate is typical for a paper questionnaire in regards to 
health intervention (Care Quality Commission, 2014). This was the target for the 
response rate for this study. All results are presented and the actual response rate 
clarified when obtained, to enable the reader to considering the representativeness 
of the data collected. 
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Clinician and Supervisor Interviews: Smith et al (2014:56) suggest that IPA 
researchers should attempt to source a purposeful homogenous sample. He also 
suggests that a sample size of between 5-10 participants is typical for an IPA study. 
A distinctive factor of IPA is its commitment to a detailed interpretative account of the 
cases included, and many researchers recognise that this can only realistically be 
conducted on a small scale. The social constructivist perspective the research 
question is approached from means there is a need to explore sufficient individual 
perspectives to enable examination of all perspectives required in order to generate 
results that prize individuality whilst exposing collective experiences.  
 
Hefferon et al (2011) emphasise that a ‘less is more’ approach must be applied to 
IPA sample size, suggesting that the depth of analysis may be compromised if 
researchers attempt to include too many participants, they suggest 3-6 participants 
for an Masters level study, and no more than 10 participants for a Doctorate study 
such as this. In support of this, West (2013) argues that detailed IPA analysis is 
demanding, with each one-hour interview being expected to require approximately 
40 hours of analysis to provide rich analysis and understanding of each participant 
experience.  
 
The predicted sample size in the study for the semi-structured clinician interviews 
was 6-8 interviews. It was anticipated that this sample size would allow the gathering 
of data which was rich and detailed enough to answer the research question. Each 
clinician may work with 30 (or more) people with PD, which provides perspective 
upon up to 240 cases. The minimum number of interviewees was set at 4, and a 
maximum number was set at 15, interviews would continue until was saturation was 
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reached. Saturation in this context means that the collection of any new data does 
not shed any more light on the issue researched (Guest, Bunce and Johnson, 2006). 
A theoretical sampling was used, due to the specific nature of the phenomena under 
investigation and the small number of team workers with this patient group. 
  
For the supervisor-clinician interviews, a theoretical sampling method was also used, 
and the target number of interviews was set at 3-4. This is representative of 40% of 
actual employed supervisees across the teams involved in the research. 
 
3.7 Researcher Influence 
The researcher declares an interest in this particular area, having a background in 
mental health nursing, and qualification and practice as a psychotherapist. The 
researcher currently works as a Consultant Psychotherapist and Advanced Nurse 
Consultant within the NHS service in which the research was conducted.  
 
The researcher interest and service position is declared, as it may influence the 
interviewee’s participation due to their relationship with the researcher. Some 
researchers may consider this as a problem, however as this research is being 
approached from a constructivist perspective, it is accepted that any researcher will 
have an influence upon the research conducted. An independent researcher was 
considered in regards to conducting the semi-structured interviews; however it was 
considered that being known to the participants may instill trust and honesty on 
questioning, due to the pre-existing relationship, more than with a researcher 
unknown to participants. Within the AR process, it is accepted that the researcher is 
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a planner, leader, catalyst, facilitator, teacher, designer, listener, observer, and 
synthesizer (McNiff et al, 2006). 
 
 After all interviews were transcribed and analysed, coding was reviewed in depth by 
a researcher who had not been involved in the interview process. The second 
researcher received the transcripts after anonymization. After discussions, the 
results were taken to a validation group of stakeholders for further discussion and 
reflection. 
 
3.8 Payments or rewards/incentives 
No payments or rewards were provided for the interviews or questionnaires. 
Interviews were conducted within scheduled work time, which was paid by the NHS 
Trust. Team Leaders and the Operational Directors have agreed to this research. 
 
3.9 Study validity and credibility 
Evaluation of qualitative research is difficult due to the nature of the research, there 
are many variations, rather than one true perspective on reality. However it is 
necessary to make judgements, but the difficulty is that because there are many 
different types of qualitative approach, it is difficult to set criteria.  
 
Yardley (2014:243) presents a framework for demonstrating validity in qualitative 
research applied to this research study. This framework formed the basis of strategy 
included within the above sections regarding ethics, methodology, data analysis, and 
collection. The framework is considered again at the end of the thesis, in the 
strengths and limitations section.  
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3.10 - Section 3 - Conclusion 
Within this chapter, the research strategy and ethical considerations for this project 
have been described and analysed, providing rationales for the choice of method 
and methodology employed, these are summarised diagramitically at the start of the 
section in Figure 9. 
 
When planning the IPA study, clinical practice difficulties were encountered, which 
affected the study method. The next section focuses upon how the method was 
refined, and tools developed to ‘funnel’ the questioning.  
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Section 4: Heuristic Development  
4.1 Introduction 
The literature review demonstrated how the concept of making treatment decisions 
with PD patients is complicated, and clarified that there also a gap in the current 
national treatment guidance for Personality Disorder (NICE 2009a,b) concerning how 
the decision to treat is made. Associated with both of these points are specific 
process issues that were encountered in practice when planning the research, 
explored below:  
 
4.2 Locality AR Progression 
Considering local service reformation, a practice-based AR initiative (CBT Skills 
Sessions) was introduced to increase therapeutic skills of clinicians. This was at the 
same time as the locality shifted from a discipline-specific model, to an MDT model. 
 
The AR study evaluated the effects of CBT Skills Sessions; clinicians and 
supervisors repeatedly commented that a practice challenge arising from service 
reformation concerned ‘how’ clinicians are supported to make treatment choices, and 
‘why’ people were allocated/not allocated certain therapeutic interventions, forming 
the basis of this research.  
 
This generated a ‘bottom-up’ rather than ‘top-down’ (Burns, 2007:39) problem on 
which to focus a new AR iteration, prompting this research study. This issue was not 
anticipated in the original research, however through wider exploration in the 
evaluation phase, this proved to be an important issue not only for clinicians 
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delivering the newly formed service, but also GP’s referring into the service, and a 
theme raised in patient feedback and complaints.  
 
4.3 Understanding the issue 
The literature review presented in Section 4 provided evidence that that the 
Treatment Choice Encounter is under-researched, but complicated, and has 
systemic variables that influence outcomes, rather than merely specific factors 
focused on one clinician or supervisor. From an AR perspective, there was therefore 
a need to explore this issue further with participants, in order to construct the 
knowledge that is missing from current published literature.  
 
Additional to knowledge exploration, the literature review also generated a need to 
define current thresholds and decision-making processes. The participant research  
design was not purely generated by the researcher, but was decided upon after 
consultation with stakeholders through validation groups.  
 
4.4 Options for exploration and IPA interview design  
In practice, meetings with stakeholders (Figure 10) in validation groups suggested 
that semi-structured interviews with clinicians could be a helpful way of exploring the 
difficulty. This method was favoured in the validation group process, however there 
were specific issues regarding who would be sampled, and what questions would be 
asked.  
 
The validation groups explored the fact that there are now clinicians of different 
disciplines conducting Treatment Choice Encounters. When the literature review 
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outcomes were explored, validation group members expressed the need to both 
collect information from a multi-professional sample (identified as a gap in the 
literature review), and gain perspectives concerning different types of treatment 
decisions, not only psychological interventions (which was the core focus of the 
majority of literature review findings). 
 
The validation group supported the use of semi-structured interviews in a 1:1 setting, 
as they stated that with other methods (i.e. group settings), unique perspectives may 
not be as strongly represented, and it was also identified that certain clinicians may 
feel intimidated when talking in front of colleagues who make the same decisions, 
but either have less or more experience/qualifications than themselves. 
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4.5 Heuristics 
A heuristic is either a physical tool or a mental short-cut, which aids in the decision-
making process (Crowley et al, 2013). UK mental health examples of written or 
diagrammatic heuristics include algorithms for NICE guidance or ‘rules of thumb’, 
which people reference when making choices, and decision-making trees. It is 
argued that people use either cognitive heuristics or heuristic tools in healthcare as a 
core part of almost all decision-making processes (Gigerenzer et al, 2011). The need 
to consider individual decision-maker's heuristic processes was considered as 
central by the validation group, to answer the research question. 
 
Payne et al (2008:571) explain the reasoning behind heuristic use in stressful 
healthcare encounters: 
 
“Human information processing and prospect theories suggest that people 
have limited cognitive capacity. Consequently, people rely on cognitive 
heuristics to reduce complex input data to manageable dimensions. The 
management of data is especially important within the Treatment Choice 
Encounter. Clinicians process a great deal of information, often under 
conditions of uncertainty and stress” (Payne et al, 2008:571). 
 
The use of cognitive heuristics has strengths and weaknesses. A positive example of 
cognitive heuristics is associated with a rapid, exemplar-based non-analytical model 
of decision-making and expert reasoning (Norman et al, 2007; Lago 2008). However, 
a disadvantage (termed "heuristic biases”) may include misallocation of resources in 
healthcare, and in some cases, medical errors (Croskerry, 2003; Kempainen et al, 
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2003), and this can produce bias (Tversky et al, 1974). Crowley et al (2013) 
researched heuristic bias, and detail eight biases which occur in decision-making: 
anchoring, availability, confirmation bias, gambler’s fallacy, representativeness, 
overconfidence, and under-confidence.  
 
As the topic of clinical decision-making progressed in locality teams and validation 
groups, mixed responses were obtained. The consensus reached was that the 
research would be helpful in a step towards more support for clinicians. However, 
anxiety was also expressed about being ‘judged’ as a part of the decision-making 
process.  
 
Once raised, this process issue was analysed by the researcher, and in order to 
progress, it was considered that a basic heuristic using common variables for 
treatment decisions would be created, to reduce clinician anxiety, and provide a 
platform for practice exploration, as a part of the research method. Validation groups 
and clinical teams supported this methodological addition, and participants for the 
interview process increased.  
 
A reason for developing a written heuristic is that it should encourage people to 
follow a certain way of reasoning when considering treatment choices, which may be 
similar or different to their own internal cognitive heuristic that has been developed 
over their practice years.  
 
There are arguments about whether heuristic use should be or can be altered (Eva 
et al, 2005), these arguments propose that attempts to ‘de-bias’ human judgments 
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produced mixed-results (Koriat and Bjork 2006; McKenzie, 2006). However, 
arguments for the use of heuristic diagrams claim that they are produced for the 
purpose of helping the user to understand the problem, and scientifically consider 
different outcomes (Chamiso, 2011). 
 
Although clinicians may be able to articulate rational decision-making and treatment 
allocation outside of the patient encounter, research and anecdotal practice data 
provided through the validation groups demonstrated that emotive patient 
encounters may trigger so-called ‘irrational’ psychology in decision-making. 
Research emphasises that this should not be under-estimated, and can account for 
an increased use of resources, and may be indicative of staff who feel under strain 
(Hozo et al, 2008).  
 
When making treatment decisions, locality clinical teams agreed upon the following 
fixed main variables: the person, available treatment provision, the diagnosis, and 
the degree of engagement with services.  
 
4.5.1 Heuristics Outcomes 
The fact that a person has a PD diagnosis does not automatically make them eligible 
for a specialist service, in the same way that having a diagnosis of Diabetes would 
not automatically necessitate being under the care of an Endocrinologist. As a part of 
the research method, it was therefore accepted that ethical treatment allocation is 
achieved by efficient resource allocation. In healthcare, this means ‘professional 
responsibility for stewardship of finite societal healthcare resources’ (Brett et al, 
2012), with the concept of efficiency including “parsimony (conceptual efficiency), 
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speed (temporal efficiency), and cost-effectiveness (financial efficiency)” (Newman-
Toker et al, 2013).  
 
Validation groups and staff consultation agreed that current treatment decisions are 
not solely governed by cost, there is also an alteration and refinement of treatments 
offered that may trigger dependency, relevant to research into the ‘Recovery’ 
focused agenda, and the focus on self-management in mental health care (Williams 
et al, 2012). These themes derive from notions of long-term conditions management 
in physical health care (i.e.: Diabetes management).  
 
In the researched practice area, the teams analysed manage the 'gateway' to 
specialist treatments (i.e. residential therapy packages), and also provide crisis 
support to associated services, including housing and benefits agencies. Prior to the 
AR, there was no schedule or tool to aid their decision-making, and therefore, clinical 
judgement was based upon individual's knowledge of local procedures, available 
resources, team discussion, and their own subjective cognitive heuristic concerning 
treatment choice. Clinician and supervisor feedback in the stakeholder consultation 
identified that a diagrammatic heuristic, or heuristic device to aid consistent clinician 
decision-making, would be beneficial.  
 
4.5.2 ‘Treatment Choices Grid’ Development 
In response to clinician, supervisor, and patient concerns, and identified research 
gaps and paucity of direction within NICE Guidance (2009a&b), a heuristic grid 
format solution was developed as a potential practice solution, The rationale was 
that such approaches are used successfully in family and systems therapy (Sevigny 
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et al, 2014). The grid format is a basic heuristic, it does not provide an actual 
outcome, instead it focuses clinicians toward formulating the patient's unique 
problems, their understanding and acceptance of these problems, and also their 
willingness to engage in treatment. When working with PD patients, it is essential 
that engagement is assessed, otherwise intervention is focused upon risk 
management only, which is not considered a core treatment (Hamilton, 2010:181). 
 
As part of the AR process, the researcher worked with locality clinical leads to 
develop a ‘Treatment Choices Grid’ for clinicians working with PD patients, to aid 
clinical decision-making, and also provide 4 different areas to focus the semi-
structured interview upon. The Treatment Choices Grid focuses upon both the 
patients’ perception of their diagnosis, and treatment.  
 
The Treatment Choices Grid is underpinned by evidence-based Motivational 
Interviewing (Romano and Peters, 2015) principles, it incorporates NICE Guidance 
treatment recommendations (NICE, 2009a,b) and also specific treatments that are 
provided within the locality. The Treatment Choices Grid was agreed with locality 
clinicians and through the validation group, which consisted of patient and carer 
representatives as well as professionals. No changes have been made to the 
Treatment Choices Grid in the duration of this study, however in post-study research 
it's efficacy is to be evaluated.  
 
There are three versions of the same grid: (1) for direct discussion with patients 
(Figure 11), (2) for clinician guidance (Figure 12), and (3) for supervisor guidance 
(Figure 13):  
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Figure 11: ‘Treatment Choices Grid’ – Patient Version 
 
 
Figure 12: ‘Treatment Choices Grid’ – Clinician Version 
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Figure 13: ‘Treatment Choices Grid’ – Supervisor Version 
 
 
 
A grid format is utilised, as it provides consistency but is not too complicated, it 
provides a visual aid within Treatment Choice Encounters, and encourages a 
formulated approach to treatment choice. 
 
4.5.3 Influences concerning ‘Treatment Choices Grid’ (TCG) Development 
Many different factors influenced the development of the TCG tool. These factors 
include feedback from stakeholders and validation groups, literature review findings, 
utilising concepts from CBT formulation techniques (Grant et al, 2010), MI change 
cycles (William et al, 2012), and Systemic Therapy (Hedges, 2005). The TCG does 
not dictate patient treatments, but is suggested for use as a heuristic for problem-
solving when engaging PD patients.  
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4.5.4 Originality and Copyright 
The TCG uses a format similar to other heuristics and MI approaches utilised within 
physical and mental health care. It is a format that has also been used with people 
with psychosis (Romano and Peters, 2015). The grids are also influenced by MI grid 
tools used with people with substance misuse difficulties (Ezzame et al 2015:207), 
however as far as the author is aware, this is the first of its type specifically 
structured for use with PD patients. 
 
The concept of intellectual property pertains to both personal property and real 
property (Copyright, Designs and Patents Act, 1988). In terms of originality, for a 
piece of work to be considered as original, it does not have to be new or innovative, 
copyright is more concerned about the manner by which it is created. The TCG 
draws upon works from several fields of mental health, and it uses a grid format 
similar to other practice tools, however its application and design are unique, and 
originate from the author, therefore the work is considered to be an ‘original, literary 
work’, subject to copyright.  
 
4.6 Why introduce a heuristic? 
The impact of discussing the phenomena of treatment decisions changed the way 
that locality clinicians viewed their decision-making. Their apprehension about 
whether their choices were ‘right’ was highlighted via locality meetings and clinical 
supervision. Therefore, parallel to the research proposal being designed, the 
researcher conducted stakeholder engagement to explore different factors which 
may aid consistent decision-making, the result of which was the development of the 
TCG.  
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The TCG has influenced this research, as it not only enabled people to focus upon 
areas that will influence clinical decision-making and treatment choices, but also 
provided assistance when considering Treatment Choice Encounters. This in itself 
contributes to the AR process and design of the semi-structured interviews, as it 
focuses the way people decision-make with PD patients. 
 
Schleiermacher (1998) suggests that IPA concerns understanding the person being 
researched, as well as the phenomena itself, this point is key to this research, as the 
practitioner's variables (i.e training, attitude, belief system, experience) inform the 
encounter as much as the patient’s presentation. Using a heuristic such as the TCG 
allows focused and funnelled questioning, to explore both the phenomena of making 
treatment decisions, and the clinician’s individual perceptions of the encounter and 
choice itself, and assist patient questionnaires to be focused upon the decision-
making process, rather than the clinician. The literature review identified a lack of 
guidance for decision making, the TCG is considered a potential clinical heuristic that 
may aid clinicians to explore decision making. 
 
4.7 Bracketing and Interpretation 
Husserl originally discussed the concept of ‘bracketing’ in the Interpretivist  
phenomenological method (Zahavi, 2003). He explained that researchers should 
consider the consequences of their own predisposed opinions, and 'bracket' these 
off when conducting research. This is an important point when considering the 
researcher's role in this study.  
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As a psychotherapist, diagnostician, and prescriber, the researcher has training in 
decision-making concerning treatment choices, therefore has a preconceived idea 
concerning the ‘right’ and the ‘wrong’ way to make treatment choices with PD 
patients. The researcher’s viewpoints have influenced the development of the 
heuristic to enable others to make consistent treatment choices. The researcher’s 
viewpoints also shape the interview structure and interpretation of the transcriptions.  
 
The predisposed notions and subjectivity that the researcher brings is not a negative 
issue, but a part of the overall process in Constructivist research, which uses 
Interpretivist theoretical stand-points. Merleau-Ponty (1962) suggests that true 
bracketing is not possible, as there is an ‘embodied’ nature of the researcher's 
relationship with the world, meaning that the researcher's point of view will influence, 
suggesting that empathising with other's experiences is the closest that a person can 
get, as achieving a shared reality would be impossible, because of each person’s 
subjective uniqueness. Gadamer (1990) suggests that one’s preconceptions can 
hinder the interpretative process, therefore emphasises that openness is required in 
IPA research, preferably with a researcher's preconceptions concerning the 
phenomena identified in advance, otherwise to be identified as the 
engagement/research process continues. 
 
Due to the issues associated with the researcher's potential bias for particular 
outcomes and interpretations, to attempt to minimise the effect upon the research, 
bracketing was used in the study, providing their own viewpoint regarding the 
Treatment Choice Encounter, answering the semi-structured research questions, 
prior to conducting any of the research interviews. In addition, validation groups are 
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used throughout the research process, to enable analysis of any potential bias that 
the researcher may bring, to enhance transparency of the research process, and 
increase credibility. Lastly, a second researcher has checked all transcripts, which 
also helps identify any potential difficulties concerning bias and bracketing.  
 
Gadamer (1990) explores the dialogue between something old (previously held 
perceptions of the phenomena) and something new (the transcript or new 
information brought through the validation group), emphasising that Interpretivist 
research does not aim for researcher neutrality (as would be considered in 
quantitative research), but instead an appropriation of the researcher's “fore-
meanings and prejudices”. 
 
4.8 Interview and Questionnaire Design 
The study focus is upon using the TCG in a 'funnelling' technique, to discover 
clinician's viewpoints upon what influences the Treatment Choice Encounter, by 
analysing their experience of working with different PD patients to answer the 
original research question, the aim is not to test a hypothesis or to test whether the 
heuristic (TCG) is successful in practice.  
 
The introduction of the heuristic enables focus for the interview and questionnaire 
design when considering the Treatment Choice Encounter. The TCG consists of four 
quadrants, which underpin the ‘funnelling’ process concerning the semi-structured 
interview design. Validation groups (consisting of clinicians, carers, patients, and 
supervisors) have co-produced and assisted in further refinement of interview 
schedules for clinicians and questionnaires for patients.  
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No significant changes were made by the validation groups to the concepts of the 
TCG, however suggestions were made regarding colour schemes, design, and 
language.  
 
4.9 IPA Analysis 
In this research, IPA is utilised as a method, rather than methodology. This is 
because it is only one component of the AR study, the other components being a 
hermeneutic literature review, validation groups, and patient questionnaires. It is not 
uncommon for several related methods to be used to contribute to an AR process. 
 
In an overall Constructivist study, using interpretative analysis is posited to offer a 
viewpoint about the semi-structured interview transcript (which the participant may 
not be able to). In terms of using IPA, it means that a detailed and systematic 
analysis can be applied to multiple transcripts, generating idiosyncrasies, and also 
making connections between transcript themes, themes in the literature review, and 
themes raised through patient feedback. In this way, subjectivity of each participant 
and research piece is preserved, also allowing an inter-subjective dimension, to 
expose thematic dialogue emerging between practice data and psychotherapeutic 
theory/research.  
 
Smith et al (2009:28) suggest that a Constructivist process concerns analysing the 
dynamic relationship between the “part and the whole; to understand the whole, you 
look at the parts”. They reflect that this Interpretivist notion is not without critics, due 
to its “inherent circularity”, however suggest that it describes a non-linear dynamic 
hermeneutic cycle effectively. 
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4.10 - Section 4 - Conclusion 
 
In commencing this research and asking the research question, process issues were 
raised which impacted upon clinical practice. These specifically related to clinician's 
anxiety about being researched, which then affected sampling. 
 
As part of the AR process, it was necessary for the researcher to take action with 
stakeholders, validation groups, and clinicians, to stabilise the anxiety and support 
practice progression, whilst continuing to research the phenomena. The TCG was 
therefore developed, which is a clinical heuristic encouraging a formulated approach 
to treatment decisions. This tool has been positively received, and through its 
separation into quadrants, allows questions to be formed based upon each quadrant, 
to structure the semi-structured interviews and patient questionnaires. 
 
The above section gives an insight into overcoming a research process issue, which 
has provided a valuable contribution to the structure of the method and practicality of 
data collection, summarised in Figure 14: 
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Figure14: Subordinate AR Cycle 2: Treatment Choices Grid Development within the 
study exploring treatment choices for people with Personality Disorder. 
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Section 5: Participant Study Results  
 
In this section, a breakdown of the data collected is presented, reflecting upon the 
methodology section from the previous chapter. The achievements and difficulties of 
data collection is also reflected upon, in order to provide transparency for readers.  
 
Figure 15: Subordinate Action Research Cycle 3: Participant Study to explore how 
people make treatment decisions for people with Personality Disorder. 
 
 
 
 
5.1 Results Sample 
 
The results data is presented under three headings: results of the interviews, 
analysed through an IPA process, patient questionnaire data, and results generated 
by the validation groups and other validation forums. 
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5.1.1 Interviews  
A predicted sample size concerning clinician interviews was set between 6-8, the 
final number of interviews gained was 6. For the supervisor interviews, the target 
number was set at 3-4, the number achieved was 4. This provided a total of 10 
interviews which could be analysed.  
 
Participant information 
Interview information was gained from demographic information sheets (Appendix 
32), all participants agreed to complete these sheets. Demographic information is 
presented in the appendix section, summarised below in Figure 16:  
 
These participant factors are briefly discussed below, to provide context for the 
results obtained: 
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Multi-professional representativeness 
All interview participants had a core profession (Appendix 10). The reason for 
including the professional breakdown in the results was that there needs to be an 
accurate representation of professionals that constitute a typical multi-professional 
team. The results gained demonstrate a representative sample, rather than a uni-
professional sample, which was typical for the research in the literature review. 
 
Age Range 
Age range was gathered to explore whether people interviewed were representative 
of the team. The age range of participants (Appendix 11) was slightly older than the 
average of the teams surveyed, whose mean average age is 43.  
 
Gender 
Within the teams that were researched, there is a gender distribution of 
approximately 75% female and 25% male professionals (Appendix 12). This result 
means that the research sample has a slight over-representation of males than is 
actually present in the teams.  
 
Language 
The reason why people’s first language was recorded (Appendix 13) is linked to the 
methods used. Within IPA research, analysis of language and metaphor form a 
major part of the analysis process. Research demonstrates that metaphor use and 
phrasing can be different for people whose first language is not English, when 
interviews are conducted in English, as is the case with this research. In the 
transcripts, where meaning was unclear, verification was sought verbally within the 
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interview, and also after the interview was transcribed for people to not lose the 
context of the interview.  
 
Qualifications 
All research participants were qualified professionals, with a core qualification at 
either Diploma level or above. Several participants listed more than one qualification 
(Appendix 14), demonstrating evidence of significant post-graduate qualification. The 
participants had a higher level of post-graduate qualification than is average in the 
locality teams.  
 
Years working in mental health care 
Age is not necessarily representative of number of years worked in mental health 
care (i.e. a person may have qualified at 45 years old). In the sample (Appendix 15), 
there is a wide standard deviation (SD) of between 8.5 – 36 years (SD = 27.5 years), 
with a mean value of 20 years’ experience. 
 
This result shows that all professionals interviewed started in mental health care at a 
younger age, and demonstrates a significant amount of experience within the group 
as a whole to draw upon in terms of answering the research question. This is 
considered as more positive in terms of validity than if the average length of 
experience was 5 years, as this may mean that practitioners are providing opinions 
based upon very little personal experience.   
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PD Patients on current caseload 
It is important to explain the number of patients that participants work with at the 
current time, as it helps contextualise the information which interviewees have 
provided. This also helps contextualise whether examples are provided from working 
with only a few, or with many, PD patients.  
 
One participant did not include their current caseload on the demographic 
information sheet, and therefore this must be considered as incomplete. There is a 
large standard deviation (SD = 685) concerning caseloads (presented in Appendix 
17), as some participants work in a clinic setting and some in a care-coordinator role. 
Due to this, the mean caseload is not considered as representative. However, when 
reflecting upon the rich data that participants bring, the fact that as a group they can 
draw upon their experiences with 1289 patients, adds value to the results gained.  
 
Comorbid diagnosis 
People with PD rarely present to mental health services because they have one 
problem, as indicated by literature review. Therefore it was important to consider with 
participants, whether the patients that they worked with have a sole diagnosis of PD, 
or other mental health comorbidities. All participants have people with comorbid 
mental health problems on their caseload (Appendix 18).  
 
Interview information 
Interview information is presented in Appendix 19. This demonstrates that just under 
10 hours of data was collected through interview, generating 6514 lines of text to 
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analyse with IPA. The interviews varied in their timing, however all interviewees 
answered all questions.  
 
Supervisor interviews lasted on average longer than clinician interviews by several 
minutes, as the interviewees were more expansive in their answers. Five out of six 
clinician interviews had similar timescales; however one person was more 
expansive. Three out of four supervisor interviews had similar timescales; however 
one supervisor lasted significantly longer.  
 
Interview Validation  
The interview data was transcribed, and a copy of the transcription was sent to the 
interviewee for checking and validation. All interviewees confirmed in writing that this 
was an accurate representation of their interview and opinions. 
 
5.1.2. Patient Questionnaires  
Patient questionnaires were included in the research to gain information about their 
experience of the Treatment Choice Encounter, and the TCG that had been 
introduced to help structure the encounter. 
 
No sample size was set for the questionnaires; however an aim of a 50% response 
rate was set over a period of 4 months. This data collection was difficult. The 
response rate was low, only n=15 questionnaires were received out of a potential 62 
PD patients who were referred in the time period set. This resulted in a response 
rate of approximately 24%.  
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Of 15 questionnaires received, demographic information was obtained pertaining to 
all patients, including: Gender (Appendix 20), Age (Appendix 21), Diagnosis 
(Appendix 22), and previous mental health service experience (Appendix 23).  
 
This demographic information demonstrated that 20% of respondents were male and 
80% female, spanning an age range of between 18-60 years old. Over 50% of 
responders indicated that they had a secondary mental health diagnosis other than 
PD, which is reflective of the literature review findings, and only 20% patients were 
new to mental health services.  
 
Quantitative data was gathered through the questionnaires concerning patient's 
opinion regarding use of the TCG (Appendix 24), which indicated that the majority of 
respondents found the TCG useful in understanding why treatments were/were not 
selected. Although this is a very limited number of respondents, this may be useful 
data for a future study concerning testing the validity of the TCG in clinical practice.  
 
In terms of qualitative data, only 60% people who returned the questionnaires chose 
to provide narrative feedback. The responses provided were very brief where 
completed, and are detailed in Appendix 25, 26 & 27. 
 
This low response rate and incomplete data meant that this part of the research was 
considered as lacking. The reasons for the low response rate were explored with 
both stakeholders and validation groups, with consideration about whether a return 
to ethics board was required.  
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5.1.3. Validation Groups 
Five validation groups were held during the study, each group having three core 
members who attended to review progress, and 14 other members who attended 
one or more groups. The validation groups consisted of stakeholders listed in Figure 
10, and conducted at the following stages: 
 
(1) Commencement of the research, to devise the plan.  
(2) Prior to ethics board application.  
(3) After the literature review was completed.  
(4) To discuss the research sample, when patient data issues were identified. 
(5) To discuss final results and recommendations. 
 
Discussions in the validation groups are incorporated into the following sections.  
 
5.2 Difficulties encountered in gathering results 
The following difficulties were encountered when gathering the results for the field 
study component of this research: 
 
 Recruitment of interview participants was initially difficult. This eased after  
development of the TCG, and after stakeholder group presentations were 
provided to explore the research aims and objectives. This is an important 
finding, as validation groups supported the fact that recruitment difficulties 
were connected with two themes: high workloads, meaning that prioritising 
non-patient time (i.e. for the research interview) was difficult, and secondly the 
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fear of criticism in terms of decision-making processes. These themes will be 
explored in the results and discussion sections as a key finding.   
 
 Difficulties in gaining feedback via patient questionnaires. After one month of 
data collection, no patient feedback questionnaires were returned. This was 
considered as abnormal, therefore meetings were held with locality teams to 
discuss research progress, and an additional validation group was requested 
to explore this issue and potential solutions. The following themes were 
raised: 
o Clinicians felt unconfident to provide PD patients with a questionnaire 
which they feel may reflect badly upon their clinical practice. 
o Certain clinicians stated that they felt uncomfortable in providing the 
patient questionnaire, when the encounter had been problematic, or if the 
person did not accept their diagnosis.  
o Clinicians explained that some patients refused the questionnaire, 
because they felt that they ‘already feedback about services’.  
o Certain clinicians stated that they have not used the TCG with patients, but 
found it more helpful in peer-supervision, individual case reflection, or 
when discussing referrals with GPs. Supervision and reflection were 
expected uses for the TCG, but its use as a communication tool with GP’s 
was unexpected.  
o Some clinicians stated that they saw patients place the questionnaires in 
the bin when they left the building.  
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Although it was felt to be a problem that insufficient patient feedback was gained, 
the themes above are interesting results in themselves. A return to ethics board 
with the aim of conducting a semi-structured discussion group to gain patient 
feedback was considered by the validation group, however it was reflected to the 
researcher that significant emphasis had been placed upon gaining patient 
feedback, but that this is slightly at odds with the research question, concerning 
how clinicians formulate treatment decisions. The validation group suggested that 
the above themes provide rich information to the study concerning the Treatment 
Choice Encounters. The research method was therefore not changed, data 
collection was completed, which gained n=15 responses. 
 
A further difficulty was encountered concerning equipment failure, specifically the 
recording equipment, meaning the last interview was delayed by 2 months. Also 
the Illness of the second researcher, further delaying transcript analysis by 4 
weeks.  
 
5.3 Data Analysis 
This Chapter expands upon the methodology described in the previous section, by 
detailing how the IPA method was used in terms of data analysis. The method of 
transcription analysis concerning the IPA follows the process defined by Smith et al 
(2009). Figure17 details the data analysis process, including the actual time spent 
conducting the analysis:  
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Figure 17: Diagram concerning the process for the transcript analysis for the IPA 
study concerning treatment choices for people with Personality Disorder.  
                       Using the Smith, et al Model (2009) (pg79-107) 
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5.4  The Transcription Process 
5.4.1 Step 1 – Reading, transcribing, and re-reading 
The interviews were transcribed in full by the researcher. This was important for the 
first stage of the IPA process, as it enabled the researcher to fully hear the interview, 
and transcribe to examine the detail and immerse self in the process.  
 
Whilst conducting the transcription, the vast amount of data gathered was 
intimidating and overwhelming. However, as the process continued, this anxiety 
reduced, as in the transcription process itself, clear themes emerged and were 
repeated throughout each text.  
 
A problem and learning point for the interviewer was that transcribing of scripts 
began prior to the final two interviews, it was therefore more difficult to ‘bracket-off’ 
the researcher's own thoughts on emerging themes, and so not influence the final 
two interviews. 
 
After transcription, the interviews were sent to each candidate for validation, prior to 
being anonymised and included in the study. No candidate withdrew their script, and 
all provided feedback upon the interview process. Only one candidate asked that 
three items were altered in the transcript, one was a spelling error, and she wanted 
two statements to be adjusted, as she felt her phraseology meant that they could 
have been “taken out of context”.  
 
In terms of the AR process and practice change, the process of interviewee 
transcript validation was powerful. The interviewees reflected that the process 
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helped them consider their own values and attitudes, and how this affected the 
Treatment Choice Encounters. One interviewee additionally reflected that it had 
helped her examine how she conveyed things, and her significant use of metaphoric 
speech and symbolism, which she aimed to reduce, as she felt that her “meaning 
could be misinterpreted”. The process also appeared to have an additional affect 
concerning increasing case discussions regarding treatments in clinical teams, this 
was reflected by the validation group. 
 
5.4.2 Step 2 – Initial Noting  
The aim of the initial noting section was to read through and list all initial impressions 
concerning the script itself, and the messages that the interviewee is conveying. The 
reason for this was that selective bias may be generated by the researcher’s 
perceptions, and although this may form part of the end result, it is important that this 
can be bracketed off, to not detract from the micro-analysis of the script itself.  
 
The next step concerned analysing the transcript in detail, making descriptive notes, 
commenting upon the language used, and beginning to highlight potential themes. 
This was a very time-consuming process, and significantly added to the word count 
for each script, this process is detailed as the Left Hermeneutic Analysis (Example 
transcript is provided in Appendix 37).  
 
This initial analysis enabled the researcher to examine each interviewee's 
statements in detail, and analyse the meaning and context of interviewee's opinions. 
Each transcript revealed that as the interviewee appeared more relaxed in the 
interview itself, their interaction was less formal, and their answers were more 
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expansive. This was evident in the number of words that they provided in answer to 
questions, and the type of language used. 
 
The way interviewees referenced their experiences in the first, second, and third 
person, was of interest concerning the ownership they took for the views they 
expressed. Additionally, the interaction with the researcher changed at different 
stages of the interview process. Some interviewees spoke directly to the researcher 
instead of answering questions, and some sought reassurance from the researcher 
concerning the answers they provided. This demonstrated a degree of vulnerability 
and uncertainty in discussing the research questions themselves.  
  
5.4.3 Step 3 – Developing Emergent Themes 
This stage involved re-reading the transcripts and all of the right hermeneutic notes, 
to generate themes, and distil the wording of each theme into specific concepts, 
detailed as the Right Hermeneutic Analysis (Appendix 37). 
 
5.4.4 Step 4 – Searching for connections across themes 
After the complete transcript was analysed via the Left and Right hermeneutic 
Analysis, the whole transcript was further analysed in terms of thematic generation 
and connection. Smith et al (2009) suggest specific ways of interpreting patterns in 
themes raised, by: Abstraction, Subsumption, Polarization, Contextualisation, 
Numeration, and analysis of function. All of these processes were examined in order 
to produce independent Super-ordinate themes for each transcript. 
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5.4.5 Step 5 – Moving to the next case 
The aim of the IPA research is to both prize the subjectivity of each interviewee’s 
perspective, and also examine connected themes between the different encounters. 
The concepts of subjectivity and collective themes are given equal importance in this 
research, adhering to the principles of Constructivism and Interpretivism. 
 
To minimise potential contamination of each transcript analysis, 5 days was left 
between conducting IPA Steps 1-4 on each case. This delay was important to 
bracket off themes from each script, allowing individual analysis.  
 
5.4.6 Step 6 – Looking for patterns across cases 
The super-ordinate themes from each of the 10 transcripts were then analysed to 
generate superordinate themes for the entire analysis. This process was both 
challenging and time-consuming, and required re-wording and also contextualising 
the answers that each interviewee provided.  
 
What was clear, was that even though a distinct set of clinicians and 
clinician/supervisors had been recruited for the study, with anticipation that the 
supervisors would hold more specific opinions about what may help clinicians, 
surprisingly, the clinician/supervisors demonstrated similar levels of vulnerability and 
difficulty in the Treatment Choice Encounter as the clinicians. They additionally spent 
a significant time exploring their individual experience as a decision-maker rather 
than a supervisor. For these reasons, although the original intention was to separate 
clinician and clinician/supervisor responses, the analysis and discussion section will 
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be presented as a collective response, with indications where individual variation 
was identified. 
 
5.5 Section Summary 
Within this section, results are presented concerning the sample interviewed for the 
IPA study, the patient questionnaire data, and the use of validation groups. This 
section is presented in brief, as the main analysis of the themes generated by the 
results is to be presented in narrative format in Section 6.   
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Section 6: Results and Analysis 
6.1 - Introduction 
Within this chapter, results obtained through interviews with clinicians and 
clinician/supervisors, and also through patient questionnaires, will be analysed to 
answer the overall research question: 
 
How can mental health care staff use a pre formulated guided decision 
process in the selection of  therapeutic interventions for people with PD, within 
the context of rationalisation and service change?  
 
Excerpts from interviews and questionnaires will be presented, to gain an 
understanding of the lived experience of the Treatment Choice Encounter, this is 
important, as it is something identified as absent from current research concerning 
UK PD treatment.  
 
Within this section, variations between clinician's experiences of this encounter will 
be explored, specific results will be identified that either are consistent, reinforce, or 
differ from existing knowledge. In this way, results from the interviews will provide an 
original contribution to the body of knowledge regarding PD. Comments will be 
provided, exploring how results generated impact upon practice, exploring how this 
research may inform future practice change, when considering how the research 
question above may be answered.  
 
This chapter will conclude by providing an evaluation of the study conducted, 
reflecting upon strengths and weaknesses of the methodological approach, learning 
points, and considerations for change, should the research be repeated.  
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6.2 Super-ordinate Themes 
To explore the research question, super-ordinate themes were generated from all 10 
transcripts, presented in Figure18. Each theme is analysed and discussed in the 
following sections: 
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Appendix 38 provides a breakdown concerning which transcripts supported each 
theme. This not only allows a clear view about whether themes are representative of 
the whole sample, but also allows identification of individual variations, discussed 
below. The breakdown is not included in the main text, as the qualitative IPA 
approach does not seek to draw conclusions concerning the quantity of people who 
identified each theme, instead it is to contextualise, and demonstrate coherence and 
transparency. 
 
6.2.1 Superordinate Theme A: Difficulties with Boundary Management 
The need for ‘consistent boundary management’ in Treatment Choice Encounters 
was a theme raised within all transcripts. The definition of ‘boundary’ here is: the 
physical and psychological limits of the relationship inside and outside of the 
encounter.  
 
Within the description of this theme, clinicians described the impact of boundary 
management at various different levels with: patients, organisations, and other 
workers. This finding combines and builds upon other findings in the literature review 
pertaining to Q2, Q4, and Q6, partially discussed by Brown et al (2012).  
 
The lived experience of boundary management issues from the clinician perspective 
in the Treatment Choices Encounter fall within 5 sub-categories. Each category was 
prioritised to a lesser or greater extent (Appendix38). The numerical value is not 
intended to demonstrate which variable is more important than another, as this 
cannot be extrapolated from this type of research, however it shows that by virtue of 
Student Number: 100104045 
158 
 
repetition, each specific clinician places value upon a particular boundary 
management issue.  
 
A1: Boundaries between patient and clinician 
 
The primary boundary theme identified concerned the clinician/patient relationship:  
 
Interviewee1(Clinician): “We obviously have to be flexible and boundaried at the same time, 
so it is obviously difficult. You know, we are here to offer a service, and we can offer what we 
can offer, and you know, that’s all well and good, but sometimes it’s not what they want” 
(T:1,P:9,L:395-401) 
 
 
In the above extract, the interviewee encapsulates the struggle with boundary 
management, demonstrating that boundaries are not easily defined, with need for 
‘flexibility’, implying boundary movement.  
 
The interviewee uses ‘obviously’, which would indicate a generalisation that 
‘everyone’ may feel boundary management is difficult. This is then followed by two 
uses of ‘you know’, suggesting a degree of reassurance-seeking and checking-out 
from the clinician/researcher. This sense of vulnerability triggers existential 
questioning in each interviewee, and is linked to the factors triggering the TCG 
development.  
 
The boundary discussed by interviewee1 concerns patients expecting something 
different from what services can offer, also experienced by several other 
interviewees, provoking internal conflict in the clinician holding the boundary: 
 
Interviewee 10(Clinician/Supervisor): “if you have a client who has never, ever been given 
any boundaries, then they're going to kind of, somehow create that system for themselves as 
much as they can, so that’s when professionals start acting in ways that they wouldn’t 
normally act. So, you might have a set of clinicians who are amazing parents; they go home 
and - ‘mummy, can I have ice-cream, -no you have to eat your greens first and then we will 
think about pudding’… you know, but when it comes to work they suddenly find themselves 
incapable of setting a boundary.” (T:10,P:21,L:975-985) 
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Interviewee10 echoes the boundary difficulty, and compares the clinician role to a 
parental role. The statement that the patient will ‘create’ a system in the encounter 
suggests a power-struggle, resulting in clinician's vulnerability potentiating effects on 
boundary management: ‘act in ways they would not normally act’, rendering them 
‘incapable’. This is considered as an interpersonal dynamic between the 
patient/clinician, but it additionally links with an intra-personal boundary dynamic; the 
struggle between ‘clinician-role’ and ‘personal-role’ (that of a parent).  
 
Intrapersonal struggles connected with counter-transferential and transferential 
issues were raised in the literature review by multiple researchers (i.e:Liebman et al 
2013, Friedman, 2008). However, the literature review research derives from 
encounters in psychotherapeutic programmes, rather than a Treatment Choice 
Encounter, meaning that results of this research may add to the body of knowledge. 
Intrapersonal variables will be expanded upon, under subordinate theme A3.  
Interviewee8(Clinician/Supervisor): “usually the Borderline Personality Disorders, they can 
befriend the therapists [term used for all clinicians, not discipline-specific]. So we need to 
keep the boundaries between the between the therapist and the patient. We have to make the 
relationship positive, but we have to keep within our boundaries, just like Personality 
Disorder patients in the high-secure units, when they try to help nurses to dispense the 
medication, they try to convince the nurses that they are fully responsible” (T:8,P:6-7,L:299-
309) 
 
 
Interviewee8 reinforces the needs for boundaries, providing a specific example of 
potential boundary violations. Rather than a ‘parental role’, interviewee8 suggests 
another ‘personal-role’ (friendship) which then affects the Treatment Choice 
Encounter. As framed in the literature review by Hare (1991) and Cleckley (1982), 
boundary challenges regarding personal/professional role-conflicts are framed as 
having a sinister intention, emphasising how professional roles must not stray into 
Student Number: 100104045 
160 
 
personal roles, due to the potential of sinister consequences, this theme is echoed 
throughout several transcripts.  
 
Other interviewees provided specific contextual examples concerning the impact of 
boundary violations connected with roles and responsibilities. Interviewee6 describes 
a patient enacting behaviour in the knowledge that it will receive a specific response: 
 
Interviewee6(Clinician): “He sends lots of texts saying that he is going to kill himself, and the 
services have then to respond. .. each time that the client sends a text then the worker is 
rushing out, and this is not making any change for the client, it just means that he keeps 
feeling the need to do that” (T:6,P:4,L:185-194) 
 
Boundary violations are not only described as problematic to the patient's health and 
well-being, but also impact upon clinician well-being: 
 
Interviewee10(Clinician/Supervisor): “And the ‘rescuing thing’ also puts on pressure on the 
staff because they don’t end up making any progress with these people, so they end up feeling 
like they’re not doing their job properly, and that they are failures” (T:10,P:6,L:277-281) 
 
Building upon the theme of role variation, the next section explores conflicts raised in 
the transcripts regarding how the different roles a professional encompasses affect 
Treatment Choice Encounters.  
 
A2: Conflict of multiple clinician roles. 
Each transcript identified role conflict as a ‘difficulty’ and a ‘struggle’. There is little 
research pertaining to the issue of ‘role-conflict’, the majority of research presented 
utilised experiences from a uni-professional perspective (i.e. medical), indicating a 
paucity of systemic research regarding PD treatment choice. The multi-professional 
experience captured by this study explores perspectives of clinicians from different 
disciplines making the same choice: 
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Interviewee2(Clinician): “I think sometimes, if I have my OT hat on, I find it difficult.” 
(T:2,P:11,L:513-514) 
 
Certain clinicians discussed role-struggles metaphorically, i.e.: Interviewee2 using 
the term ‘hats’. Figure19 below demonstrates the different professional ‘roles’ listed 
throughout all transcripts, that each clinician feels they are expected to adopt within 
changing models of health and social care. 
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Various examples of role-conflict are provided in the transcripts; however the 
boundary issue between Resource Manager and Negotiator triggers most internal 
struggles regarding decision-making for all interviewees, explored further in 
subordinate theme A4.  
 
An additional theme raised by several interviewees concerned how the ‘gate-keeper’ 
role is influenced by past experience of treatment efficacy, and how this impacts 
upon treatment selection:  
Interviewee3(Clinician): “I have seen people who have had longer-term therapy for years 
and years, and I am not convinced that it has done that much good, as they have still been in 
the system.” (T:3,P:3,L:140-144) 
 
 
Flores et al (2014) raise the issue of clinician experience affecting treatment choices 
in the literature review, acknowledging that these factors affect clinical encounters. 
Interviewee3 provides a description concerning his lived experience, his judgement 
is that ‘long-term therapy’ was not beneficial, arguing this with the fact that patients 
are “still in the system”.  
 
Interviewee 3 is not the only interviewee to raise these types of opinions concerning 
treatments such as talking therapy and medications. The results of this study 
therefore reinforce Flores at al (2014) findings, however also highlight a need to 
explore contextual factors concerning value-judgements that underpin perceptions 
based on past experience. This research therefore contributes to the body of 
knowledge by asking: must treatment efficacy always result in immediate discharge? 
If someone receives effective treatment, does this mean they will never re-enter 
services?  
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Interviewee 8 elaborates, demonstrating that not only ‘value judgements’ and internal 
‘role-conflicts’ influence treatment choices, but also variations in professional training 
which prompt ‘different’ boundary management issues: 
Interviewee8(Clinician/Supervisor): “Some people are reluctant, because there is usually 
some hidden agenda because of the way each discipline have been trained. Whether they are 
social workers or nurses, or they are doctors or OTs, each discipline unfortunately have been 
trained in a different way to formulate their decisions. And then there is the power-struggle 
between the MDT members. And then the different members of the team might say different 
things.” (T:8,P:3,L:120-129) 
 
The issue of inter-professional conflict was highlighted in the literature review by 
writers including Levine et al (2006), who asked “who has the right to prescribe a 
certain treatment?” Rather than experiencing this as a  “right”, what the interviewees 
suggest is that in reality, multiple members of the MDT are in a position of making 
treatment choices with patients, however not only is it often a difficult in-session 
issue to navigate, but there are outside-session variables that then influence the 
treatment choice itself. 
 
Interviewee 3 expands, concerning ‘power-struggles’, focusing upon not only role-
conflict in terms of decision-making, but also hierarchies of roles and treatments: 
Interviewee3(Clinician): “I think that there is some treatment that is seen more important 
than others. Psychology has always been seen as the top echelon of treatment that you could 
receive. But actually, it depends how you look at it. If you are a bloke stood there in crisis and 
you need a social worker who is going to help you, going to do something practical to 
alleviate your current distress, that’s probably more valid than psychology. The majority of 
our treatment is risk-management and crisis management. I think that’s why I struggle with 
the direction of travel, that we are going to turn everybody into mini-therapists” 
(T:3.,P:8,L:372-387) 
 
The literature review explained that certain power-struggles have been researched 
concerning treatment selection (i.e.: Ulvenes et al, 2014), however that differs from 
the interaction between the clinical hierarchy of power cited by interviewee3.  
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This is an interesting finding when considering the current literature base for PD 
treatment and treatment choices. Within the literature review, 102/144 articles were 
from Psychology/Psychotherapy or Counselling-specific journals. This is not to say 
that nurses and social workers do not work with or research treatments for PD, 
however they are under-represented in academic research, which may contribute to 
the power imbalance that interviewee 3 describes.  
 
Important results that are absent from the literature review are therefore: what 
treatments are provided by the majority of people who work in a PD team, and how 
can their voice be heard and represented? These questions are also important when 
considering the research question. 
 
The data is unbalanced, as most research originates from the upper sections of both 
triangles, principally from psychiatrists and psychotherapists, concentrating 
particularly upon self-actualisation, esteem, and relationships.  
 
However, there is little research in what treatments nursing and social care staff  
bring to PD care, and how they provide it, not only in terms of biological, 
physiological, and safety needs, but also in terms of esteem and self-actualisation. 
This imbalance is one reason for practice perceptions of valid or invalid treatments 
and power-struggles. 
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A3: Personal and Professional Role Boundaries.  
Expanding upon subordinate theme A1, transcript information suggests that 
personal/professional boundary management difficulties can influence treatment 
choice: 
Interviewee10(Clinician/Supervisor): “because what people with PD do is they hook into the 
very part of you that’s vulnerable, and you don’t want them to see anything, so you shut down 
and you become, you know, you become very defended” (T:10,P:25-26,L:1207–1211) 
 
Interviewee10 builds upon the internal role-conflict described in subordinate theme 
A2, describing a type of role-reversal, where the PD patient attempts to impact 
personally, rather than use the professional as a resource, causing a boundary 
management issue if not adequately recognised.  
 
Other transcripts raise similar issues concerning boundary related vulnerabilities, 
often described as resulting in clinicians attempting to bracket-off emotions to protect 
the vulnerable part of the self, which may then lead to uncompassionate responses. 
This issue is demonstrated below: 
 
Interviewee7(Clinician/Supervisor): “So yes, as a secondary service, we are happy to say this 
is what you have got, you might not accept it, and be happy about it. But it is not our job to 
make you happy by just telling you what you want to hear. So, if you don’t accept, it is very 
difficult to offer you treatment for this. However this is the treatment you need whether you 
accept your diagnosis or not. You decide and let us know.” (T:7,P:8,L:284-292) 
 
A slight difference in the transcripts is that Clinician/Supervisors are more aware of 
(or disclose more about) potential boundary violations, than clinicians who are not 
also supervisors.  
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A4: Organisational Resource Management. 
Resource reduction and its impact upon treatment choice was significant for both 
Clinicians and Clinician/Supervisors, supporting findings in the literature review 
(Leichsenring et al 2010). However, the literature review discussed general budget 
cuts, whilst the interviews generate an insight into the specific realities of cuts. An 
example of this is within the area the research was conducted, concerning the lack of 
access to talking treatments in IAPT services for people with a diagnosis of PD. This 
is an issue that has been briefly touched upon in reports such as “We Still Need To 
Talk” (MIND, 2013:11), however is central to themes raised within the transcripts.  
 
Boundary issues related to treatment concern thresholds, access to resources, and 
capacity/demand concerns. Interviewee1 explores the secondary gain some patients 
experience by being in a Treatment team, which may be considered as a boundary 
violation, when viewed from a financial perspective: 
 
Interviewee1(Clinician): “Quite often we will also get people come for an assessment and 
they sort of ask us to fill out the Benefits form. Or sort of, if we have talked about discharge 
with someone, they have said, well what about my Benefits.” (T:1,P:5,L:206-212) 
 
Some interviewees suggest that this is a type of ‘malingering behaviour’, however, 
others state it is the lack of support for PD patients post-discharge: 
 
Interviewee3(Clinician): “There is a difficulty in discharging these people, not just because 
they come back so quick, but also because there is a lack of other services to go to.” 
(T:3,P:6,L:273-276) 
 
 
This is linked to the research underpinning the current “Parity of Esteem” agenda 
(NHS England, 2015b), and pertains to people with mental health difficulties being 
supported by all services. When comparing this rhetoric with the reality experienced 
by interviewees, this research demonstrates that resource management is ‘difficult’ 
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and emotionally evocative, not only due to cost reduction, but also the lack of 
systemic support for people with PD: 
 
Interviewee7(Clinician/Supervisor): “It becomes a resource issue as well, you think well, can 
I afford to be a bit more generous, rather than putting it all in the client's hands with as much 
explanation as possible? Because yes, unfortunately resources are extremely scarce, and you 
can’t help. As cruel as that might sound”. (T:7,P:13,L:618-624) 
 
Building on this, resource boundary issues raised within transcripts do not just 
concern a lack of resource, but also relate to the proportioning of resource based on 
current national ‘cluster’-specific treatments (DoH, 2011e): 
 
Interviewee9(Clinician/Supervisor): “I think that we do struggle to provide interventions. I 
think that there are resource issues. I also get concerned about the same people providing the 
same interventions. I suppose if you look at the NICE guidance and look at the current model, 
if you were setting up the team from scratch, then you wouldn’t have this skill mix. And I think 
that this is always the case when you are trying to introduce a new service made up from an 
old service. You are expected to have the knowledge and understanding and skills.” 
(T:9,P:16,L:793-804) 
 
Competency concerns are shared by other interviewees, anchored in service change 
and reformation, connected to a historical model where people were employed to 
only provide treatment for certain disorders (i.e. psychosis), which each interviewee 
remarks are distinctly different from PD. 
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A5: Consistency in managing difficulty 
Linguistically, the terms ‘difficulty’ and ‘struggle’ appear frequently in the transcripts, 
displayed in Figure 20: 
Figure 20: Number of times the terms: ‘difficulty’ and ‘struggle’ are used each 
transcript of the IPA study concerning treatment decisions for people with 
Personality Disorder. 
Transcript Number Number of ‘difficult’ references Number of ‘struggle’ references 
Transcript 1 N = 60 N = 4 
Transcript 2 N = 24 N = 10 
Transcript 3 N = 26 N = 4 
Transcript 4 N = 41 N = 8 
Transcript 5 N = 25 N = 0 
Transcript 6 N = 24 N = 9 
Transcript 7 N = 59 N = 5 
Transcript 8 N = 33 N = 7 
Transcript 9 N = 54 N = 10 
Transcript 10 N = 69 N = 18 
Total: N = 415 N = 75 
 
The use of the words 490 times demonstrate a consistent theme. All interviewees 
identified the main difficulty regarding boundary management as being a lack of 
systemic consistency. This parallels literature review findings, however literature 
review findings typically focus upon how to provide boundaries concerning the 1:1 
encounter (Chiesa et al, 2009), rather than the need for systemic boundaries 
regarding treatment choice. This difficulty is highlighted by interviewee 6:  
 
Interviewee 6(Clinician): “So what is needed is that people give exactly the same explanation, 
exactly the same message, exactly the same hand-out, if it’s going to be done right... People in 
our team struggle to give consistent messages.” (T:6,P:9,L:418-425) 
 
 
Interviewee 6 suggests that patients become confused without consistent 
boundaries, emphasising the need for in-session and out-of-session consistency, 
proposing written leaflets to be given post-session. The interview transcripts support 
the difficulty identified within the literature review, pertaining to people with PD not 
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retaining messages provided in clinical encounters, defaulting to prognostic 
assumptions about treatments (Constantino et al, 2012).  
 
Interviewee7 expands, explaining that boundary management issues do not just 
occur if the patient does not retain the information provided, but also if the peripheral 
services disagree:  
Interviewee7(Clinician/Supervisor): “..and then they go back to their GP and then get 
referred back in. So, they kind of split. The split in the service is between the secondary 
service and the GP. But you know, what am I to do? I have done my best, what am I going to 
do - pin them down and give them a depot injection? Which is not going to make any 
difference. Or what? So it is that conflict. In the system, they split the system.” 
(T:7,P:8,L:395-403) 
 
The final issue raised concerning consistent boundary management pertains to 
messages patients are given regarding resources. This was partly raised within the 
specific literature review (Mendelberg, 2014), but more recently linked with debates 
concerning the “7-day NHS” proposals (NHS England, 2014).  
 
Interviewees identified two levels of service for people with PD; longer-term 
treatment (for people who accept their diagnosis and actively accept treatment); and 
short-term crisis intervention (typically prescribed for people who may not accept 
their diagnosis, and do not accept or adhere to formal treatments). This type of 
division in treatment provision is not adequately detailed in PD research, although it 
is recognised to an extent in NICE Guidance (2009a&b). There is a conflict between 
personal responsibility and service responsibility, highlighted by interviewee8: 
Interviewee8(Clinician/Supervisor): “Those patients are often very challenging, to services, 
to carers [professionals], and they are very time-consuming to the resources… we have to 
make that explicit with patients, and the commissioners, and the GPs, and the Department of 
Health. And say; ok those patients, they disagree they have a problem, and they don’t want to 
engage, and they are capacitous. If they are not capacitous, we go through different ways. If 
they are criminal, we go through legal system. If they are not capacious, we may need to 
treat, if they are capacitous, we need to discharge them.” (T:8,P:11,L:536-553) 
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The clinician/supervisor interviewees discussed areas they felt would aid clinicians in 
the encounter, explaining that it is not only about the clinician/patient relationship, but 
also about supporting particular frameworks: 
Interviewee 9 (Clinician/Supervisor): “I suppose we talk about being consistent. Having that 
dialogue of being fairly strong and confident to stick to that script. And I suppose staff do 
benefit a lot from support with that person, and they could really do with some guidance, 
maybe written in policy or something about how you do manage that person.” 
(T:9,P:9,L:438-444) 
 
Interviewee 10 suggests that the TCG has been useful, not only to focus exploration, 
but also as a consistent boundary management tool:  
Interviewee 10 (Clinician/Supervisor): “it [TCG] makes easy sense. What I’m saying is it puts 
in a static Grid and um, it’s also containing, because it aids understanding on the part of the 
supervisor, and the supervisor has, kind of, understanding how to have a logical 
conversation, and it’s meant to empower the clinician” (T:10,P:19,L:887-893)  
 
 
A lack of consistency does not appear isolated to adoption of the TCG, but appears 
thematic in terms of boundary management when working with people with PD, 
reinforced by interviewees. 
 
Boundary Management Theme Summary: 
In summary, boundary management difficulties within the Treatment Choice 
Encounter are experienced as ‘difficult’, consistent with the literature review. 
Boundary issues are multi-layered, and pertain to intra-personal boundaries, 
interpersonal boundaries, and systemic boundaries. It is therefore suggested that 
either individually, or via the team, boundary breaches must be identified so that they 
can be managed, to result in healthy boundaried relationships for patient, clinician, 
and system.  
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Hierarchical power-struggles and a lack of research can underpin boundary 
management issues. There is a need to focus upon comprehensive training, to 
ensure treatments are selected and provided as per government guidance, rather 
than from personal values concerning past experiences.  
 
When considering the findings of this Subordinate theme, three possibilities are 
suggested when considering the research question: (1) boundary management 
training at all levels, (2) assertiveness training which incorporates boundary 
management identification, and (3) research regarding the treatment roles of non-
therapists considering specialist health and social care provision for people with PD. 
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6.2.2 Superordinate Theme B: Diagnostic Stigma 
Evidence presented in the literature review demonstrated that there have been 
changes in diagnostic considerations concerning PD (Moran, 2007), and shifts in the 
concepts of ‘treatability’ (Norton et al, 2005). The literature sourced primarily focuses 
upon problems originating from conflicting service provider and clinician’s viewpoints, 
then becoming a potential blocking factor. Stigma was identified by all interviewed, 
and is therefore a Super-ordinate theme, however the variations concerning stigma 
resulted in 5 sub-themes, explored below:  
 
B1: Patient Stigma: Perception of ‘self’.  
The interviews provide insight into the nature of personal stigma concerning negative 
views that patients hold: 
 
Interviewee 1 (Clinician): “I mean the term Borderline actually freaks a lot of people out, 
‘cause they think you are just borderline… So, on the edge of having a disorder, rather than 
having a proper disorder”. (T:1,P:4,L:146-149) 
 
Evocative language (i.e.: ‘freaks’) exemplifies many patient's reactions to the term 
PD being used in Treatment Choice Encounters. Interviewee1 emphasised that this 
happens in many cases, rather than just being a 'one-off', suggesting this is an issue 
to be addressed prior to making treatment choices. The terminology used by 
interviewee1 to describe feelings evoked in patients “on the edge”, emphasises the 
anxiety present in the encounter. This is then added to a sense of invalidation, with 
the suggestion that some patients see PD as not being a 'proper disorder’.  
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Reasons that patients may become emotionally overwhelmed concerning diagnosis 
varied, however the sense of personal stigma was consistent throughout each 
interview. Interviewee3 attributed a lack of understanding on behalf of the patient: 
 
Interviewee 3 (Clinician): “Well, with one lady in the review clinic, I actually sat down with 
her and said: this is where I think you are, where do you think you are? And it became clear 
that she’d been given the diagnosis, but no one had actually explained to her what the 
diagnosis meant.” (T:3,P:2,L:50-55). 
 
 
Other interviewees agreed, however some suggested that this only applies to certain 
patients. With others, the problem does not concern a lack understanding, but is due 
to a personally held stigma concerning the disorder itself: 
 
Interviewee 7 (Clinician/Supervisor): “They want to have a different diagnosis; they want it 
to be called something else”. (T:7,P:7, L:330-332) 
 
 
Interviewees consistently stated that patients do not typically disagree with PD 
symptoms, but the PD label itself. They attribute this to the perceived ‘untreatable’ 
label discussed in the literature review.  
 
90% of interviewees cited Bipolar Affective Disorder (BAD) as the label that patients 
most felt they should have. The frequency that BAD is mentioned indicates that it is 
not just an individual experience, but something frequently encountered by clinicians.  
 
Interviewee 9 (Clinician/Supervisor): “I think 20 years ago, there were a lot of problems 
because there was some reluctance to diagnose Personality Disorder. Particularly in this 
locality, the people did tend to get diagnosed with a Bipolar disorder instead, even though 
they had a Personality Disorder, and that this happened because of some of the values that 
the doctors providing the diagnosis held, and the fact that some of the symptoms of the two 
disorders are similar… We had a lot of medical staff who probably shied away from saying 
what it probably was, and then I think we had a population of people who have been treated 
for the wrong condition and therefore not got better.” (T:9,P:8,L:355-370) 
 
Interviewee 9 discusses how different levels of personal stigma have affected her 
experience. She contextualises her experience to her locality, however raises a point 
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that PD has been previously misdiagnosed. She states that diagnosticians have 
‘shied away’ from providing the diagnosis in the past, implying unstated professional 
stigma surrounding the diagnosis. The issue surrounds the ability of a clinician to be 
able to assertively and compassionately deliver a diagnostic explanation, otherwise 
diagnoses are avoided and stigma reinforced. Avoidance of discussing the diagnosis 
is detailed by other interviewees:  
 
Interviewee 1 (Clinician): “Well,  I will try and explain more on the symptoms, rather than 
focusing on the diagnosis, and then feed the diagnosis in using the ICD-10, then explain that 
this is what it is termed, but it is actually a group of symptoms” (T:1,P:3,L:136-140) 
 
Interviewee 1 introduces the need to ‘feed’ the diagnosis to the patient. This is 
interesting phraseology, as it could be interpreted to mean that the patient requires 
to 'ingest' the concept to make it integral to themselves, or could be suggested that 
the patient requires nurturing in the form of ‘feeding’, enabling them to progress, 
either way there is a sensory element to this issue, echoed linguistically in other 
transcripts.  
 
When considering the effect of the introduction of the TCG, there has been an 
interesting finding concerning diagnosis. When considering different ways that 
clinicians feel patients perceive their diagnosis, there have been positive and 
negative encounters. Interviewee 9 provides a contextual case example:  
 
Interviewee 9 (Clinician/Supervisor): “And she kind of found it difficult to understand the 
concept of Personality Disorder, and so rejected that concept. So she’s not even in pre-
contemplation, it’s not; ‘I might think about it’. Instead it’s; ‘this is not me, and I will use all 
of my energies to disprove that’. I mean, she even printed off the diagnostic criteria for 
Personality Disorder, and ticked and crossed things she agreed or disagreed with, even 
though this was at odds with what everyone else around her knew about her behaviour.” 
(T:9,P:9,L:418-429). 
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Feedback pertaining to the low-return rate for patient questionnaires was suggested 
to pertain to the difficulty certain patients have concerning the PD label. The difficulty 
that compounds this issue is that people who rejected the label correspondingly 
rejected the questionnaires, meaning a biased questionnaire response only from 
people who accept their diagnosis. The core question for this study does not pertain 
to diagnostic rejection; however transcript and questionnaire results suggest that this 
may be a beneficial future area of research.  
 
B2: Clinician Stigma: Perception of ‘other’ 
The interviews generated themes connected to ‘otherness’ in terms of the diagnosis 
of PD, and associated with diagnostic stigma held by clinicians. These are 
connected to the 'otherness' section raised within the literature review (i.e. Heilbron 
et al 2010), however interviewees provide specific evidence of how this is 
experienced within Treatment Choice Encounters. 
 
The theme of ‘otherness’ is apparent in many transcripts, evidenced by phraseology 
and terminology used (i.e.: “us and them”). In the transcripts, terminology that 
separated and pertained to “otherness” was linked more to people with a PD who 
exhibit socially unacceptable behaviours, rather than all people with the diagnosis: 
 
Interviewee 7 (Clinician/Supervisor): “So the bottom line is that, never mind how horrible 
what they have done might be, or how unsavoury the character might be, or how nasty they 
come across, just explain it to them that this is what you think. Just explain to them that this is 
how it has come about [PD development].” (T:7,P:12,L:578-586) 
 
 
Interviewee 7 highlights how value-laden responses can be connected to socially 
unacceptable behaviours such as violence, which can become the focus for some 
clinicians. The language used shows how the focus on negative behaviour can 
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obscure the encounter. The notion of associating negative behaviour with a disorder 
is raised differently by other interviewees: 
 
Interviewee 8 (Clinician/Supervisor): So one of the cases we were talking about - with the 
antisocial Personality Disorder and sexual orientation problem. It is one of the mental 
disorders mentioned in ICD-10, but it is not a criminal act unless they offend. This is the 
same, whether we are right, if we consider ourselves as normal, what’s normal? Unless we 
conduct a criminal act then we are normal. But once we go for that, we afford to the legal 
system. So the public should know that, the legal system should know that, and the staff 
should know that.” (T:8,P:8,L:374-385). 
 
 
Interviewee 8 focuses upon the difficulty that he feels was brought about by changes 
in working practices. He discusses the notion of criminality, and then switches to 
discuss the perception of pathology by clinicians in the team who may be less 
trained regarding PD. He suggests that clinicians may be either frightened about 
making more proactive risk decisions for people with PD, or may have treatment 
choices obscured because they lack understanding about the delineation between 
what behaviours are treatable by mental health services, and/or those that would be 
considered as concerning criminal justice services. There is a paucity of research 
regarding the non-forensic PD community, which could be a reason why there is a 
lack of clear guidance for clinicians reflected by the interviewee.  
 
Interestingly, the examples provided so far in this subsection concerned 
clinician/supervisor's experience of the Treatment Choice Encounter. They are more 
senior, but show inconsistency in how they describe their own practice standards, 
compared with how they reflect about their expectations from their supervisees. 
When considering the personal beliefs of the clinicians, it is important therefore to 
provide an example of a non-supervisor clinician describing their experience and 
perceptions of the diagnosis of the term PD: 
 
Student Number: 100104045 
177 
 
Interviewee 6 (Clinician): “I think because Personality Disorder is a negative name, and er, 
diagnosis, then most people think that they have got Bipolar. Most people that don’t accept 
their diagnosis, it’s because they think that they have got Bipolar. I don’t like the name 
Personality Disorder, if I am talking to clients, I look at it as the problems that they have 
rather than the label, because a lot of people think of it as negative, whatever we think.” 
(T:6,P:7-8,L:349-360). 
 
 
The terminology used in this excerpt is personal (‘I think’) and illustrates a parallel 
between the struggle concerning clinician’s diagnostic acceptance, and the struggles 
they perceive the patients are having in accepting the diagnosis. This is a further 
example of where avoidance is utilised to manage a difficulty. 
 
Interviewee 5 demonstrates how there may be a difficulty for clinicians, when 
considering how their past experience of  PD influences their own feelings within the 
Treatment Choice Encounter: 
 
Interviewee 5 (Clinician): “People’s motivation can change, and therefore they should be 
provided with a period to engage, rather than merely being discharged. Otherwise we are just 
dooming them to fail, and they turn back up anyway… usually in a sorrier state... usually 
angry with you, because the other service discharged them before.”. (T:5,P:6,L:264-271) 
 
Interviewee5 articulates the experience of working with unengaged patients 
discharged from services. Not only does this excerpt indicate a struggle, it also 
suggests a division between individual clinicians and teams providing treatment for 
PD patients. Despite being raised as an issue by many interviewees, little evidence 
was found in the literature review concerning people with PD being declined 
services, discharged from services without treatment, or re-entering services.  
 
Interviewee 8 (Clinician/Supervisor): “We as the clinicians, have not got to stick blindly to 
the diagnosis. And this is one of the pathologies that clinicians have got. When we say that 
this is an antisocial Personality Disorder, and we tell in ourselves, and we give the message 
to the patient that they are untreatable. Like the old-fashioned message.” (T:8,P:7,L:325-332) 
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Interviewee 8 demonstrates a risk of either holding a traditional view of ‘untreatability’ 
which was raised in the literature review (DoH, 2003), or using that view to manage 
the impact of recent resource reduction. He discusses the need not to ‘stick blindly’, 
which could be interpreted as needing to 'open one’s eyes' to alternative ways of 
working together, to provide consistent treatment choices. Expanding, Interviewee9 
suggests there may be a need for clinicians facilitating the encounter to anticipate, 
and be able to manage, different emotional responses to the diagnosis and 
treatment choices: 
 
Interviewee 9 (Clinician/Supervisor): “I had tried to put a positive spin on it [Diagnostic 
explanation]. I mean I have had people who have said; ‘thank you, that’s explained 
everything’ and have been quite relieved, but then I have also had somebody who was 
actually quite sad, and said; ‘that sounds really awful’”. (T:9,P:7,L:327-335). 
 
 
 
It is interpreted that the patient who rejects the diagnosis, like the clinician who 
develops prejudice, becomes over-focused upon particular anti-social symptoms of 
PD. This distorted focus underlies prejudice, better education and regular 
supervision will enable more of a balance in terms of responses. This type of 
response will also help build a positive profile for other agencies who provide 
services for certain symptoms of PD (i.e. GPs, A&E, and Police), to increase 
consistency, maintain boundaries, and reduce stigma. A diagrammatic presentation 
is provided in Figure 21 to represent how people become over-focused on certain 
PD symptoms. 
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Figure 21 - Diagram to demonstrate how over focus can be placed upon different Borderline 
Personality Disorder symptoms which can affect worker compassion and treatment choice. 
 
 
 
 
B3: The impact of media representation  
 
Over half of the interviewees identified a requirement for wider public health 
promotion to improve the public image of PD. The interviewees suggested that 
negative publicity impacts upon diagnostic acceptance and treatment choice, linked 
with the representation of certain symptoms, as discussed in the previous section:  
 
Interviewee 8 (Clinician/Supervisor): “And we should educate the public that having a 
Personality Disorder does not make a bad person.” (T:8,P:8,L:371-374) 
 
Diagnostic stigma has long been recognised as affecting a person’s likelihood to 
approach services for treatment, however past research has mainly focused on non-
PD disorders (Crisp et al, 2000). Changes in media portrayal was also suggested to 
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have an influence upon other providers who serve people with PD, but are not 
specialist mental health clinicians: 
Interviewee 5 (Clinician): “The difficulty appears to be influenced by the person's own 
individual views of mental illness, but also the media. It also does not help that GPs are not 
clear that the symptoms may be attributed to a number of diagnosis, and they actually ask or 
sometimes state that you must provide a diagnosis of Bipolar”. (T:5,P:4,L:180-186) 
 
 
The discussion of media expands from considering positive media as positive health 
promotion, to considering the topic of inclusion and belonging, which in itself 
connects to the theme of ‘otherness’, discussed in subordinate theme B2. 
Interviewees highlighted patient's struggles concerning the lack of positive media 
role-models, as discussed by Interviewee 6: 
 
Interviewee 6 (Clinician): “I think that the media representation is quite stigmatising for 
people with Personality Disorder, and I think that there are a lot of problems with things on 
the internet… because they get a bit stuck with some of the more negative sites. I was working 
with a girl last week and she said – ‘when I am down I start looking at websites, which then 
make me more down, because they say bad things about Personality Disorder, and things like 
you don’t want to be mixing with people with Personality Disorder because they do this and 
do that, and say things like they are off their head, and that gets me more down’.” 
(T:6,P:8,L:371-380) 
 
 
Interviewee 2 expands, suggesting there are no positive role models for PD, 
therefore people often connect with celebrities with Bipolar, because there are 
“similar symptoms”, suggesting this provides a positive mental health anchor, 
however reinforces the difficulty people have concerning personal identity and 
diagnostic stigma: 
 
Interviewee 2 (Clinician): “A few [PD Patients] have said to me, it’s because celebrities have 
got it [Bipolar Affective Disorder].” (T:2,P:5,L:244-245). 
 
 
Interviewee 5 suggests that 'connection' helps people overcome their sense of 
‘otherness’, and provides a sense of ‘validation’ and ‘status’: 
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Interviewee 3 (Clinician): “nine times out of ten, they want to have a Bipolar Disorder. That’s 
what they want…… Status. Status, maybe. It’s ah… popular I think. Maybe status is not the 
right word. But it’s like Robbie Williams. Then they can say I am like Robbie Williams, and 
that gives them a status, and it kind of validates their experience.” (T:3,P:5:L:200-211) 
 
There were various examples in the transcripts where clinicians linked public views 
of PD having an impact on the Treatment Choice Encounter, which is a potential 
area of future research. Interviewee 10 links the lack of exploration and the lack of 
positive role models with a general stigma:  
 
Interviewee 10 (Clinician/Supervisor): “it’s never mental health and Personality Disorder, 
they are never prioritised in either [political] party, because they would rather deny it 
exists…as I say they’d rather someone else deal with it, so they can deal with all of the kinds 
of like normal stuff that feels comfortable.. you know, stuff. Personality Disorder is something 
that is very uncomfortable.” (T:10,P:7,L:308-314) 
 
 
 
B4: The impact of feeling ‘disconnected’/ different 
In the previous two sub-sections, examples are provided concerning what stigma 
public, professionals, and patients can experience concerning the PD label, 
prompting a sense of ‘otherness’. Disconnection is described in the research 
connected to ‘otherness', and it was also evident within the interviews, in that 
clinicians also feel a sense of isolation and 'otherness' in the encounter itself: 
 
Interviewee 10 (Clinician/Supervisor): “society needs somewhere to dump people who don’t 
fit into normal society, and mental health services have always been that place that they can 
go into. For the people that work for mental health services are like sacrificial lambs in 
society, who for some reason or another decide to take that particular role of holding these 
people” (T:10,P:6,L:244-250) 
 
 
The use of evocative words such as ‘dump’ suggests that this is abandonment of the 
patient by other services. This sense of abandonment is echoed in other transcripts, 
where clinicians discuss the lack of other services, and the lack of access to primary 
care. This theme is recognised at a National level and has current focus (NHS 
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England 2014), though as yet there have not been specifically-focused initiatives for 
PD. 
 
Interviewee 10 describes clinicians as “like the sacrificial lambs of society”. The 
meaning of this phrase is defined by Collins (2015) as: “someone that is surrendered 
or metaphorically sacrificed for the good or benefit of something else”.  
 
The context that interviewee 10 brings by using this phrase, suggests that in her 
experience, mental health services are being used as a focus for degradation and 
destruction by a system that is not inclusive of people with PD. This notion is echoed 
in other scripts, and again reinforces the need to examine the systemic influences 
concerning stigma affecting the Treatment Choices Encounter. 
 
The damaging experiences pertaining to team dynamics were more cautiously 
discussed by each interviewee. Interviewee 8 reflects both on the negatives and 
positives concerning working in a team with people with PD:  
 
Interviewee 8 (Clinician/Supervisor): “In terms of conflict, there might be a lot of different 
opinions, and this is what we are looking for. However, one of the problems that we have is 
that some of the disciplines treat the medical view like it is the medical model. And as if it is 
something which is a stigma, and it is not.” (T:8,P:4-5,L:186-192) 
 
 
 
Interviewee 8 is not speaking generally, he is reflecting upon his personal experience 
of making treatment choices as a doctor working in an MDT. He discusses inter-
disciplinary disagreements concerning diagnostic-specific treatments, that was 
touched upon in subordinate them B2. He also symbolically demonstrates how 
power-struggles concerning different discipline's perceptions of ‘good’ and ‘bad’ 
treatments can affect patient care and also the clinician's experience of teamwork.  
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Professional conflict was identified within the literature review (Beutler et al, 2012), 
but only in terms of specific psychotherapeutic approaches taken, rather than 
discipline-specific conflict. When considering decision-making processes, this is an 
important consideration, and is proposed to be explored further, to see whether this 
is a personal or team experience.  
 
B5: Conflict: ‘wanting Bipolar Affective Disorder’ 
Building on the theme of conflict raised above, desiring a less stigmatised diagnosis 
is a consistent theme in all interviews, patients wishing for a different diagnostic 
label, the most identified label was BAD. This appears to be both a source of 
difficulty when making treatment decisions, and also linked with a symptom of PD: 
‘identity disturbance’: 
 
Interviewee 10 (Clinician/Supervisor): “well, one of the things talked about is Bipolar, and 
how a lot of people feel that they would rather have Bipolar than um… Personality 
Disorder.” (T:10,P:10,L:454-456) 
 
 
Interviewee 10 suggests that people have a preference in terms of diagnostic labels. 
The theme of preference was not only raised in the transcripts pertaining to patient’s 
viewpoints, but also other services, specifically GPs: 
 
Interviewee 5 (Clinician): “Yes, so somebody came last week. The referral, for once, didn’t 
state that they have Bipolar.” (T:5,P:3,L:102-104) 
 
 
 
The emphasis: “for once”, combined with the fact that multiple interviewees raised 
this fact, demonstrates a need to educate GPs and patients about the diagnosis of 
both PD and BAD.  
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Difficulties are experienced by clinicians when GPs provide a statement that people 
could be suffering from BAD, which influences patient expectations of a particular 
type of treatment; this is described by all interviewees as a source of initial conflict in 
the treatment encounter. The patient has been provided with different messages 
from people in positions of power, which have then triggered ‘old behaviours’ 
generated when feeling ‘unsafe’ (i.e.: anger, self-harm). This issue can have both a 
damaging and adversarial effect, articulated by Interviewee 9:  
 
Interviewee 9 (Clinician/Supervisor): “as they are the ones that can cause some difficulty 
when working with other members of the team. We have had, sort of like, demanding second 
opinions. So they often think that they have other things wrong with them, like a Bipolar 
disorder, or OCD”. (T:9,P:7,L:308-314) 
 
 
This same interviewee discusses the difficulty concerning past diagnosis, suggesting 
that there is a need for confidence and assertiveness in the Treatment Choice 
Encounter for both senior staff (diagnosticians) and junior staff members making 
treatment choices: 
 
Interviewee 9 (Clinician/Supervisor): “I also think that another reason in this area is that if 
somebody came who was pretty astute, and they did get diagnosed with a Personality 
Disorder, and they came and articulated themselves well and complained about their 
diagnosis, it may then be changed to a Bipolar disorder, maybe a type two, so I think there is 
something about these patients that a part of their symptoms may be the fact that they don’t 
accept that they conduct themselves in a particular way, which is a reason that they reject the 
diagnosis or confront doctors about the diagnosis.” (T:9,P:8,L:380-392) 
 
 
There is research available concerning both the variance between PD diagnosis and 
Bipolar Affective Disorder (Borda, 2016) and the diagnostic comorbidity (Álvaro et al 
2016).  
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Stigma Theme Summary: 
The theme of stigma is consistent throughout all transcripts as an issue that causes 
problems in the Treatment Choice Encounter. Transcript excerpts have been 
presented in the above section and discussed, however due to word limit, not all can 
be covered, therefore a word cloud is presented in Figure 22, providing examples of 
additional figurative speech used to capture the struggle with diagnostic stigma: 
 
Figure 22: Word Cloud concerning stigma taken from transcripts of IPA interviews with clinicians 
and supervisors concerning Treatment Choice Encounters for PD patients. (T=transcript) 
 
 
The theme of stigma was also identified in the literature review, however what was 
not evident in the research, was how each level of stigma interacts, and also what 
effect the person's own stigma has upon the Treatment Choice Encounter.  
 
In summary, as a partial answer to the research question for this study; the 
interviews have generated an interesting set of personal narratives, which contribute 
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to an understanding of all interacting effects and what may help overcome the effects 
of stigma on the encounter, summarised in Figure 23: 
Figure 23: Interacting diagram developed via an IPA analysis of interviews 
conducted concerning how treatment choices are made with Personality Disordered 
patients. 
 
 
 
The interviewees emphasise the need to develop appropriate education material for 
patients, carers, staff, and referrers, to ease the Treatment Choice Encounter and 
engagement generally.  
 
  
PATIENT 
Issue: Personal perception of 
diagnosis 
Potential solution: Personalised 
psycho-education material 
ENVIRONMENT 
Issue: family and others perception 
of diagnosis 
Potential Solution: Improved 
diagnostic psycho-education. 
CLINICIAN & ORGANISATION 
Issue: Clinicians and teams holding 
differing views concerning the 
diagnosis. 
Potential Solution: Team Training 
SOCIETAL VIEPOINT 
Issue: Diagnostic Stigma, negative 
media respresentation. 
Potential Solution: Public health 
education issue.  
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6.2.3 Superordinate Theme C: The focus on time 
Resource pressures are identified as a key issue when considering treatment choice 
for people with PD. The key resource that interviewees focused upon above others is 
‘time’, this is the reason that time has been used as the superordinate theme, rather 
than resource. This is a slight variation from the literature review findings, which tend 
to focus on a lack of resource and reduced cost, but do not always factor time into 
this resource. 5 sub-themes are identified that contextualise why appropriate use of 
time is important: 
 
C1: Orientation and direction 
The link with time and orientation was evident in the language people used. 
Clinicians described directionality and disorientation as a major factor concerning 
‘time-management’ and ‘wasted-time’ for the patient and the service, as shown by 
the excerpt below:  
 
Interviewee1(Clinician): ‘Because a lot of people think they are sending them back and they 
haven’t even tried. …. Also quite often, the people that often not attended, they will come back 
in two months and either the GP will send them back or the Access team, and it is more often 
than not then they will not come back. The crisis can often go away in the week, and the risk 
will reduce, so they may not need treatment, this is the nature of the Personality Disorder.” 
(T:1,P:6,L:292-302) 
 
 
When considering how this short paragraph described the patient journey for a 
person with PD, it is disorientating. The description highlights a sense of rejection 
and lack of support for the patient. The movement appears anchored in the fact that 
the patient does not fit with either service (GP or mental health), however has a need 
for service support. In other examples, clinicians discuss how patients can 
productively use time: 
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Interviewee 6 (Clinician): “’and this happened, and I remembered what you said in the group 
the other week about stop and think, and I recognised that I was on hyper-alert’. And that was 
great to see, someone actually getting it, and recognising what they are doing, without 
workers being there, and actually getting it, and putting something in to change themselves, 
and then coming back to the group and reflecting upon it. I think that’s great”. (T:6,P:5-6,L: 
248-258) 
 
 
A sense of orientation appears to be of particular importance in the Treatment 
Choice Encounter, as interviewees reflected upon disorientation symbolically as a 
negative factor, and ‘being in the right place’ as symbolically a positive factor in 
treatment choices. Interviewee 3 provides an example: 
 
Interviewee 3 (Clinician): “So you can say, well you are not in a place where you are able or 
willing to work at the moment, and we are not in a place where we can do anything 
therapeutic at the moment, with the beliefs and opinions that you hold about treatment.” 
(T:3,P:2,L:67-73) 
 
 
The introduction of the TCG meant that clinicians focused much more upon 
identifying ‘where the patient is’ – framed as a psychological rather than physical 
construct. This was an interesting outcome, as the TCG concept is not based upon 
anything that the clinicians did not already state that they knew, it primarily focuses 
upon diagnostic acceptance and acceptance of treatment as choice variables. 
However, what the interviews showed was that there can be a sense of 
disorientation for the clinician in the encounter, this was represented in the 
transcripts by repeated phrases used: “where are they?” “And where am I?” Also 
with repeated phrases concerning ‘loss of direction’, and ‘going down the wrong 
road’. Interviewee 1 describes how the TCG has been used as a type of ‘map’ to 
orientate the direction of the encounter: 
 
Interviewee 1 (Clinician): “I have been through the sections [in the TCG] and have asked 
them if they can understand where they’re at, and explained my understanding of where 
they’re at, and they seem to get it.” (T:1,P:2,L:81-85) 
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Another point concerned ‘wasted time’ and disorientation, related to certain 
clinician’s use of the TCG. It was initially implemented to focus the investigation and 
explore the research question, and aimed at use in the encounter itself, or in post-
encounter reflection. However, 40% of interviewees reflected that they had used the 
TCG in different relationships, particularly with GP’s and other referrers. They used 
the TCG to explore ‘time wasted’, with patients moving backwards and forwards, and 
also to enable referrers to consider a rationale for why they are referring a person 
with PD. Interviewee4 was one of these clinicians:  
 
Interviewee 4 (Clinician): “What we have noticed is that they are not getting back to us as 
much, complaining [meaning GP’S] that we have not taken them into service [meaning PD 
patients]. And we are not seeing a high proportion of them being re- referred, so I think that 
they are taking on board the message that it is not just because they have a Personality 
Disorder that they need treatment, but that there is a level of engagement that is needed” 
(T:4,P:1-2,L:43-51) 
 
 
 
Interviewee 4 demonstrates that having a clinical heuristic such as the TCG is helpful 
with referrers who have previously ‘complained’, and merely referred back into 
treatment. It is interpreted that orientation is linked with rationales for acceptance or 
rejection of treatments.  
 
The transcripts provided multiple references and uses of figurative speech relating 
to: time, movement, and direction, summarised within the ‘word-cloud’ presented in 
Figure 24: 
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Figure 24: Word Cloud concerning ‘Time and Orientation’ taken from transcripts of IPA interviews 
with clinicians and supervisors concerning Treatment Choice Encounters for PD patients. (T=transcript) 
 
 
 
C2: Engagement time 
The ‘right time’ for treatment was a phrase repeatedly used by interviewees, and 
central to the decision-making choices for any treatment. Interviewee 9 
demonstrates this: 
Interviewee 9 (Clinician/Supervisor): “she was well-motivated. It was a fantastic experience 
for her it was transformational, I mean she had Personality Disorder which caused her 
relationship difficulties and other difficulties, but she wasn’t extremely severe, so she did not 
have comorbid complex PTSD, but it did cause her problems, and she was definitely in the 
team remit, and she was at the point of admission, which means that she was quite severe. It 
just demonstrated how the treatment came at the right time.” (T:9,P:6,L:271-282) 
 
 
A difficulty with the use of terms such as ‘right’ and ‘wrong’ time, is that they appear 
to place a subjective value on treatment preparedness, which affects decision-
making. Certain clinicians anchored ‘readiness’ or ‘right time’ in terms of the degree 
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of motivation and engagement a patient showed. Other interviewees discussed it in 
the context of the amount of insight they have about their diagnosis, and how 
treatments may affect that diagnosis. Interviewee 1 demonstrates that this can cause 
a difficulty and cross-service conflict: 
 
Interviewee 1 (Clinician): “All we can kind of do is be here if someone does want a treatment, 
or for when someone feels ready for a treatment. Then just pass that back to a GP, and they 
end up saying, ay-up, hang on a minute” (T:1,P:4,L:178-182) 
 
Clinicians have then discussed how the use of tools such as the TCG can enable 
them to reflect upon the subjectivity of their perception about whether this is the ‘right 
time’ for the patient. Interviewee 5 demonstrates that there is a need to focus upon 
‘in the moment’ problems which may be amenable to treatment: 
 
Interviewee 5 (Clinician): “I think that historically, there has been a way in which we write 
the assessment; we write the person's story and we say, ok they have got a Personality 
Disorder, and so write that, they then go to a Treatment team. Whereas now, with the Grid, I 
think that the Grid helps us add to the assessment, and look at not only the symptoms, the 
diagnosis, and the story, but also assess the motivation to change. I think that now we sit 
down and we say, ok, what is it at the moment what is causing you the most distress, and can 
that be worked on?” (T:5,P:2,L:63-75) 
 
Interviewee 4 builds upon this, raising another dimension about ‘right’ or ‘wrong’ 
time, concerning internal waiting times: 
Interviewee 4 (Clinician): “We get them, they come in crisis, obviously, and they engage here, 
but if then we find that they are motivated, or we engage them to enhance motivation, the 
problem is then the time that they wait to be seen for actual treatment when they are put 
through to the actual Treatment teams. And so, then they may not engage, and then they might 
just be seen in crisis, because by the time that they get to see the Treatment team, they have 
disengaged again”. (T:4,P:3-4,L:139-149) 
 
 
‘Treatment readiness’ and ‘right time’ are phrases that interviewees used 
interchangeably. In their experience, it appears to be a transient stage that people 
move in and out of, dependent upon their environment; their relationships, and also 
their perception about whether they need treatment or not. This finding raises three 
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issues when exploring the research question; firstly it concerns how internal waiting 
times for treatments affects people's treatment decisions, secondly what people 
perceive as valid treatment, and thirdly about whether ‘time’ as a healing process 
needs to be explored in more detail, when considering the transient nature of 
distress and disturbance for people with PD. 
 
A final point raised by interviewees concerned whether ‘engagement’ is a treatment 
that can be prescribed, and if so, how long it would be prescribed for, concerning 
resource pressures. Interviewee8 contemplates this: 
Interviewee 8 (Clinician/Supervisor): “So they do not trust others and do not trust themselves. 
So if they come to the service, in the beginning they decide in themselves dynamically, 
unconsciously, I will prove to the whole world I am rejected. So if we allow the 
disengagement, we reinforce the belief, so I think a 3-month assessment period is required.” 
(T:8,P:8-9,L:423-430) 
 
 
The impact of considering this type of intervention would appear to be centred in the 
experience of the clinicians interviewed, however it has a cost implication for the 
organisation, when considering the national payment systems.  
 
 
C3: Length of time in services 
The focus upon length of intervention is something undefined in the literature review. 
However, the question is repeatedly raised by clinicians: ‘when is enough, enough?’ 
(Bryan et al 2012). This identifies a dilemma for clinicians, supervisors, and services. 
When interviewees have discussed people's length of time in services, they have 
had different, sometimes ‘value-laden’ descriptions of patients: 
 
Interviewee 7 (Clinician/Supervisor): “…clients are not saying it, but there are alternative 
motives. They linger around a long time”. (T:7,P:10,L:502-504) 
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There is a sinister sentiment in this statement, concerning ‘alternative motives’ 
coupled with the use of the word ‘linger’ which means “to stay in a place longer than 
necessary because of a reluctance to leave” (Oxford University Press, 2015). This 
are phrases used by other clinicians as being anything not deemed as a social or 
health care treatment, but expected by some patients with PD (i.e. to apply for 
Benefits). The difficulty in exploring reasons for these issues is that PD patients can 
have a tendency to abdicate responsibility, but services aren’t always clear about 
what they provide in terms of “nursing and social care”:  
 
Interviewee 3 (Clinician): “In the community teams which I have worked, there have been 
people who have had long-term therapy and they have still walked out of the door, and they 
have crisis, and the therapy has had not made a significant difference.” (T:3,P:3,L:147-151). 
 
In this excerpt, interviewee 3 describes a difficulty arising in the Treatment Choice 
Encounter for people who have been in services a number of years. It raises two 
issues: firstly concerning dependency that may be caused by “long-term treatment”, 
and secondly about how clinicians who have worked in services a number of years 
perceive relapse, neither of these aspects were adequately covered in the literature 
review. This problem was expanded upon by interviewee5: 
 
Interviewee 5 (Clinician): “I think the consequence of responding to people with Personality 
Disorder in the way that the service currently does, is quite a harsh way, and not specifically 
productive. I am aware of the need to ration services due to the changes, and I understand 
that many people with a Personality Disorder self-discontinue services, however I have 
assessed a number of people that have come back and have expressed dissatisfaction with the 
treatment teams, unhappiness with the length of wait, and also a preference not to be re-
referred. Service users just say to me: ‘well what will they do different now?’. (T:5,P:6,L:276-
288) 
 
 
Service refinement is an emotionally evocative theme for certain clinicians 
interviewed. Interviewee 5 describes frustration about the waiting times and also time 
restrictions put in place. The use of ‘harsh’, provides context to patient's 
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‘unhappiness’ and ‘dissatisfaction’. He appears to suggest that this is a difficult issue 
to manage in the Treatment Choice Encounter, and suggests that despite treatment 
limits, people return shortly after discharge, meaning they extend their treatment 
longer than prescribed. This links into Category Theme E, pertaining to recovery and 
dependency.  
 
 
C4: Movement, ‘stuckness’ and wasted time 
 
Time and movement are discussed under subordinate theme C1 concerning 
disorientating factors. However, interviewees also raised issues concerning the cost 
of time, considering the pace of change, 'stuckness', and the metaphorical 
movement through services: 
 
Interviewee 2 (Clinician): “Where there is a history of disengagement, we will do a bit about 
engagement first, to try and enable them to continue, rather than just disengage again. 
Because it’s then not using up a space for somebody else who needs the treatment and will 
turn up.” (T:2,P:7,L:352-357) 
 
Interviewee 2 stated: ‘using up a space’, this emphasises the preciousness of the 
resource, but also places a value upon whether the person is in need of treatment, or 
not. This is not just linked to engagement, but also attendance factors, this is a 
monitored organisational cost in terms of non-attendance rates.  
 
‘Wasted time’ did not only arise in the transcripts as a patient-factor, it also pertained 
to organisational behaviour, specifically related to internal waiting-lists: 
 
Interviewee 1 (Clinician): “The waiting list for the other therapies such as psychology and 
CBT is phenomenal, and then we end up saying the same thing in the clinic every week while 
they are waiting for this treatment, which is frustrating for them and also for us”. 
(T:1,P:9,L:436-442) 
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This internal wait indicates that it is a variable requiring systemic monitoring. When 
considering the research, little was found about problems or benefits concerning 
people receiving pathways of care which may have different providers (or different 
levels of waiting times). There are also few studies that include multiple providers of 
teams; typically the results are presented from one provider viewpoint: once the 
patient is in therapy. 
 
Despite the difficulties described, there was a sense of compassion about the 
chaotic nature of a person’s life, an appreciation about how ‘stuckness’ or ‘snags’ 
that hinder progress may occur with a diagnosis of PD: 
 
Interviewee 7 (Clinician/Supervisor): “You have got the ones that tolerate, and the ones that 
hit a lot of snags. And somehow they are admitted to hospital and they do not come to 
therapy, and you try to get them back, and yes they are there, but because of the difficult 
experience they have and the experiences that trigger memories of past experiences that they 
have had, then what you get is that they hit lots of snags, which then affects the treatment” 
(T:7,P:5-6,L:245-254) 
 
 
The compassionate response is caring, but impacts upon time boundaries, and 
precipitates a reluctance to change interventions once stability has been achieved, 
due to anticipated destabilisation, also demonstrated by interviewee3: 
 
Interviewee 3 (Clinician): “Because, sometimes with people, you get stuck in a rut, and it 
[TCG] helps you focus where you are and where you are going. ‘Cause I think sometimes you 
can get stuck with people sometimes.”(T:3,P:1,L:38-44) 
 
The ‘stuck’ sense described is linked with a lack of movement or progress towards 
an end goal of discharge or recovery, perceiving PD primarily as a long-term illness, 
rather than an illness that can be recovered from. This clinician, like others 
interviewed, demonstrates some contradiction within their statements, stating that 
they do not find it difficult to discharge people if the Treatment Choice Encounter 
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requires it, however then make statements (such as in the excerpt above) 
demonstrating difficulty in reviewing the treatment for discharge.  
 
Within the transcripts, the lack of consistency in discharge approaches as an option 
in the Treatment Choice Encounter indicates that they are either not conscious of the 
fact that this happens with some patients, or they may feel it reflects badly on them 
to admit to this. This is explained by interviewee 9:  
 
Interviewee 9 (Clinician/Supervisor): “There are people who come along and are wasteful, 
non-purposeful interventions, it’s just; ‘how are you’, moaning and groaning, and the staff 
moaning and groaning and reflecting that back. And this is non-helpful interventions” 
(T:9,P:12,L:570-575) 
 
 
Interviewee 10 suggests that when patients become ‘stuck’, either reaching a 
treatment plateau, or due to disengagement, then a parallel process occurs where 
the staff become stuck: 
 
Interviewee 10 (Clinician/Supervisor): “So the staff feel stuck as much as the client feels 
stuck, and they want to pass it on. So there is a passing. There is a lot of hot potato stuff that’s 
goes on”. (T:10,P:13,L:589-592) 
 
 
This excerpt displays a level of discomfort deriving from ‘stuckness’, which may be 
anchored in time-wasting. There is an avoidance of addressing the discomfort, or 
evaluating treatment, resulting in movement of patients triggering patient 
destabilisation, then further need for treatment.  
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C5: End point - Recovery rather than cure? 
 
A final theme raised concerns the impact of ‘time’ connected to the use of the 
Recovery Model in Treatment services. Over 50% of the interviewees demonstrated 
knowledge of the Recovery Model and supported its principles, however suggested 
that patients struggle with it: 
 
Interviewee 2 (Clinician): “A cure. They want a cure and to be on a level. It’s the instability 
they don’t like, and they just want to be on a level.” (T:2,P:5,L:228-230) 
 
 
The concept of ‘cure’ suggests that the person no longer has the disorder. Many 
clinicians interviewed cited this as a reason that patients longed for a different mental 
disorder, which they perceive would make a ‘cure’ more achievable: 
 
Interviewee 8 (Clinician/Supervisor): “Just like any other medical condition. If someone is 
having chronic sinusitis, we can help treating the fever but not the chronic. Therefore in 
Personality Disorder, we ask what are the symptoms we can treat, as cure is probably not 
possible. But it can be improved”. (T:8,P:7-8,L:352-358) 
 
 
 
Lack of acceptance of Recovery principles mean some PD patients perceive that 
they need services, even when recovered. All interviewees stated that this was the 
case; however they varied in their reasoning. Some explained that it is due to 
patients fearing being unable to cope alone, and some anchored reasoning to early-
life trauma which triggered ‘being unwell’. This second point is under-researched in 
relation to PD, but underpins discharge struggles: 
 
Interviewee 1 (Clinician): “The other thing is discharge, if you are nearing discharge there 
will be a crisis, or something will happen to prolong discharge” (T:1,P:10,L:452-454) 
 
 
Interviewee 1 articulates the struggle in a generalised manner, indicating that it is an 
occurrence in many rather than few cases. This is expanded upon by interviewee 3: 
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Interviewee 3 (Clinician): “Bloody hard work.  I think why they are the hardest work because 
they want you, and even if you get to the point where you are discharging them, they come 
back straight away.” (T:3,P:4,L:242-246) 
 
 
The language that interviewee 3 uses indicates a physical struggle, and also an 
anticipation of return. In answer to the research question posed in this study, it 
highlights a need for additional support for clinicians, should discharge be 
anticipated. Additionally, wider systemic support is required to uphold boundaries via 
the discharge process, detailed by Interviewee 9: 
 
Interviewee 9 (Clinician/Supervisor): “[on discharge] I have then sent a really nice letter 
saying that if you do want to come back, the door is open. I mean we don’t want those people 
to feel that they cannot come back, or they have to come back under the Mental Health Act, so 
we almost need like an ongoing care plan, or a WRAP plan with the GPs, about how they 
come back into services” (T:9,P:14,L:688-695) 
 
 
This excerpt suggests that re-entry must be planned for, to support discharge and 
also manage disengagement processes, indicating that it must be done in a 
compassionate way, to avoid causing disharmony, which may affect the relationship 
if re-engagement occurs. 
 
 
Theme Summary: 
The time theme has multiple aspects that can impact upon the Treatment Choice 
Encounter. The research question asks how clinicians can be supported to make 
choices, one of the ways is to understand how the different perceptions of time, time 
limits, and time costs, may conflict. Figure 25 provides an example of how time may 
be prioritised differently for those involved:  
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Figure 25: Conflicting time demands diagram developed through the IPA analysis of 
transcripts exploring the phenomena of treatment choice working with patient with a 
Personality Disorder 
 
 
To help the clinician make the decision, there are suggestions within the 
subheadings above that certain types of support may be required:  
  
 The need to orientate self and others concerning treatment choices, this can 
be accomplished by using a tool such as the TCG. 
 The need for a clearly defined engagement phase, with time limits that are 
written into care pathways and also supported by payment tariffs. 
 The need to support people to reflect upon stable patients, rather than just 
unstable patients, specifically concerning the time they have been in service. 
 The need to examine systemic approaches to discharge in terms of PD, with 
the acknowledgement that people will struggle with relational endings. 
 A greater focus upon Recovery Model principles, within all points of contact 
and diagnostic explanations.   
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6.2.4 Superordinate Theme D: Meta-cognitive ability 
Metacognition relates to higher-order thinking, meaning a person is able to use 
higher cognitive processing concerning problem management and learning. It is a 
phenomena that has significant focus in CBT literature over the past 10 years, 
underpinning therapeutic techniques developed with patients to manage their own 
mental health problems, and was briefly detailed in the literature review 
(Bandura,2006), mainly pertaining to patient's experiences. 
 
It is important to reflect here upon the reason for developing the TCG. In asking the 
research question for this study, anxiety was triggered in the staff group concerning 
their reasoning ability and use of procedural, declarative, and conditional knowledge, 
to plan, monitor, and evaluate their experience in the moment. Some clinicians 
began to question their decision-making ability, and their own internal cognitive 
heuristic for decision-making. This then caused increased anxiety, connected with 
meta-cognitive processing. The TCG was created to help the clinician ‘think about 
what they needed to think about’ in the treatment session. 
 
Expanding upon this, the interviewees all discussed difficulties in terms of meta-
cognitive processes, however many of them did not use this phrase to name their 
experience. The ability to ‘think about thinking’ – or use meta-cognitive processing, 
was raised as problematic in different ways, explored within the 5 sub-headings 
below: 
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D1: Clinician's in-session meta-cognitive ability 
Rather than patient’s meta-cognitive ability being affected in the Treatment Choice 
Encounter (as identified in the literature review), pre-research preparation, and 
research interviewees, identified that it is actually clinicians who have their meta-
cognitive processing affected, impacting upon treatment choice: 
 
Interviewee 5 (Clinician): “But with Personality Disorder, it is again complicated, it may be 
due to self-harm, or high risk-taking behaviour, there is a lot of life events to go through, erm, 
you know, we need to pick through and think, alright, where is this person, so these will go to 
clinical discussion”. (T:5,P:1-2,L:46-52) 
 
 
The experience interviewee 5 describes is somewhat overwhelming and complex, 
and he explains the need to remove oneself from the session to ‘think’. In interviews, 
clinician's in-session meta-cognitive ability was explored, many clinicians identified 
difficulties concentrating in the encounter, demonstrated by interviewees 1&3: 
 
Interviewee 1 (Clinician): “… the chaos of the crisis, and that’s when I think that you lose the 
direction of the treatment. Because if you just keep plodding on with something that is 
possibly not effective anymore, then you are going to use the Grid to take a step back ,and say 
where am I at with this person”. (T:1,P:7,L:322-328) 
 
Interviewee 3 (Clinician): “You are not going to magically change something that it has taken 
somebody forty years to get to. That’s about a little bit of realism, and to look at what have 
we got in front of us. That’s what I believe in anyway, I believe very much in dealing with 
need rather than want” (T:3,P:3,L:167-173) 
 
 
Both interviewees describe difficulty in ‘thinking’ in the encounter. The need to think 
about one’s own thoughts is also central for both, for interviewee 1 this is because 
doing things without thinking may not be ‘effective’, for interviewee 3 this is because 
a sense of unreality occurs in the encounter, which distorts the ability to clearly think 
about the decision. Each interviewee identified that the Treatment Choices Grid or 
other such tools are helpful in-session, by enabling them to ‘think’ about the 
decisions they make: 
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Interviewee 1 (Clinician): “But if you are with somebody and your mind goes blank, then you 
can just refer to it. Also if you try and help them see where they are, and you try and help 
compare them to other people to help them see where they can improve.” (T:1,P:7,L:340-345) 
 
 
All interviewees are experienced clinicians, and all describe difficulty in ‘thinking 
about thinking’ in this encounter. The clinicians also described the experience as 
emotionally evocative, which can affect the decision-making process, demonstrated 
by Interviewee5: 
 
Interviewee 5 (Clinician): “With Personality Disorder over other diagnosis, there can be an 
emotional aspect of decision-making. Problems can come from either clinicians feeling sorry 
for the service user, or feeling angry with the service user, or by feeling intimidated. The Grid 
helps reduce this.” (T:5,P:8,L:384-390) 
  
 
What the clinicians appear to describe is that without an anchor, their thinking is 
influenced by their conditioned past responses to people who have displayed similar 
behaviours. Over half of the interviewees also commented that this can sometimes 
adversely affect the encounter:  
 
Interviewee 2 (Clinician): “She was brought back in, but she was so much better than the 
previous year, so I am thinking, you know, if she had had a year where she basically has not 
seen anyone and she has got better, then why would we need to give her treatment now?.. So I 
suppose I had those ideas before I went into the appointment with her. What the Grid helped 
with is, because she accepted the diagnosis and also accepted talking about it and also 
treatments for it, she was newly diagnosed, she wanted treatments, so I brought her in. I think 
that previously I would have said, well, no you don’t need the interventions, but since having 
the Grid it made me think again”. (T:2,P:2,L:58-75) 
 
 
 
As a part of the research, supervisors have begun concentrating more upon people's 
emotional reactions to people with PD, and techniques enabling meta-cognitive 
processing, including managing one’s own emotional reactions to certain behaviours. 
Interviewee6 explores not only the new intervention that has been raised through 
posing the research question, but also certain situations that may hinder the 
clinician's ability to use meta-cognitive processing: 
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Interviewee 6 (Clinician): “We can then explore the fact that working with these people is not 
just about the interventions or treatments that you give, it’s about how you feel on the day, 
how you react to what they do, and how others react as well, either their family or other 
clients. I think that this is really important in order for us to remain compassionate and not to 
do things that may damage people, clients and staff. I think that people with Personality 
Disorder remember lots of things we say, and we need to be careful about what we are saying 
and how we are saying it, in order to remain engaging but also boundaried”. (T:6,P:11-12,L: 
567-580) 
 
The ability to think clearly and make decisions is not only linked with emotional 
arousal, but also the clinician's physical health state. 
 
Interviewee 8 (Clinician/Supervisor): “This parallels with the Grid, because you may exclude 
some patient from treatment by using the Grid on one day that is not representing the person 
typically. For example, you have come to interview me today in the morning; if you come at 
lunch when my blood sugar is down, I might not be able to respond in the same way.” 
(T:8,P:14,L:689-695) 
 
 
This raises an interesting point when considering how we can support clinicians to 
make decisions. It indicates that there may be better times of day to plan Treatment 
Choice Encounters, and also suggests a need to ensure staff take appropriate 
breaks and attend to their diet to support others.  
 
Clinician vulnerability was a final point raised. This concerns the clinician’s ability to 
manage feelings evoked within themselves, and be mindful of potential transferential 
and counter-transferential responses. Interviewees 10&1 provide two different 
examples of ways in which the encounter may be affected due to clinician 
vulnerability, and the effects this can have upon meta-cognitive processing: 
  
Interviewee 10 (Clinician/Supervisor): “[Relating to the supervisory process]It is the client 
sometimes who’s like; ‘give me therapy’ but it's more the ones who just are genuinely just like 
they can’t cope, and they’re the ones who pull our heart strings” (T:10,P:18,L:857-860) 
 
Interviewee 1 (Clinician): “sometimes they make me feel a bit anxious and a bit like I’m not 
very good at my job if they are constantly asking me questions, and I’m having to feel that I 
cannot give them the answers without saying that I have got to go back and look at whatever, 
but with the Grid in the room, then I can refer to it in the session, which helps”. 
(T:1,P:8.,L:357-364) 
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These two excerpts are quite different, but pertain to the same subject; the need to 
support clinicians who conduct these types of encounters. Interviewee 10 proposes 
that clinical supervision is a positive way to regulate and monitor this process. 
Interviewee1 takes a different approach, which is to remove herself from the 
encounter, personally reflect, and use a tool such as the TCG to review the situation.  
 
D2: Patients meta-cognitive ability 
The literature review revealed the difficulty that PD patients have in terms of meta-
cognitive processing (Williams et al, 2007), therefore there will not be significant 
focus on this concept within this section, except to say that research findings are 
supported. An example is provided by interviewee 6: 
 
Interviewee 6 (Clinician): “Some people in this area think that they are dissociated, or that 
they can’t work on their problems. But often what is happening is that they are responding in 
a way because of their past experience, and their ‘detached protector’ [Schema Therapy; 
Young et al 2003] is taking over. What we need to do is make sure that they are aware of 
what this is, and that it is within their control to problem solve around this, and then they can 
do some work, but for some people this is not possible” (T:6,P:9,L:442-452) 
 
 
Another experience described by the interviewees concerns discussing the chaos of 
a patient's life, and how this appears to function as a meta-cognitive avoidance 
strategy, demonstrated by interviewee 6: 
 
Interviewee 6 (Clinician): “For these clients it is just too much sometimes. So you help then 
concentrate on one thing, rather than being chaotic and focussing upon everything and 
becoming overwhelmed. They just need you to help them focus on one thing, which the Grid 
does, and give them that bit of understanding that if they can control one thing then this is a 
big step for them.” (T:6,P:2,L:67-74) 
 
 
When analysing this however, care must be taken that perception of lack of meta-
cognitive ability is not confused with other factors, e.g. reactions to past traumatic 
relationships related to a disproportionate power-balance, described by interviewee7: 
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Interviewee 7 (Clinician/Supervisor): “Because it might be that they don’t want to talk to you 
because they don’t trust you. They need to tell you all these difficult things, but they need to 
trust you. And they need to know that you are not going to judge them on all that stuff. So they 
need to know that all those preconceived ideas that they have about clinicians, that needs to 
be completely removed over time by developing a therapeutic relationship”.(T:7,P:9,L:428-
437) 
 
 
The results concerning lack of meta-cognitive ability once again reinforce the need 
for psychoeducation material, as interviewees have experienced patients not being 
able to think about what was discussed in-session, post-session: 
 
Interviewee 9 (Clinician/Supervisor): I think people say things in the room, and then they 
come away and reflect-was that a criticism, that they said that I wouldn’t talk, and obviously 
if they had the Grid they would see that it is not  a criticism, it’s just where people are”. (T:9, 
P:15,L:736-741) 
 
A lack of education does not solely constitute a part of a poor meta-cognitive ability. 
People are only able to think about their thoughts if they are educated enough to 
reason, and have alternative information to reason with. Some people have not 
received diagnostic psycho-education, which affects their ability to process, as 
demonstrated by interviewee 6: 
 
Interviewee 6 (Clinician): “And sometimes when a client comes into service, they don’t 
understand. They don’t understand their diagnosis, they don’t understand what they want, 
and they don’t understand what treatment there is, and why his may help them. So 
engagement, and helping them understand what it is that they need now and what will benefit 
them is so important, and this is what the Grid does”. (T:6,P:4,L:159-168) 
 
 
D3: The organisation's ability to think about the person 
Personalised care is promoted in all aspects of mental and physical ill-health. This is 
difficult when there is a system that commissions a specific set of treatments, as 
personalisation can only then occur within the parameters of what has been set. 
What the literature review has shown is that services for PD have been established 
inside services originally designed for non-PD mental health problems. This in itself 
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poses a challenge for the organisation to think clearly about the individual, and it is a 
point clearly expressed within the interviewee's experiences.  
 
Concerning the host organisation for the research study, like many mental health 
trusts, the portfolio of services is large, therefore it is a challenge to consider and 
respond appropriately for an individual inside such a large organisation. This links 
with the consistency section, as interviewee 3 describes an anonymised encounter:  
 
Interviewee 3 (Clinician): “I don’t think we’ve got it wrong necessarily, I think it’s a 
challenge. A challenge for the organisation, as in the NHS. Because I believe that actually, 
when – say, Bill, who shouts a lot, gets to the end of his three years, and shouts a lot, and 
goes to the press and makes a complaint etc, and said that this has happened, and that has 
happened, and demands more treatment. I suspect that the NHS and we as a Trust will say -
well ok, you can have more of a service. But some other somebody, not Bill, or somebody who 
is not as confident, when they get to discharge they will go – oh, alright then. Then it is the 
quiet ones that will always suffer.” (T:3,P:7,L:309-323) 
 
 
This description suggests that despite national guidance for treatment duration (DoH, 
2011e), these will be overridden locally if required, which is in a sense personalised, 
however it does not indicate parity. Interviewee 3 describes people with a certain 
type of PD who may be able to override parts of the system, and therefore breach 
the boundaries, potentially causing a rift between the clinician and the organisation.  
 
When considering organisational effects regarding the Treatment Choice Encounter, 
interviewees did not just discuss their own organisations, they also discussed the 
impact of other organisational value systems, approaches, and budget cuts:  
Interviewee 6 (Clinician): “.. it is also at times about Benefits, and also about criminal justice 
involvement. We are getting a lot of people coming through now because the prison service 
and the probation service are having cutbacks like the NHS is. This is meaning that some 
people have put into their release that they must come to mental health services and they have 
a Personality Disorder. These people often don’t attend, and if they do they are quite 
medication-focused. Often with Benzo’s. I use this Grid with probation and other agencies 
because it helps them get why we are saying that the person won’t work. I think it’s difficult, 
because it’s not just about us making treatment choices, but it is about other people’s 
perceptions of what we do” (T:6,P:10,L:477-494) 
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The link interviewees have made concerning the changes in direct organisational 
responsibility, and allied organisation's approaches for people with PD, affects the 
ability of the clinician to think fully about options available and contractually obliged 
within the session itself. This affects the meta-cognitive processing ability of the 
person, and therefore the type of ‘logic’ that they applied to this type of encounter, 
highlighted below by interviewee 10: 
 
Interviewee 10 (Clinician/Supervisor): “and it goes through all levels, because the person 
with Personality Disorder themselves finds it difficult every day to apply logic to any 
situation… they have got so much stuff going on that… you know, the window of tolerance is 
so small, they have they can’t think logically. Their frontal lobes are often closed to thinking 
logically, and that gets replicated throughout the ways of, um, social circles around them. I 
think it’s very common that.. for any service that is managing Personality Disorder… it is 
surrounded by illogical thinking, you know, if you get a group of professionals together who 
want to talk about working with Personality Disorder …  patterns, like:- meetings get 
cancelled at the last minute”. (T:10,P:6-7,L:289-303) 
 
 
Interviewee 10 is not just describing the experience of the Treatment Choice 
Encounter here; she is explaining how she perceives that different systems consider, 
and behave around, planning for PD services. The last two lines suggest that the 
behaviour is not always a conscious one, but one that is systemic, powerful, and has 
'ripple' effects that affect treatment choices.  
 
Interviewee 3 (Clinician): “I suppose the difficulty is, within our payment by results, this guy 
should only be in the service for up to three years or whatever. Actually are we doing this 
chap a disservice? Or actually, do we say that there are this cohort of people that will need 
longer-term, lower-level services such as this and actually it maintains their stability. I am 
not saying the service is not right..” (T:3,P:6,L:289-300) 
 
 
Interviewee 3 also discusses the impact of higher-level organisations when 
considering funding streams, and a reason why he perceives that a model which fits 
other types of mental health problems may not fit a person with PD. Both this 
viewpoint, and the point he makes about the funding streams, have an impact upon 
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the Treatment Choice Encounter. This viewpoint is to some extent reflected in the 
literature review, but without such personal comparisons and contextualisation.  
 
D4: The impact of Cognitive Dissonance 
Cognitive Dissonance is discomfort caused by having inconsistent thoughts, beliefs, 
or attitudes, concerning a certain attitudinal change or behaviour decision. It is linked 
with meta-cognitive processing, because it is important that we think about an issue 
if two conflicting viewpoints are held, otherwise this can have a confusing effect on 
decision-making. 
 
Examples of cognitive dissonance and meta-cognitive dissonance were evident 
within the Interviews, an example is provided by interviewee 4: 
 
Interviewee 4 (Clinician): “I think that we have seen a switch in our attitude over the past few 
years. So rather than the fact we don’t want anything to do with them, we are now feeling that 
they are nice and we feel sorry for them, but I think it is more about being more caring, but 
also what is best for the client. So when you have someone with a Personality Disorder, it is 
important that everyone is looking at that person in the same way and saying: Are they in 
need of an actual mental health service treatment and engaged enough to access that 
treatment? Rather than just: do they feel sorry for them or not. Because sometimes, looking 
after people isn’t the best, and it can be damaging and make them more dependant in the 
long-term.” (T:4,P:5-6,L:235-251) 
 
 
The different viewpoints held by the same clinician are: feeling sorry for the patient, 
despite having a past view of ‘not wanting anything to do with’ the person with a 
diagnosis of PD. The effect of cognitive dissonance in this sense appears to be that 
people can either become overinvolved, or provide inconsistent treatment decisions, 
due to the conflicting feelings they experience.  
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The differing opinions about a similar concept are also linked by clinicians to the 
diagnostic debate which they have cited as central to the Treatment Choice 
Encounter, described by interviewee 4: 
 
Interviewee 4 (Clinician): “We get a phenomenal amount [of referrals] every week with 
symptoms of Personality Disorder, but no symptoms of Bipolar. Yet the GP refers them in for 
an assessment for Bipolar, and that is what they are expecting to have. For people it seems 
much more palatable, everybody wants Bipolar rather than a Personality Disorder, despite  
the fact that we as health professionals know that it’s a horrific disease, and the majority of 
these stars that say that they have Bipolar also may not have, and may have a Personality 
Disorder….It’s like we have got a guy at the moment who has got a narcissistic PD diagnosis 
and EUPD, his partner could have accepted if he has got Bipolar, ‘cause somehow she could 
have accepted that this would have in some way meant that he was not responsible for his 
abusive behaviour towards her. But when PD was diagnosed she left him, and she said, ‘you 
know, I knew it was going to be that’. His behaviour was appalling, and it shouldn’t matter 
what you call the mental illness, but it does, and it mattered to her and him. And that’s why 
she left him, she said she may have stayed if it were Bipolar.” (T:4,P:7,L:306-337) 
 
The inability to explore and assimilate the two opposing viewpoints is a significant 
sticking point for some people with PD, and services enabling the separation of 
these viewpoints may be a part of this, as demonstrated by interviewee 3: 
 
Interviewee 3 (Clinician): “But actually I think he sees coming and sitting here as actually his 
time that he has to talk, but that he does not want to talk about it at home. They all know that 
granddad or dad goes into the shed and burns himself every so often, but they don’t talk 
about it. And this is his place to come where he is away from home, where he can talk about 
it.” (T:3,P:6,L:60-72) 
 
 
Interviewee 7 suggests that there is also a problem with the fact that people with PD 
can hold two viewpoints - that they do/don’t want treatment at the same time, 
causing in-session conflict: 
 
Interviewee 7 (Clinician/Supervisor): “A systemic problem in that, the GP has referred them 
because they have got all these problems, and the GP wants you to deal with this. Then, when 
you see the individual, they don’t want to deal with that problem, or they do not tell you about 
that problem that the GP has described. They have got this Personality Disorder and the 
treatment is required”(T:7,P:8,L:364-371) 
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Care must be taken to clarify whether the engagement issue described by 
interviewee 7 does concern cognitive dissonance, and is not due to another aspect 
of the person's symptoms, described by interviewee 9: 
 
Interviewee 9 (Clinician/Supervisor): “Sometimes people do actually just need time. And I 
think that there is a problem with this in the current service model, because there is a 
pressure on caseloads, and a pressure on number of appointments. So that the minute a 
person says that they don’t want to see you, that you need to discharge them, and I think 
sometimes that they just need time.” (T:9,P:13,L:642-649) 
 
 
Interviewees describe struggling to make discharge decisions in the encounter, 
linked with the different viewpoints they hold regarding risk management:  
 
Interviewee 10 (Clinician/Supervisor): “he is not responding to medication, practically he is 
not psychologically-minded, the clinician is like tearing her hair, out because she doesn’t 
know what else to do with him. She thought… she said, can you give me any ideas, and it’s 
disappointing, but I can’t do anything with him, because he is no way in a million years he is 
going, I have actually seen him on the ward, and he can’t respond, you know. He is very, very 
stuck, but he is of an age and situation that he presents as high-risk for completed suicide, 
mental health issues, so I don’t see that he is somebody that we can just discharge, because 
there is something about him that is quite risky”. (T:10,P:14,L:629-642) 
 
 
Interviewee 10 provides examples where cognitive dissonance affects discharge 
processes and clinician's perceptions of what interventions they may be providing, 
inside and outside of the Treatment Choice Encounter. The interviewee continues, 
arguing that supervisees who have a rigid viewpoint concerning what therapeutic 
treatments are, struggle with the concept of the role of ‘therapist’ within the team: 
 
Interviewee 10 (Clinician/Supervisor): “The thing is, I think they do a lot of [therapeutic] 
treatment, that they don’t feel like it is treatment. But if you ever say to them that they are 
doing treatment, they get really, really, anxious about that, because they think it’s not their 
role.” (T:10,P:16,L:751-755) 
 
 
Interviewee 10’s example cannot be considered as representative of the whole 
sample, as only her supervisor and one other clinician described this experience. 
Despite the lack of statistical representativeness, the experience provides rich 
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information when considering the movement towards therapeutic workforces and 
multi-professional working.  
 
D5: The impact of vacillation: idealisation and denigration 
The ability to think about treatments, while managing emotions triggered by 
evocative behaviours, can result in idealisation or denigration in the encounter. 
Interviewee 7 provides a specific contextualised example: 
 
Interviewee 7 (Clinician/Supervisor): “some of the antisocial ones are quite charming. They 
make you feel like they are the victim. Quite often they might come to you via the criminal 
justice system, you know, so the client may be trying to hoodwink the system into thinking that 
the reason why I committed this crime is that, the reason that I have beaten my wife, or my 
child, or the reason that I have been looking at child pornography, is that I am not well. Or 
that I need the mental health label so that I can escape the criminal justice. Some of them 
come in that guise. A lot of them come in that guise….Erm, and so some clinicians feel sorry 
for them and want to take care of them, some clinicians, are just completely disgusted.” (T:7, 
P:12,L:576-560) 
 
 
The presenting difficulties evoke strong emotional responses, which can result in 
either idealisation (‘feel sorry for’), or denigration (feel 'completely disgusted' by) of 
the patient, which can affect whether a person is offered treatment or not. This factor 
was discussed in the literature review when considering behaviours that evoke 
value-laden responses (Brown et al, 2012), however the concepts of idealisation or 
denigration in the research primarily focus upon the behaviour being enacted on 
behalf of the patient, rather than the clinician (Evans, 2011). Interviewee9 also 
provides an insight into the potential consequences of this type of engagement: 
 
Interviewee 9 (Clinician/Supervisor): “staff sometimes get overwhelmed, and we know that 
this group of patients can be very difficult to work with. If they are in placement, or if they are 
ringing up saying  'I don’t want anything to do with you', it is quite easy to think actually, it 
would be easier for me to discharge, and I will get more reward out of that group that will 
work, that group that is less abusive, complain-y and resistive, than with this other group”. 
(T:9,P:4,L:173-182) 
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When the interviewees did reflect upon the idealisation and denigration that they 
experienced from the patients, it conformed with the descriptions from the literature 
review. Interviewee 10 describes the potentially detrimental effects, should the 
clinician reciprocate and enact the role which they are expected to do, due to either 
the idealisation or denigration. In this example, the clinician's meta-cognitive ability to 
recognise the idealisation and not reciprocate, prevents the encouragement of 
dependency: 
 
Interviewee 10 (Clinician/Supervisor): “but what they do is, they go into ‘I’m stuck, I need 
you’, ‘you’re the answer’, ‘you’re the oracle’, and that point you get a lot of pressure…” 
(T:10,P:4,L:190-193) 
 
 
The interviewees that provided most of the examples of this behaviour in the 
Treatment Choice Encounter are clinician/supervisors, however it is also mentioned 
by clinicians. Another point that was not found in the literature review, but has been 
described by interviewees, concerns the behaviour of the current health and social 
care system towards people with PD. Interviewee 9 describes what appears to be a 
similar vacillation effect, which results in destabilisation of the patient: 
 
Interviewee 9 (Clinician/Supervisor): “It’s like you get all the care you need, or you’re out 
the service and you get nothing, because there is no primary care service for Personality 
Disorder. It’s like a really Borderline process in itself, all or nothing.”(T:9,P:15,L:712-717) 
 
 
A final point raised concerning this issue, pertains to the multi-professional working 
practices of a team; Interviewee 10 explained the danger of unilateral decision-
making for people with PD:  
 
Interviewee 10 (Clinician/Supervisor): “it is very unhealthy for a team to leave the 
responsibility for deciding referrals just with the therapist in the team, or with just one 
worker. It has to be a team decision, you know, and because that fits in very much with the 
idea of the ‘Recovery Model’, and team-working. And if you leave… if you leave the therapist 
as the person who makes the decisions, and they remain oracle, and the expert, and the 
special kinda care person, a magical mystery tour, you know, that we are trying to get away 
from, you know, psychology used to be like that, the ivory tower.”(T:10,P:9,L:397-408) 
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Category Summary 
Within this section, the effects of meta-cognitive processing have been discussed in 
terms of the Treatment Choice Encounter. The findings from the interviews are 
consistent with those of the literature review, in that people with PD will often 
struggle with meta-cognitive processing, and subsequently display a difficulty in 
thinking about their thought processes, problem-solving, and also coping with 
boundaries within Treatment Choice Encounters. This can result in un-boundaried 
and sometimes aggressive interactions, consisting of either: ‘ad hominem' attacks 
upon clinicians, or alternatively idealising clinicians. 
 
Findings from this section that are outside of those in the literature review, are that 
there may be similar processes at work from the clinician and organisation which 
affect the encounter. A first indication of this was when the research project was 
initially discussed, resulting in a destabilised response from certain clinicians, 
prompting the development of the TCG, as a part of the AR process.  
 
The TCG appears to have been effective in allowing research exploration of the 
subject matter, however it has also raised different points concerning people's meta-
cognitive processing in the encounter itself. Clinicians and Supervisors have 
reflected on the TCG's effects, suggesting that they act as an orientating, containing, 
and grounding factor in the encounter, which enables a more consistent approach to 
treatment choice. This is summed up by interviewee 6: 
Interviewee 6 (Clinician): “I use the Grid for my own reflection, not just work with the client. 
To see what am doing, and whether I am making a difference. Because when you are working 
with this client group, and it's chaotic, and chaotic, and chaotic, and you think you are going 
wrong at times, don’t you? Whereas if you look at this Grid, and think actually no, I can see 
that they are struggling to understand or accept their diagnosis, so I have got to help them do 
this, so I am doing everything right, and it's reassuring. It's making us feel reassured as 
clinicians, I think”. (T:6,P:7,L:306-317) 
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6.2.5 Superordinate Theme E: The potential for Iatrogenic harm. 
 
The literature review suggests that with people who have a PD, there is a need to 
consider the potential, not only for whether the available treatment will be effective, 
but also consider the potential negative effects of certain types of treatment 
(Castonguay et al, 2010). What the interviews demonstrate is a more in-depth and 
personal experience, recounting how experience in clinical practice can impact upon 
decision-making. The theme of potential iatrogenic harm is then split into five further 
sub-categories, explored below. 
 
E1: Passivity as opposed to active engagement 
Over half of interviewees described a passivity phenomenon in PD patients they 
have assessed. They particularly described these as being patients who may or may 
not accept their diagnosis, but reject active treatment. Interviewee 6 explained that 
passivity is clear in many of the patient's relationships, not just the care relationship: 
Interviewee 6 (Clinician): “People who are being exploited, or other people are taking 
advantage, rather than them self-harming, because again it is about enabling them to take 
control, encouraging them not to be dependent upon their people to problem-solve for them, 
but instead encouraging them, and helping them to learn to develop problem-solving skills of 
their own” (T:6,P:5,L:219-227) 
 
 
 
Interviewee 6 demonstrates the risk to the patient if this type of relationship is 
formed, she explains that passivity causes dependency on others, and a potential 
then for ‘exploitation’. The transcripts show a level of increased effort on behalf of the 
clinician rather than the patient, suggesting passivity. This is demonstrated by 
interviewee 2: 
Interviewee 2 (Clinician): “Sometimes I think that they’ll come along and yes, they understand it, 
but I .. I don’t want to say the ‘cup of tea’ visit, because we try not to do that. But they come 
along, and in the review clinic we review what we planned from the last visit, and say - this is 
what we planned at the last clinic review, and have you done this, this, and this. And they say, 
no, no, and no.” (T:2,P:6,L:263-271). 
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The disproportionate effort is clearly frustrating for the clinicians, reflected in the 
violent language that they use, interviewee 2 continues: 
Interviewee 2 (Clinician): “there is also a little bit of ambivalence or being unsure. And you 
have to kind of work with them a bit to be sure, or give them that bit of a kick… obviously not 
a real kick, or that bit of a shove, to make sure that they are ready” (T:2,P:7,L:329-334) 
 
 
When this passivity was identified, the clinician struggled to consider the next stages 
with these patients, specifically in making the treatment choice to discharge, as 
described by interviewee 1: 
Interviewee 1 (Clinician): “… they say that they need more appointments, or they need to see 
someone more frequently, but some of them don’t say why, or what they think that they would 
need within that other appointment. So we say ok, you are offered an appointment that you 
come to for an hour, but you are saying you are struggling between appointments, but you are 
not getting in contact with us. You can contact us by phone, and we have an emergency 
appointment slot every day in the clinic, which it would be possible for you to have if you 
contact us. But they don’t do that. But then they say they need more support.” (T:1,P:9,L:408-
422) 
 
 
Many interviewees describe a power-shift in the relationship, related to patient 
passivity, resulting in a degree of psychological control over the clinician, 
Interviewee8 summarises this feeling succinctly: 
 
Interviewee 8 (Clinician/Supervisor): “We clinicians are tools used by the patients”. 
(T:8,P:8,L:366-367) 
 
 
This dynamic does not appear to have been fully researched when reflecting upon 
literature review findings, but is a reinforced interviewee experience. Interviewee7 
explains how the therapeutic relationship must be monitored for passivity, as there is 
a sense that the patient is trying to form a ‘friendship’ and ‘caretaker’ role, rather than 
a role requiring active engagement: 
 
Interviewee 7 (Clinician/Supervisor): “they have got a genuine problem, but they don’t want 
to do anything about it. They are just happy to have it, and they have got a friend in you. They 
have got their benefits and they are being looked after. All they want is to be generally looked 
after, they don’t want responsibility”. (T:7,P:10,L:486-492) 
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Passivity-roles are linked with the overarching theme of iatrogenic harm, as they are 
damaging for the patient, clinician, and the wider system. In terms of the research 
question, focusing upon managing passivity, and being actively aware of 
iatrogenisis, may aid clinicians to make treatment decisions.  
 
E2: Chaotic lifestyle factors fuelling difficulties 
‘Chaos’ is described as an obscuring factor that fuels difficulties. The message that 
interviewees convey is: unlike people presenting with other disorders, people with 
PD have multiple issues occurring in their life at one time, all of which they feel that 
services must help them with. This is demonstrated by interviewee 6: 
 
Interviewee 6 (Clinician): “It’s like a jigsaw, it’s not just one thing with these clients, it is like 
a jigsaw, and it takes them to have a lot of pieces for it to start to come together” (T:6,P:6-
7,L:299-302) 
 
 
The comparison to a jigsaw is a repeated theme in other transcripts, thematically this 
could indicate two issues: firstly that the encounter is metaphorically a ‘puzzle’, and 
secondly, that each of the pieces require focus. Interviewee 10 demonstrates how 
people can become distracted by certain parts of the jigsaw, or certain behaviours: 
 
Interviewee 10 (Clinician/Supervisor): “A bit like the lady who, um, kind of cuts her genitals, 
it’s so full-on that everyone forgets about why she did that in the first place, or you know, 
whether they have done something which could kind of increase that behaviour, you know, 
there is no thinking around that, because it’s just too- you know”. (T:10,P:22,L:1031-1037) 
 
 
Perspectives concerning treatment choices required for people with PD appear 
divided in the transcripts. The majority of interviewees discuss the need for short-
term crisis-type problem-solving intervention, some advocate more longer-term in-
depth work. Interviewee 4 advocates short-term intervention, due to the potential 
dependency factors: 
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Interviewee 4 (Clinician): “I believe that with these people, triage is often an intervention in 
its own right, because you can do a lot to sort things out and signpost and educate at this 
part, which is mostly what these people need.” (T:4,P:14,L:675-680) 
 
 
Some clinicians state that it is important to make a differentiation between those 
patients that require short-term crisis interventions, and those requiring additional 
support: 
 
Interviewee 5 (Clinician): “These people often enter services when they are extremely 
distressed, or require help in solving one issue, such as Benefits, or problems with the 
criminal justice system, or relationship problems. The service user in this bit [indicating 4
th
 
Treatment Choices Grid quadrant] may engage for a short time, however they may also 
discontinue their engagement after the crisis is over, and may not need services longer-term” 
(T:5,P:7,L:312-322) 
 
 
Enabling clinicians to consider containment, and what is required to help them to feel 
contained when dealing with chaos, appears to be a core part of the encounter. 
Interviewee 10 details this: 
 
Interviewee 10 (Clinician/Supervisor): “the house is about to be repossessed… you know, and 
then they just couldn’t possibly cope with therapy at that point…. you know, so therapy isn’t 
the answer. But, the staff member feels the pressure to treat because of the person is like, ‘do 
something!’, ‘I can’t cope with this’, you know, it’s in some cases it’s not that the client is 
saying you do it, it’s like they literally can’t think straight anymore, and they are just like, 
please take this away from me.. They are also asking for somebody just to help them feel more 
contained” (T:10,P:18,L:824-836) 
 
 
E3: ‘Doing for’ - creating dependence 
The third category in this subsection refers to the repeated theme of ‘doing for’ that 
arose in the transcripts. This theme is connected to patient and referrer expectations 
about what mental health services are going to ‘do for’ the patient, which does not 
always match the service remit. Interviewee 4 provides an example: 
 
Interviewee 4 (Clinician): “They ring up and say I’m referring them and you are going to do 
this. And if we said we are not, they would not be happy” (T:4,P:2,L:59-61) 
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Another difficulty interviewees discussed related to certain clinician’s need to 'do’ 
something for the patient. This could be considered as a form of transference or 
projection, or it could be anchored in the clinician’s vulnerability. This is 
demonstrated by interviewee 7: 
 
Interviewee 7 (Clinician/Supervisor): “So, engaging one minute and then disengaging. And 
the psychologist felt a bit like she had come to the end of the road. So, like she felt that she 
had to do something” (T:7,P:1,L:44-47) 
 
 
There is a need for the clinician to be supported, to reflect upon the balance between 
‘doing for’ and enabling people to ‘do for’ themselves in the Treatment Choice 
Encounter, highlighted by interviewee 2: 
 
Interviewee 2 (Clinician): “… have got this person and she will take up a lot of time, and the 
family will take a lot of time up. These people often come in and just want to off-load’. They 
don’t do anything to get better, and they don’t want to do anything if it is offered, but 
sometimes they just want to moan” (T:2,P:9,L:426-432) 
 
 
There is a sense of difficulty in the way the interviewees discuss this issue, some 
describe the need to reduce dependency, yet correspondingly demonstrating 
encounters where they do the opposite, as highlighted by interviewee 3: 
 
Interviewee 3 (Clinician): “I think with this chap, he talks to me because he trusts me, he 
trusts that I am a nurse, and I work for the NHS, he knows that I am not in a special place. 
But he doesn’t really want to talk to anyone else about it. I don’t know, I think it might be 
because I ride a bike and he rides a bike. I don’t know, but whatever it is he talks to me, and 
he doesn’t want to go that deep into it, but he talks to me just enough.” (T:3,P:6,L:276-285) 
 
 
When discussing the topic of ‘doing for’, it is linked in the transcripts to the iatrogenic 
concept of dependency, as described by interviewee 6: 
 
Interviewee 6 (Clinician): “Because especially with this client group, you can do more harm 
doing things that make them too dependent, than not doing anything at all” (T:6,P:2,L:82-85) 
 
The interviewees describe the sensitivity needed in managing this subcategory: 
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Interviewee 7 (Clinician/Supervisor): “So I think it had something to do with the clinician 
feeling unsure and feeling like they had to do more. The need to 'do' was important for the 
psychologist, it was the real problem. In fact she said that the client said to her that she felt 
that she was not doing enough for her. So she has two conflicting feelings, on one hand she 
feels that she is not doing enough for her, but on the other hand she feels that she is doing a 
lot for her”. (T:7,P:4,L:154-163) 
 
The ways in which clinicians discuss the patient's need for help to make treatment 
choices:  
 
Interviewee 6 (Clinician): “I said well, you know, we are keeping you here, we are pacifying 
you. We are running out when you ask us to, but this is not helping you to move forward. And 
this is keeping you here (demonstrated on TCG). We are not helping you deal with these 
urges and do something different. I said, ‘what can we do to help you with that, without 
running out?’ This is important, as it’s the running out that makes the person more dependent 
on workers, rather than feeling that they are able to cope with whatever the problem is that 
they are encountering” (T:6,P:4-5,L:197-210) 
 
 
E4: Medication as an avoidant strategy 
The literature review demonstrates that medication can be a treatment intervention 
for people with PD (Beutler et al, 2012), however there appears to be a 
disproportionately represented focus in the encounter, and the support for 
medication use is varied, certain medications are referred to by clinicians as 
‘avoidant strategies’ rather than active treatments, highlighted by interviewee 2:  
Interviewee 2 (Clinician): “Some of the people we see are quite focused on medications, and 
medication is not always helpful in Personality Disorder, and they need to engage, which 
would help them more, and they need to work towards changing themselves, which they are 
sometimes reluctant to do”. (T:2,P:3,L:105-111) 
 
 
The issue of patient expectation is raised here, connected to the provision of 
medication. Unlike in the literature review, where research primarily focuses upon 
whether a particular medication is effective or not, when considering the transcripts, 
interviewees focus more on wanting medication to make problems “go away”, as 
described by interviewee 9: 
Interviewee 9 (Clinician/Supervisor): “I think this has been a problem, and when you refer 
clinicians to incorporate the Personality Disorder into a narrative, and you try to put the 
Personality Disorder diagnosis into the psychoeducation with the patients, its frowned upon, 
because people become unhappy by your response, because you are not saying; ‘here’s a 
high dose of an SSRI and all your problems will go away’.” (T:9,P:8,L:396-404) 
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The difficulty with this expectation of medication is that it is unrealistic. Distress is not 
switched off by any psychiatric medication, however there may be a dampening 
effect with certain medication. The perceived medication misuse has a cross-over 
with substance misuse, aimed at the same type of ‘numbing’ effect; as described by 
interviewee 8: 
 
Interviewee 8 (Clinician/Supervisor): “Again there is the issue of expectations, say if they 
come with some substance misuse. They are expecting they can get whatever they want. To 
legalise what they are taking illegally. So we have to be aware of this” (T:8,P:10,L:479-484) 
 
 
In the transcripts, where prescribers were interviewed, they particularly highlighted 
difficulties with evidence, in terms of some of the medications that have been 
provided for people with PD, highlighted by interviewee 4: 
Interviewee 4 (Clinician): “Why they would just want a medication to cure them, which 
doesn’t work long-term, but they don’t want to engage? We should be looking at this more. 
And actually, we know that the prescription of Benzos is discouraged, but instead of dealing 
with this, what has happened is Benzo prescription has gone down, but antipsychotic 
prescription has just been used as a substitute. And we know that antipsychotic prescription 
has harmful effects and shortens people’s lives.” (T:4,P:13,L:618-628) 
 
 
The issue of 'cure' is raised again here, the unrealistic view of cure is evident within 
the language that certain clinicians use, for example interviewee 2:  
 
Interviewee 2 (Clinician): “Sometimes I struggle. You know, they are not accepting it, or 
sometimes they are asking for treatment such as the 'magic pill' again. And, you know, they 
have just seen a Consultant who has reviewed their medication, then they come into me and 
they say 'it’s not working'. But it’s what their expectations are about what the medication will 
do. But they say that 'everything’s not working'.” (T:2,P:5,L:214-222) 
 
 
Interviewee 2 appears to suggest that the wish to have medication prescribed is for it 
to do something ‘magic’, rather than what the current medications can do. This 
suggests an unrealistic expectation of medication that is not healthy, but sought by 
patients coming to Treatment Choice Encounters, linked with intolerance of distress, 
which is a core symptom of PD (WHO, 1992). 
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E5: Risk and personal responsibility 
All those interviewed linked a low level of personal responsibility in a patient to the 
potential for a high level of dependency on a mental health service, and a 
subsequent struggle with boundary management and discharge process. The notion 
of personal responsibility for patients is not described as a static risk factor, it is 
instead described as fluctuating dependent upon stress levels, as demonstrated by 
interviewee 4: 
 
Interviewee 4 (Clinician): “So an example would be, for Mrs Smith, every October, because it 
is the anniversary of her son’s death, she becomes unwell and tends towards self-harm, so 
why don’t we put that in the plan, that services should expect contact at his time, and this is 
the type of intervention that Mrs Smith would like, and she will not need anything after this 
time. And so what she does is go into the crisis bed for a few days, and then she is back out of 
services, not referred into a treatment team. In this way, Mrs Smith would know she had been 
heard, she would know she was cared for, she would know that the service is available to her, 
so she does not have to demonstrate her distress or risk to get it. And the crisis is averted.” 
(T:4,P:16,L:793-808) 
 
 
This suggests that the clinician role in the encounter is to understand whether what 
has caused the relapse is a recognisable and manageable trigger in the short-term, 
or whether it is something that requires a longer-term service. The ability to take 
responsibility for treatment is linked with risk management, as highlighted in the 
literature review (James et al, 2007; Dimidjian et al, 2010).  
 
The expectation for the service to provide purely risk management interventions for 
people who do not wish to have active treatment is central, and connected to teams 
feeling over-committed, as demonstrated by interviewee 1: 
Interviewee 1 (Clinician): “Sometimes they are referred in more for risk management rather 
than treatment. But sometimes they are referred in for treatment and they just don’t want it, 
and that is a real difficulty for us, as we are a treatment team.” (T:1,P:4,L:171-175) 
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The discussions concerning how risk should be managed vary in the transcripts, 
certain transcripts are clear about discharge processes and disengagement 
processes for PD patients, as described by interviewee 2: 
 
Interviewee 2 (Clinician): “They have not turned up for 3 appointments, we have tried ringing 
them, and this, and this, and this, but they have still not engaged, so we are going to 
discharge them, and we have a discussion with the GP about it, but if there is still concern, 
we will go out and do a cold call. Which is a lot more than physical services would ever do” 
(T:2,P:8-9,L:397-404) 
 
 
This is not a consistent view taken by all though. The variables that influence 
decision-making appear to be processes and legal frameworks pertaining to risk and 
how risk consequences are evaluated, summarised by interviewee 10: 
 
Interviewee 10 (Clinician/Supervisor): “and talking to the consultant psychiatrists who are 
the ones who usually take the responsibility. They explained that the problem for them is that 
when somebody commits suicide they are held up as accountable in different way to a doctor 
in a physical health service. So a doctor in the physical health service, you know, his patient 
smoking after he had been told not to, and ends up dying of the illness that, you know, the 
smoking-related illness, it’s not his fault; if the same thing happens in mental health services 
it is the consultant's fault, and that’s what I see to be the problem”. (T:10,P:14,L:656-668) 
 
 
Over-engagement due to perceived risk management obligations has ethical 
difficulties in terms of iatrogenic harm. Interviewees again relate this to potential 
dependency and potential boundary management difficulties related to 
Superordinate theme 1. This is discussed by interviewee 9: 
 
Interviewee 9 (Clinician/Supervisor): “There is one set that we are involved with due to risk, 
and in some way we over-engage with them. And we intervene because we fear the risks, and 
we manage the risk, and put them in placements because we fear the risks. And then there is 
probably people that just  don’t want to engage, but because there are not so many risks, we 
don’t put them in placements or use the Mental Health Act”. (T:9,P:14,L:664-672) 
 
 
Actual examples are provided by clinicians concerning patients who have received 
lengthy treatments, but due to the dependency they have developed, their contact 
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with services is increased, despite their risk being decreased. One example is 
provided by interviewee 4: 
 
Interviewee 4 (Clinician): “Yep, we’ve got a lady in a treatment team, went away to a 
specialist treatment unit, out of the area. She has mixed PD, and used to cut and harm herself.  
What she has done is that she doesn’t cut anymore, because the therapeutic unit has shown 
her how to stop this, however what she has now become is dependent on services, we have 
helped her to moderate one area of her life which is good, however she has nothing left, and 
nothing to replace it, so she is absolutely dependent upon our services now. In the team, she 
is going round telling people how she has improved, because of the reduction in self-harm. 
And yet in Crisis team we have had more positive contact, she has not been so abusive, her 
contact is positive, however significantly more frequent.” (T:4,P:8,L:376-393) 
 
 
 
Theme Summary 
When considering the core principles of beneficence and non-maleficence, the 
concept of iatrogenic harm must take the forefront of any support provided to 
clinicians making treatment decisions with service users. This is a difficult subject 
when considering the care and treatment of people with PD, as providing any 
treatment could be considered as potentially disabling, if the treatment means that 
there is a dependency developed from the individual upon the clinician.  
 
The issue of dependency is described in the literature review, but the impact upon 
service delivery, over-occupancy of mental health treatment teams, and available 
management strategies, is not something that is detailed or focused upon in terms of 
management.  
 
The difficulty expanded upon by the interviewees concerns the fact that this is not 
merely a mental health service issue, but an issue for the wider health and social 
care system. Otherwise, if the decision to discharge is made, people can end up 
returning straight back, because wider non-mental health services have not agreed 
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to sign up to support them, and there is a wider perceived assumption, i.e.  by 
services such as the coroner's court, where risk management decisions are 
scrutinised based on non-accidental death, that risk-management consequences in 
mental health should be evaluated differently, which processes then impact upon 
care delivery and treatment decisions.  
 
The recommendation is therefore to analyse the risks that exist, and deliver more 
comprehensive training packages for GP’s, linked with the public health need for 
stigma reduction, so that people with PD could be understood and supported in all 
systems, not just specialist mental health care.  
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6.2.6 Clinician results: individual variations  
Within the IPA above, indication has been provided where variations between 
clinicians were found. For a super-ordinate theme to be identified, over half of the 
interviewees had to have raised the theme, however for the sub-theme, this was not 
always the case. To demonstrate variation, Appendix 39 is presented, this allows 
readers to understand the level at which each clinician supported or detailed the 
theme within their transcript. In providing this figure, subjective differences in results 
are demonstrated with wider contextual analysis, which is a core principle of IPA.  
 
6.2.7 Clinician/Supervisor results: individual variation 
When considering the presentation of the results section, the original intention was to 
present the clinician and clinician/supervisor results separately. This was due to the 
assumption by the researcher that there may be distinctly different themes raised by 
the different groups. This assumption was proved as false after intensive analysis, 
and analysis of the transcripts by the second researcher.  
 
The reason for this is that the clinician/supervisors reflected upon many of the same 
issues that clinicians did. Rather than providing significant focus upon their role as a 
supervisor, they discussed at length their joint role of clinician. They reflected upon 
their struggles in the clinical encounter, and strategies they have found have helped 
or hindered their clinician work. This appears to indicate that the issue of making 
treatment choices is not something that current supervisors have the answer to, but 
is something that they also struggle with, and would value more research into, 
confirmed by all supervisors interviewed. 
 
Student Number: 100104045 
226 
 
Despite stating that there were similar themes raised, there were a few aspects 
where the supervisor/clinicians differed from the clinician’s transcripts, summarised 
below: 
 The lengths of the supervisor/clinician transcripts were on average 300 lines 
longer than the clinicians. They were more reflective and detailed in their 
accounts. It is difficult to account for these differences, however it could be 
that due to their role, they are more experienced and comfortable in reflection, 
or have been involved in past research studies.  
 The supervisor/clinician’s contextualised their experience in different ways, 
evident from their transcripts; they spoke with more assertion when reflecting 
upon their direction as a supervisor, however with more uncertainty and 
vulnerability within their role as a clinician. The confidence in their statements 
altered, demonstrating they struggled in their clinician role, which contradicted 
on occasion their advice when reflecting upon their supervisor role (i.e. in 
decisions such as discharges). This finding appears to be linked to the 
difficulty in meta-cognitive processing detailed in subsection D1 above. 
 The weightings for specific variables differed in the supervisor/clinician and 
the clinician responses, detailed in Appendix 41, this may be associated with 
the fact that all clinician/supervisors are also diagnosticians, and 75% are also 
independent prescribers.  
 
No conclusions are drawn about whether the supervisor/clinician’s experiences are 
more valid than the clinician's. This is associated with the research question itself, 
which focuses upon how people make decisions. For this reason, the clinical opinion 
of all interviewees are seen as valid in terms of the results, and what the interviews 
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have demonstrated is that each person struggles and requires assistance to make 
decisions, whether a supervisor/clinician or clinician, which has been summarised 
collectively within the super-ordinate variables  discussed above.  
 
The question was asked about what supervisor/clinicians could do to assist decision-
making. The factors supervisors stated were the same as the factors that the 
clinicians also felt may help, these have been discussed in the superordinate 
themes, but also pertain to having: (1) increased access to appropriate psycho-
education (in different formats), (2) consistency in supervisory advice and 
boundaries, (3) training in MI techniques, and (4) the ability to participate in a multi-
professional system which supports decision-making.  
 
6.2.8 Patient outcomes  
The questionnaire data collected generated insufficient results. The results that were 
gained must also be considered as biased, as they were formed only from patients 
who had insight into their diagnosis and accepted that prescribed treatments may 
assist them. What the literature review and participant research has shown is that 
this does not represent the group that clinicians struggle in making treatment 
decisions with.  
 
Despite the fact that the number of questionnaires generated made this quantitative 
result insignificant, the process issues that it raised and the discussions it generated 
within validation groups (which included patients and carers) was a significant result 
in itself, and one that was not expected.  
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People who reject the PD diagnosis and/or NICE Guidance recommended treatment 
for PD constitute an under-researched area, with little reference found in the 
literature. However, in practice, the interviewed clinicians, supervisors, and validation 
groups have found that this group is one that is most frequently in contact with acute 
mental health and physical health services, and the criminal justice system.  
 
This finding is important when considering the research question, it suggests that 
increased psycho-education may aid a person in accepting diagnosis and treatment, 
but also suggests that an increased level of understanding is needed about this 
cohort. This increased understanding is challenging, due to the reluctance of people 
to engage. It was considered with the validation groups, R&D team, and university 
supervisors, whether, in order to answer the research question, further research was 
needed in this study, however as this is not the core component of the question, it 
was agreed that the research would not be altered, but this finding would be 
suggested as a post-research strand. 
 
6.2.9 Treatment Choices Grid Outcomes 
The aim of the study was not to validate the TCG, however it was appreciated that 
feedback would be provided which may indicate whether future research is required 
in terms of its efficacy and validity as a clinical tool. If testing the TCG’s validity had 
been the focus, a different methodological approach would have been used, e.g.  
experiment method, this is a typical and evidence-based way of testing and 
validating a clinician tool.  
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However, an outcome of this research is that a further research study using this 
format is indicated for the TCG. A brief summary of the reasons for this is presented 
below, gathered from each different part of the research: 
 
Clinicians and Supervisor/Clinicians: All clinicians and supervisors cited it as a tool 
they would use in clinical practice. However the reasons for this varied:  
 
 Some interviewees used the TCG with patients, some did not.  
 Certain interviewee’s expressed that it aided in the education of referrers, and 
have explained that they have seen a demonstrable reduction in complaints 
and re-referrals since its introduction, due to the fact it provides an evidence 
base for treatment or discharge decisions.  
 Certain interviewees have used the TCG for individual or group reflection. 
 Some interviewees have used the TCG for themselves as a ‘grounding’ or 
‘containing’ object, which has aided them to focus in the encounter. 
 All interviewees reflected that the patient version of the TCG (Figure 11) is the 
only version they have used in practice, rather than the clinician or supervisor 
TCG (Figures 12&13). 
 
Patients: Due to the low number of responses received, and the bias concerning the 
type of patient who replied, interpreting the patient questionnaire feedback must be 
approached with caution. However what results have demonstrated is that with those 
who did provide feedback, their experience of the TCG was predominantly positive: 
 86% of respondents found the TCG helpful to the session. 
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 86% suggested that the use of the TCG enabled them to understand why a 
certain treatment had been offered to them at the time of the session.  
 86% suggested that the use of the TCG enabled them to understand why  
certain treatments had not been offered to them at the time of the session.  
 86% stated that by using the TCG, they understood that as their needs 
change, so will the treatment choices available to them. 
 79% of respondents found the wording used in the TCG easy to understand. 
 80% of respondents stated that the TCG helped structure their care plan. 
 86% of respondents would recommend that the TCG is used with other 
people with PD entering this service. 
 
The narrative feedback concerning the TCG has been incorporated in the Super-
ordinate Themes above. This is to contextualise the experience of the Treatment 
Choice Encounter, which has been affected by the TCG introduction. There is more 
information contained in the transcripts than has been presented here in terms of the 
TCG, however the reason for its exclusion is that it may detract from the original 
research question.  
 
In summary, the introduction of the TCG appears to have been beneficial, both in 
progressing this research, and funnelling IPA questioning sensitively. However an 
outcome of the research has not been to suggest whether the TCG is a valid tool, as 
this would require an alternative methodological approach. If the tool is validated 
through this future research, then appropriate guidance would need to be provided 
alongside of the tool, focusing upon not only how to use the TCG, but with whom it 
should and should  not be used.  
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6.2.10 Results and Analysis Summary 
 
Within the analysis and discussion Section, the research question has been focused 
upon, alongside the literature review outcome, to generate findings from the 
interview transcripts provided by clinicians and clinician/supervisors, and the 
questionnaire feedback obtained from patients.  
 
Analysis has been performed using an IPA framework, and presented in a narrative 
format under five superordinate themes concerning: Boundary Management, 
Diagnostic Stigma, Focus on Time, Meta-cognitive Processing, and the potential for 
Iatrogenic Harm. Each of these super-ordinate themes were cited by each 
supervisee, however the sub-themes contextualise the ways in which themes were 
explored and referenced by each individual, contextualised through transcript 
excerpts. This enables the reader to understand the analysis presented, and 
appreciate where subjective differences are generated within the collective results 
presented. 
 
The analysis and discussion section has generated results which can both provide 
an additional insight into potential locality practice changes, and also areas for future 
research, this will be explored further within the synthesis and discussion section, 
including recommendations for practice change and future research. 
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Section 7: Synthesis and Discussion 
 
 
7.1 Introduction 
This section provides synthesis and discussion concerning how each component of 
the study compliment and contrast. The section will draw upon both the outcomes of 
the hermeneutic literature review and interviews analysed via IPA, identifying points 
of convergence and difference which inform the overall AR study.  Aspects of the 
research participant’s experiences which are missing in the literature will be 
highlighted. 
 
This Section is presented in six sub-sections, within which the qualitative analysis 
presented in Section 6 above is expanded further in narrative form, as proposed by 
IPA researchers (Smith et al, 2009). The next three sub-sections will focus upon 
patient, clinician, and supervisor issues. Narratives and hypothesis are generated, 
relating to key similarities and differences in how clinicians formulate treatment 
decisions, and how this affects patient/service relationships. Subsection headings 
are: 
 7.2: Patient factors related to diagnostic formulation, symptom severity, 
comorbidity, treatability, and acceptance/perception, which are cited as 
contributory factors within the Treatment Choice Encounter. 
 7.3: Clinician factors, including personal and professional beliefs and 
perceived resource availability, which contribute to their ability to manage the 
Treatment Choice Encounter. 
 7.4: Supervisory factors that have been identified to support the ability to 
formulate consistent treatment choices and justify decisions. 
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The sub-sections are structured to encompass the superordinate themes identified in 
the IPA analysis in reference to the main research question:  
How can mental health care staff use a pre formulated guided decision 
process in the selection of  therapeutic interventions for people with PD, within 
the context of rationalisation and service change?  
 
Each of the sub-sections include a discussion of the overarching issues raised, 
which illustrate how IPA superordinate themes are related. The two qualitative 
methods used within the overall methodology of AR have already initiated changes 
in practitioner approaches to the phenomena of treatment choice, but this section 
also aims to contribute towards actual practice change. The final two sub-sections 
presented focus upon study recommendations, and a summary of strengths and 
limitations. 
 
 
7.2: Patient factors related to diagnostic formulation, symptom severity, 
comorbidity, treatability, acceptance/perception, which are cited as 
contributory factors within the Treatment Choice Encounter. 
 
 
All of the interviews illustrate the uncertainty regarding changes in diagnostic 
categorisation and PD diagnosis, often viewed differently to other mental health 
problems, reflected in the literature review debates (Widiger et al, 2011; Rottman et 
al, 2009; Pilgrim, 2007) and the current NICE Guidance for PD (NICE,2009a&b). The 
interviewees suggest that this then confuses the Treatment Choice Encounter, as all 
clinicians interviewed explained that it is difficult to focus upon whether the person 
presenting has a PD which requires a specific treatment, or whether their PD traits 
mean that they may experience other mental health problems (which may or may not 
require treatment, i.e. depression) differently.  
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The majority of the clinicians and supervisors interviewed suggested that the variety 
of symptoms that complicate PD presentations, which differ from other mental 
disorders (i.e. Bipolar Affective Disorder), means that it is difficult for staff to develop 
structures for the Treatment Choice Encounter itself, or define whether a patient's 
presentation is at a sufficient threshold to require the current treatments offered. This 
point is consistent with the research gap identified in the current PD literature, which 
suggests there is lack of ‘clinically syntonic’ studies that involve tasks intrinsically 
linked to clinical practice (Castonguay, 2013) and that a standardised or ‘one size fits 
all’ type approach is not possible for the heterogeneity of the PD patient population 
(Ebner-Priemer et al, 2009).  
 
A related theme within many interview transcripts concerned the lack of appropriate 
diagnostic psychoeducation material for PD patients, different to other mental health 
problems. The majority of interviewees expressed a desire for better recovery-
focussed psychoeducation, which could be used to support patients in the Treatment 
Choice Encounter, linked to the IPA superordinate themes of: ‘focus on time’ and 
‘boundary management’.  
 
The research suggests that the ‘Recovery’ movement is expanding in mental health, 
particularly in the field of psychosis, however there is still insufficient literature related 
to non-psychotic disorders such as PD (Bryan et al, 2012), meaning patients may 
often focus upon the need for treatments to provide ‘cure’ rather than ‘recovery’, 
which all interviewed stated causes conflict in the Treatment Choice Encounter, and 
reinforces dependency rather than independence. Through wider reading, the 
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concept of ‘health literacy’ connects these factors in the research, when considering 
treatment choices for other disorders, but is absent in the current literature for PD. 
  
‘Health Literacy’ is defined by the WHO (2015) as “the cognitive and social skills 
which determine the motivation and ability of individuals to gain access to, 
understand, and use information, in ways which promote and maintain good health”. 
Much is written about the topic in terms of physical health conditions (See figure 26 
below), and the need to promote better health literacy with PD patients is consistent 
throughout all transcripts, however is absent in the hermeneutic literature review. 
Understanding the factors that promote and hinder ‘health literacy' in this patient 
group is an important factor in formulating treatment decisions.   
Figure 26: Excerpt from the Office of Disease Prevention and Health Promotion 
(2015) factsheet concerning the topic of health literacy. 
Health literacy is dependent on individual and systemic factors: 
 Communication skills of lay persons and professionals. 
 Lay and professional knowledge of health topics. 
 Culture. 
 Demands of the healthcare and public health systems.  
 Demands of the situation/context. 
 
Health  literacy affects people’s ability to: 
 Navigate the healthcare system, including filling out complex forms and 
locating providers and services. 
 Share personal information, such as health history, with providers.  
 Engage in self-care and chronic-disease management. 
 Understand mathematical concepts such as probability and risk.  
 
 
 
All supervisors and most clinicians interviewed suggested that what this 
psychoeducation deficit means, is that if either a patient or professional is not 
‘literate’, then they have difficulty contributing to formulation processes which provide 
a rationale for treatment decisions, causing conflict in the Treatment Choice 
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Encounter. Both the interviews and the literature (Spring, 2007; Hunsley et al, 2005) 
demonstrate that the ability to formulate complex problems, and convey what parts 
of PD presentation are treatable, is essential. 
 
Most clinicians and supervisors interviewed suggested that the ability for patients to 
understand diagnosis and also available treatments, is complicated, firstly due to the 
health system's prioritisation of certain treatments, and secondly, the patient’s 
perceptions about what treatments may be efficacious for them (i.e. psychology or 
medications), which may not be aligned with locality service provision.  
 
The subject of systemic prioritisation of certain treatments reinforces interviewee 
experience when considering the outcome of the literature review. This is because 
the research sourced demonstrated significant bias in terms of publications derived 
from psychotherapy and psychology over other treatments (Appendix 3), despite the 
fact that practice guidance advocates multi-professional team working (NICE, 
2009a&b), which  underpins locality practice team structure. This disconnect 
between research and practice generates disempowerment for some professionals, 
which is highlighted in Section 6 (i.e. Interviewee 3: T:3.,P:8,L:372-387), and is an 
underpinning factor in the superordinate theme of ‘boundary management’. 
 
When considering the patient themes concerning perceived value of certain 
treatments, literature generated concerning ‘expert patient’ knowledge (Castonguay, 
2013) to some extent may explain why interviewees have a difficulty with some PD 
patients in the Treatment Choice Encounter, again linked with the notion of ‘health 
literacy’. This is because, whilst interviewees acknowledged that many of the 
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patients they encounter are ‘experts’ in terms of their own illness, and therefore able 
to contribute reciprocally in the Treatment Choice Encounter, certain patients deny 
that either their difficulties are due to PD, and/or they decline talking treatments, 
which poses a problem in terms of what treatments they feel may help.  
 
The super-ordinate themes concerning; the potential for ‘iatrogenic harm’, and 
‘diagnostic stigma’, are related to this, and are points of convergence in both the 
literature reviewed and the Interviewee reflections. However, an underpinning 
difference is that the ‘stigma’ described in the literature is primarily focussed upon 
the ‘other's’ (i.e. public) xenophobic perception of the diagnosis (i.e. Pickersgill, 
2012; Lewis and Appleby, 1988), whereas in the interviews, clinicians explained 
there was little effect upon the Treatment Choice Encounter related to stigma from 
‘the other’, instead they cited a major effect upon treatment being personal stigma 
held by the patient (self-stigma) concerning their PD diagnosis.  
 
The personal stigma that certain PD patients hold, observed by interviewees, 
interfered with treatment choices, due to patient's preoccupation that ‘something else 
is wrong’. This type of self-stigma was found in a few of the literature reviewed 
articles (Defife et al, 2012; Moses, 2009), however the literature focus explores the 
issue as being representative of a ‘split sense of self’, rather than providing 
information to clinicians about how to manage the phenomena in the Treatment 
Choice Encounter.    
 
Many of the interviewees explained that ‘self-stigma’ appears to be generated from 
negative beliefs about PD diagnosis, and is linked to the superordinate themes 
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concerning: ‘diagnostic stigma’, ‘meta-cognition’ and ‘focus on time’. The problems 
with time factors in terms of treatment decisions is detailed in the literature reviewed 
(McMurran et al, 2010; Green et al, 2004).  
 
It is difficult to evaluate the extent that time pressures affect the Treatment Choice 
Encounter via the literature reviewed, due to the different health systems that the 
research is taken from (i.e. American insurance paid health care system vs UK tax 
funded health system). A difference here between IPA outcome and literature review 
outcome is that all of the interviewees spoke from a UK health perspective, although 
3 candidates had worked in other countries, however only 25 literature sources 
originated in the UK, in comparison to 82 from the USA (Appendix 5). Therefore, it is 
proposed that more specific research is required in evaluating this factor, as there 
may be different pressures upon the clinician and expectation from the patients in 
differently funded health care systems.  
 
This cross-comparison of different health care models and subsequent effect upon 
treatment is something that appears to be only just emerging in the literature, and 
coming from UK health policy (Bell, 2015). But it is something that generates a 
debate about different health economies and how funding is impacting upon 
treatment decisions in very different ways than has been seen previously in the UK 
health system. It may be a way in which the difficulties that interviewees have 
described can be better understood, considering the current research gap. This 
factor is then linked with the superordinate theme of ‘boundary management’, 
concerning multiple clinician roles, which will be focused upon in section 7.3. 
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In summary, there are many patient factors identified within the IPA analysis and the 
literature review that affect the Treatment Choice Encounter. When considering the 
above patient-related factors, the following outcome is linked with the structure of the 
Treatment Choices Grid:  
 
All interviewees suggest is that if a person accepts their PD diagnosis and talking 
treatments, the encounter and decision for treatment is least complicated. The only 
exception to this concerns certain patients who are described as ‘dependant’ upon 
mental health services, and therefore are reluctant to be discharged (i.e. Interviewee 
4 - T:4,P:5-6,L:235-251). For those people who refute their diagnosis and/or refute 
the efficacy of talking treatments, all interviewees reflected that the Treatment 
Choice Encounter is problematic, and when considering the literature review results, 
there is little available research to support decisions concerning what to do about 
this. This is because most research sourced focuses either upon PD’s already in 
treatment, receiving some form of talking therapy, or risk management.  
 
The identification of this divergence between the literature reviewed and the practice 
experience is therefore significant in identifying ‘outliers’ (meaning differing from the 
‘norm’ of the group), whose differences pose difficulty for clinicians in the Treatment 
Choice Encounter.  
 
Services and policies are currently structured around people entering treatment who 
accept their diagnosis and are accepting of treatments for this. Practice data gained 
through the validation groups for the IPA study supported this, identifying that only  
15-25% of people who enter the locality services for PD treatment could be 
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considered within as ‘outliers’, 75-85% enter treatment accepting their diagnosis and 
also the evidence-based treatments offered for this.  
 
What is known about the culture of ‘outlier’ management in healthcare is that it is 
related to heightened risk and system problems (Wakeam, Hyder, Ashley, Stanley 
and Weissman, 2014). There was consistent feedback from all interviewees that 
making treatment decisions with these ‘outliers’ is a source of difficulty, and this is 
captured within the superordinate themes concerning ‘boundary management’, 
‘focus upon time’ and ‘potential for iatrogenic harm’, specifically related to treatment 
thresholds. This research therefore makes an original contribution by identifying the 
current ‘outliers’ in practice in terms of PD treatment choices that lack a research 
base to guide treatment decisions. 
 
 
7.3: Clinician factors, including personal and professional beliefs, and 
perceived resource availability, which contribute to their ability to manage the 
Treatment Choice Encounter. 
 
All interviewees identified that ‘boundary management’ was a difficult theme when 
making treatment choices. This concerns boundaries at multiple levels, inside and 
outside of the encounter itself. However, boundary management was sparsely 
researched in the literature in regard to treatment decisions, instead it focused 
mainly on boundaries within a therapeutic treatment encounter (Kopala-Sibley et al, 
2012). This could be considered as an area of divergence in the literature, and also 
from clinician training, when considering the overall research question itself.  
 
What the literature review has provided, which the interviews did not, was indications 
of how boundaries can be managed in individual PD treatment sessions (Brown et 
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al, 2012; Duggan et al, 2007), that could then be drawn upon to consider similar 
strategies being used within the Treatment Choice Encounter. 
 
Expanding upon points made in 7.2, clinician factors were identified in both 
interviews and literature reviewed, concerning the difficulty in ‘benchmarking’ 
treatment decisions in order to promote consistency, which is a core part of the 
research question posed. Slightly different perspectives have been provided 
concerning this phenomena by the literature review and the IPA study, however they 
correspond with the same difficulty in terms of treatment choice.  
 
The literature review raised difficulties with clinicians having different viewpoints in 
what constitutes effective treatment for PD’s, specifically focused upon different 
modalities of talking treatments (Beutler et al, 2012; Magnavita et al, 2010). Certain 
interviewees validated this factor, reflecting on clinical practice experience, however 
all interviewees raised difficulties with clinicians having different viewpoints in what is 
effective and required for PD patients across thresholds (i.e. Primary care GP’s 
considering a PD patient requires specialist mental health care treatment, and 
specialist mental health services considering that they do not). Both of these factors 
link in with the super-ordinate themes of: ‘boundary management’, ‘diagnostic 
stigma’ and ‘potential for iatrogenic harm’.  
 
With PD treatment choices now being linked with commissioning (Osley,2014; DoH, 
2011e; Chiesa,2008), this area will need further research, and poses a specific 
challenge for the ‘Parity of Esteem’ (NHS England, 2015b) agenda, linked with the 
‘Five Year Forward View (NHS England, 2014). Certain of the Interviewee data (i.e. 
Interviewee 7 - T:7,P:8,L:395-403) suggest that a potential reason for this is that 
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there may be a different level of understanding of the diagnosis between mental 
health services and GP’s, and also a disconnect between understanding the notion 
of Recovery in terms of PD as opposed to other long-term conditions (i.e. diabetes), 
which causes inconsistency of approach between referrer and gatekeeper.  
 
The presence of conflict between clinicians or clinical services and management of 
difficulty are core themes in three out of five ('boundary management', 'diagnostic 
stigma' and 'meta-cognitive abilities') of the super-ordinate themes. This is focused 
upon clinician skills, and is something that is lacking in the literature, despite there 
being much published research concerning the difficult behaviours that can be 
exhibited by people with a PD, after they have been accepted into treatment 
(Liebman et al, 2013).  
 
When considering this factor, there was a difference expressed within the IPA 
interviews, rather than between interviewees and literature reviewed. Within three 
out of four of the supervisor/clinicians interviewed in one part of the transcript, they 
identified the need to manage boundaries and the need to support clinicians in 
boundary management, yet when they reflected upon their own clinical encounters, 
they reflected upon the difficulty they have in terms of boundary management, 
despite the additional knowledge and training that they have. This may suggest that, 
although training in boundary management may assist clinicians in the Treatment 
Choice Encounter, there is something about the encounter itself that has an effect 
upon the clinician’s ability to manage boundaries with some patients (mainly the 
outliers identified in 7.2),  despite their additional training.  
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The treatment choice for ‘outliers’ is also referenced within many of the interviewee 
transcripts in relation to clinician as well as patient factors. Most interviewees 
described a difficulty in making decisions, particularly when they were faced with a 
sense of ‘disconnectedness’ in the Treatment Choice Encounter. This was linked 
with both the ‘diagnostic stigma’ superordinate’ theme and also the ‘meta-cognitive 
ability’ theme, as it was described by clinicians as both the patient's ability to engage 
with the Treatment Choices Encounter itself, and also the connectedness or 
acceptance of their diagnosis and evidence-based treatments.  
 
In this way certain interviewees reflected upon the costs and benefits of selecting or 
denying certain treatments in the patient encounter. The reasons provided are 
convergent with the literature (Castonguay et al, 2010), connected to the potential for 
either iatrogenic consequences (another superordinate theme) of treatment selection 
(Brand et al, 2014), or waste of resources (Mendelberg, 2014). This is a convergent 
factor, however it links to a divergence in the fact that there is little written about 
‘engaging the un-engaged’ and where the roles and responsibilities for risk 
management may prompt the requirement for a mental health service, despite the 
patient refusing to engage with treatments, which was a problematic factor raised by 
all interviewees.  
 
A recurrent use of specific linguistic terms within the entire transcripts suggested that 
the Treatment Choices Encounter was disorientating for the clinicians and 
supervisors, and this challenged their ability to ‘think’ about decisions, this is linked 
with the superordinate theme concerning ‘focus upon time’. It was a subject that 
appeared to evoke anxiety in the interviewees when discussed, and appears to be 
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linked with the paucity of research regarding clinician self-doubt, which was a finding 
in the literature review (Barnett et al, 2007). This requires sensitive practice 
consideration, as it is linked with the discussion about transferential, counter-
transferential and potential ‘splitting’ effects in the patient-clinician encounter, 
detailed in the literature review (Liebman et al 2013; Chaikin et al, 2004), and could 
also be considered as an underpinning factor in the need to develop the Treatment 
Choices Grid, detailed in Section 4. 
 
 
7.4: Supervisory factors that have been identified to support the ability to 
formulate consistent treatment choices and justify decisions 
 
A convergent factor between the supervisor/clinician and clinician interviews 
concerned the fact that they all experience the same struggles with the subordinate 
themes concerning ‘boundary management’ and ‘time management’. The difference 
being that the supervisors were often more aware and reflective about when 
boundary breaches and violations were occurring in both their own and other's 
practices, and their meta-cognitive abilities in-session were less affected. Within the 
literature review, there was nothing found in terms of research comparing clinician 
and supervisor experiences of engaging patients with PD, however literature was 
found concerning the importance of supervision when working generally with people 
who have a PD (i.e. Magnavita et al, 2010).   
 
Supervisor interviewees experienced conflict between their identities of both a 
supervisor and clinician, and provided several contradictory statements in their 
transcripts, which appeared to support the literature findings, which reflect the 
clinician vulnerability in the Treatment Choice Encounter (Bowers, 2002), however 
an addition that is not found in the research concerns how ‘role-conflict’ affects the 
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encounter, which is suggested as a new contribution generated from this research. 
This was also evident in most of the clinician interviews, however rather than the 
clinician/supervisor roles prompting a difference, the ‘role-conflict’ typically related to 
the gatekeeper/budget manager roles as detailed within the superordinate themes: 
‘boundary management’ and ‘metacognitive abilities’.  
 
In the supervisor interviews a more prominent theme that was raised differently from 
many of the clinicians, concerned the superordinate theme of ‘iatrogenic harm’. This  
may be because the supervisors (by nature of their role) have more active 
awareness of this subject, but reinforces the debate in the literature concerning PD 
treatability (Eastman et al, 2006; Glover-Thomas, 2006), which has continued since 
the publication of ‘Personality Disorder: no longer a diagnosis of exclusion' (DoH, 
2003).  
 
The convergent data from the interviews and literature review are associated with 
the superordinate theme of ‘diagnostic stigma’, which could be argued to require a 
better understanding connected with the current rhetoric concerning ‘Parity of 
Esteem’ (NHS England, 2015b). What the IPA study identified, that is contrary to 
most of the literature, is that diagnostic stigma experienced in practice affects 
supervised treatment choices, due to potential over-rides between systems (i.e 
primary care and secondary care).  
 
In the literature, stigma is reinforced due to the lack of representativeness of PD in 
studies that focus upon ‘major mental illness’ (Krueger et al, 2010), which by omitting 
the PD diagnosis from the trials, reinforce a devaluation of the diagnosis when 
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compared to other mental illnesses (i.e. psychosis). Additionally, many PD research 
trials omit people with diagnostic co-morbidity, which both the research (Castonguay, 
2013) and many interviewee statements suggest, means there is a disconnect 
between the complex patients encountered in clinical practice, and the research 
studies used to underpin practice policy (NICE, 2009a&b).  
 
It could be argued that the evidence-based changes made to psychosis services has 
benefitted patients by reducing acuity, however due to the lack of parity provided to 
PD services, practice data discussed by all interviewees demonstrates that this has 
meant that there is a noticeable rise in caseloads of PD patients, in comparison with 
psychosis patients particularly in acute services, which prompts the need to re-
examine parity of investment. This would then aid the clinicians in the Treatment 
Choice Encounter by prompting ‘early intervention’ and proactive rather than reactive 
strategies, which has been realised as effective in other mental health problems 
(NICE, 2014b).  
 
A further supervising factor raised within the literature connects again to the lack of 
representative research for all clinicians involved in PD treatments and treatment 
choices, as discussed in section 7.2. The supervisors interviewed represented all 
different supervisor groups within the practice setting (psychiatrists, nurses, 
psychologist and psychotherapist), but when considering the literature review, no 
representative professional studies were found, which meant that supervisors 
specifically commented upon having a lack of research to refer to when supervising 
clinicians, who are commissioned to provide holistic care to patients.  
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In summary, supervision models for PD treatment choices are lacking in the 
literature, and this is linked with the lack of heterogeneity of PD symptoms, and the 
polarised evidence-base concerning talking treatments, as opposed to the practice 
provision in UK NHS teams. The variables that the interviewed supervisors appear to 
focus upon are: the effects on the relationship and formulating difficulties to inform 
the decision-making process, informed by anecdotal data such as that gained in the 
clinician interviews, rather than research data.  
 
Clinicians and supervisors who were not trained psychotherapists expressed a 
struggle defining whether certain psychotherapeutic treatments were suitable for 
people with PD, due to the lack of research pertaining to treatment choice, and the 
lack of non-psychotherapeutic published literature concerning PD treatments.  
 
What this study provides is an original contribution to the current UK research 
pertaining to PD treatment, providing a voice of many different clinicians that are in 
practice, making treatment decisions. The literature reviewed did not generate any 
such study or multi-professional sampling. This transcript data in this way is 
divergent from the current research base, and this research may help with 
convergence.  
 
In conclusion, through the synthesis and discussion provided in sub-sections 7.2, 7.3 
and 7.4, divergent and convergent factors have been identified  in terms of: patient, 
clinician, and supervisor experiences, drawing from both the literature review 
findings and also the findings from the IPA study. An overriding factor for all of these 
appears to be the need for a joint systemic understanding when making treatment 
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decisions, that all clinicians (no matter what discipline) can apply in order to 
strengthen services for patients. The recommendations drawn from this study will be 
presented in the next subsection followed by the study’s strengths and limitations. 
 
 
 
7.5 Recommendations 
In conducting and analysing the interviews, two results were obtained. Firstly, in 
participating with the study, the teams have reflected more about the decision-
making process, and have made practice changes regarding support structures, 
policies, protocols, and working arrangements. Secondly, in terms of the data 
generated by the literature review, questionnaires, interviews, and validation groups, 
the following practice change recommendations have been suggested, to support 
staff to make treatment choices with PD patients: 
 
 A bespoke package concerning 'professional boundaries training' is required 
to support the decision-making process. This 'boundaries training' is not only 
to be focused upon clinicians making treatment choices, but extended 
throughout the Trust up to Board level, to provide support and consistency.  
 
 Diagnostic stigma impacts in multiple ways upon the Treatment Choice 
Encounter:- firstly on the patient’s ability to engage in the encounter, and 
secondly the clinician's decision-making, and finally, there has been a wider 
public health issue raised concerning media representation of PD.  
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The recommendations in terms of stigma reduction are therefore: (1) the 
development of tailored diagnostic psycho-education for PD patients in 
multiple different formats (i.e. written, podcast), (2) the development of 
specific teaching packages for staff conducting treatment sessions, 
considering the influential variables raised in this study, (3) the need to work 
with wider agencies in terms of public health campaigns concerning stigma 
reduction for PD. 
 
 There is an identified recommendation to review local protocols concerning 
time allocated to assessments for PD patients, considering the complex 
interpersonal dynamics that are often present in this type of encounter. It is 
recommended that additional time is provided. 
 
 It is recommended that the results of the research concerning clinician’s 
experiential narratives is published, and contributes to evaluations of PD 
services. This particularly relates to the current review of NICE guidance for 
PD, and the current revision of payment systems for different treatment tariffs. 
 
 There is a need to analyse and revise current local team supervision 
structures concerning clinical decision-making for PD patients, to assist the 
decision-making process, enabling a multi-professional approach, and 
understanding the impact of role expansion on the Treatment Choice 
Encounters. 
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 The need to conduct a further study to measure the efficacy of the newly 
devised TCG. This may involve a comparative analysis or experimental 
method. This study would need to be carefully designed, considering the 
personal dynamics that have been raised in this research, to ensure that it is 
the TCG that is being evaluated, rather than the person’s specific 
interpersonal dynamics.  
 
 The impact of different metacognitive processes requires reflection within the 
clinical leadership team. The practitioner reflections do appear to generate 
new findings, concerning how the clinician experiences the Treatment Choice 
Encounter itself, specifically concerning decisions being made regarding 
austerity measures which conflict with clinician's opinions pertaining to 
treatment.  
 
 Different considerations are needed concerning the potential for iatrogenic 
harm, when considering treatment and discharge for PD patient 'outliers'. 
Specific factors pertaining to this connect to the clinician experience within the 
encounter, and the changing expectations in terms of risk management. This 
is a multifaceted variable that requires multi-service locality focus (specifically 
from mental health and criminal justice services). 
 
 The ability to provide assertive yet compassionate feedback concerning 
treatment decisions has been identified as a problem, by both clinicians and 
clinician/supervisors. It is recommended therefore, that targeted assertiveness 
training is devised and provided, in order to aid clinicians in the Treatment 
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Choice Encounter. This training may be delivered through supervision using 
clinical scenarios, building on the anonymised case examples that 
interviewees provided. 
 
 Future PD research requires conducting, concerning patients who reject their 
diagnosis and evidence-based treatment strategies, in order to explore the 
phenomena, and also understand whether engagement strategies can be 
targeted. 
 
The recommendations for this study will contribute to the next AR cycle focused 
upon in clinical practice, in order to improve services for people with PD. The 
recommendations are summarised in Figure 27, with an example concerning how 
one recommendation has been used in the next stage of the research process 
(Appendix 28).  
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7.6 Study Strengths and Limitations 
Different forms of research are measured in different ways. Quantitative research is 
typically measured using three criteria: reliability, generalisability, and objectivity 
(Richie et al 2013). It would be inappropriate to use these criteria to measure this 
research, as although this is a mixed-methods study it predominantly uses qualitative 
rather than quantitative methods of data collection.  
 
When considering this study's strengths and limitations, the Yardley (2014:243) 
framework will be used as an evidence-based framework for analysis: 
 
Sensitivity to the context 
The following factors relate specifically to the study sensitivity: 
 
A literature review was conducted as a part of the study (Section 2). This has 
enabled analysis of relevant empirical and theoretical literature, exploring the specific 
social-cultural context in which the research is set. With hindsight, the literature 
review parameters set were too broad, however, in conducting such a broad review, 
this enabled research to be generated that informed the research question from a 
extensive perspective. Critically however, certain articles were not entirely specific to 
the context of the question posed. 
 
The use of validation groups at five points within the research study ensured not only 
that the study design was sensitive to the context of the research question studied, 
but it remained so as the research progressed, with the support of locality clinicians, 
patients, and carers. This inclusion of patients in the validation groups is considered 
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to be both important in addressing the paucity of patient voice within the literature 
sourced for the review in Section 2, but also in terms of enhancing the authenticity 
and relevance of the study (Guba and Lincoln, 1989:10). 
 
The limitations in the validation group use were that, although there were a core 
group of three attendees, attendance by others in the groups varied, which means 
that consistency of approach cannot be guaranteed. 
 
In exploring the question from a qualitative perspective rather than hypothesis 
testing, patterns and themes have emerged from the lived experience of the 
research participants. This has enabled the emergence of the super-ordinate 
themes, and also the unique way in which the Treatment Choices Grid has been 
adapted and used by different clinicians.  
 
A limitation of the study concerns the reduced patient questionnaire return, and the 
identification that, of those opinions gained, bias in terms of the sample results is 
likely. The low return enabled validation group analysis and clinician engagement, 
which generated interesting results in themselves.  
 
Finally, study sensitivity was not only a consideration for the researcher. Ethical 
board approval was sought for the study, through: NHS Ethics, University Ethics 
Board, and R&D Team. Gaining validation and agreement from all of these panels 
demonstrates an ethical study proposal and sensitivity to the research context, as 
reviewed by independent research panels.  
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Commitment and rigour 
 
 
The data collection and research analysis was in-depth and time-consuming (Figure 
15). This demonstrates commitment to the subject matter, and rigour in exploration. 
The employment of a second researcher after interview transcription is an additional 
factor when considering the rigour of the analysis, and also is employed to ensure 
bracketing the researcher's own presumptions, with the findings.  
 
At 6-monthly stages throughout the research, the literature review and research was 
re-visited, to explore whether new research had been published regarding the 
research question posed, in order to inform the study and keep it up to date.  
 
The sample size gained was within the original parameters set, which was deemed 
sufficient for the question posed. The data generated was significant, which posed a 
difficulty in terms of analysis. It could therefore be a reflection that should the study 
have been repeated, fewer and more focused questions would have been posed, 
after considering where unrelated information was generated in this study.  
 
Coherence and transparency  
A significant proportion of the thesis has been devoted to the methodology and TCG 
employed to conduct the research. The reason for this is to enable transparency, 
and understand the coherent flow of the research direction.  
 
Another reason for the validation groups and also the second researcher checks was 
to enable transparency, and to recognise the double hermeneutic produced by any 
IPA research, which concerns the researcher’s views upon the situation changing, as 
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they conduct research into the situation. The validation groups and second 
researcher have enabled reflection upon whether the researcher's own bias was 
affecting interpretations of: the literature, the patient feedback issue, the transcript 
analysis, and also the whole study outcome. 
 
Impact and importance 
The research was primarily conducted to make a difference in clinical practice, 
supporting clinicians, and therefore improving patient outcomes. In conducting the 
research itself, a better understanding has been gained for local services, 
considering the literature review and current evidence-base regarding decision-
making with PD patients. This literature review and dissemination into the local team 
assists in answering the research question set. 
 
The outcomes have been of benefit to the teams, as even while conducting the 
study, it enabled focus upon the subject matter itself. There have been practical 
changes made whilst conducting the research, which have benefitted the clinical 
encounter (i.e. TCG development).  
 
Where the research has prompted practice changes, there is now a further 
suggestion that research will need to be conducted, to evaluate what effect this has 
had upon the Treatment Choice Encounter. The dissemination of the results is 
summarised in Section 9, and highlights the impact and the importance of the study, 
in: attempting to answer the research question, reflect upon the difficulties 
encountered in conducting the study itself, and generating areas for future research.  
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A final important reflection concerned what would be done differently, should the 
research be repeated. The researcher reflects that the most significant unexpected 
factor concerned the destabilisation of teams and clinicians when the research 
question was asked, and sampling commenced. The impact that analysing decision-
making has had is documented by research, for example exploring the Hawthorn 
Effect (McCambridge et al, 2014), however this usually pertains to the act of an 
observer or researcher, rather than posing a research question itself. In reality, this 
significantly affected not only clinicians/supervisor's willingness to engage in the 
study, but also their clinical work with patients. The positive outcome of this is that 
the TCG has been developed, which appears to have been a collaboratively 
produced stabilising factor, which requires additional testing. 
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Section 8: Conclusion and Personal Reflection 
Within this section, a conclusion will be presented that considers all of the learning 
generated within this study. This will include both a summary of the research itself 
linked with the Action Research stages presented in figure 1. A summary of personal 
learning achieved by the researcher whilst conducting this process will be detailed 
leading on to the final chapter concerning the research dissemination strategy. This 
section will be presented in the first-person narrative, in order to explore personal 
learning generated through the research process.  
 
When concluding research, it is important to reflect upon the research question 
posed, which is: 
How can mental health care staff use a pre formulated guided decision 
process in the selection of  therapeutic interventions for people with PD, within 
the context of rationalisation and service change?  
 
The research question was generated out of a practice based AR project concerning 
increasing skills of people working in community mental health teams. The 
generation of data from clinicians means that it was core to the team, rather than just 
for myself, which generated energy for the research process, and enabled me to 
have the support from the teams and organisation to progress.  
 
To plan the research, a validation group was set up, to explore potential research 
options and also to shape, explore, challenge, and validate findings as the research 
progressed. I found this both helpful yet frustrating, having never participated in or 
used a validation group format before. In selecting a technique new to me, I was not 
only required to read about facilitating the group, I also needed to motivate others to 
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remain focused and keep participating, despite the busy work situation. This was 
both challenging and rewarding for me as a researcher.  
 
8.1: Literature Review 
An initial literature review was conducted, which found no models or frameworks to 
support clinicians who make treatment decisions with PD patients. Due to this, 
search parameters were expanded and a literature review using a hermeneutic 
model was conducted, this generated significantly more data (n=144 research 
articles), some of which were directly relevant, some had less direct links to the 
treatment decision, and discussed more general clinical encounters with PD patients.  
 
The literature review enabled a broader understanding of the research question 
posed and the complexity of the Treatment Choice Encounter. Under the headings of 
the 6 pre-set literature review questions, a hermeneutic enquiry was conducted and 
presented. This generated several core themes relating to the challenges clinicians 
face in the Treatment Choice Encounter itself, including: 
 
Analysing the history of PD as a diagnostic construct, and how perceptions of trauma 
and associated criminality have resulted in it gaining a collective identity associated 
with undesirability, provided me with a better understanding of issues that have 
prompted personal and organisational stigma, which is to an extent sustained today.  
 
As a clinician (psychotherapist and nurse), I am very aware of the potential 
relationship difficulties that can be encountered in clinical practice. However, the 
themes raised in the review pertaining to patient and clinician factors that may affect 
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the treatment outcome, but also negatively or positively impact upon the in-session 
relationship, challenged certain of my assumptions.  
 
One of the main difficulties concerned the problematic evidence-base available 
regarding: assessment, treatment, and discharge decisions for PD. Evidence 
sourced was primarily researched from a psychology/psychotherapy perspective, 
with little published concerning medical, nursing, and social support strategies 
provided for PD patients, which underpins the predominant part of the workforce in 
UK mental health services. This enabled me to reflect about why certain clinicians 
may feel more informed about working with PD than others, but also caused me to 
contemplate upon why there is such a stark amount of research for such a complex 
patient group. 
 
The literature review not only exposed areas of influence which contributed to  
answering the research question, but it also identified research gaps and potential 
solutions. One of the gaps identified was the lack of research concerning the 
clinician experience of the Treatment Choice Encounter, which is central to the 
research question, and underpins the rationale for the IPA methodology chosen.  
 
8.2: IPA Study 
In planning for the IPA, and commencing recruitment of a sample, process issues 
pertaining to the clinician's anxiety about having their decision-making technique and 
ability explored became apparent, impacting upon sampling and also support for the 
research. I found that people who were previously keen to provide opinions were 
cancelling meetings, and other clinicians began speaking about other obligations, 
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which meant that they could not assist further. Also, within my meetings with other 
supervisors, colleagues discussed how, by raising the question about how decisions 
are made, people had become more anxious about the everyday decisions that they 
make, and had started raising this more in supervision. In order to support clinicians 
and supervisors due to the destabilising effect of the research question, I worked 
with teams to develop the TCG.  
 
Positive feedback was initially obtained when we began discussing this concept, and 
it seemed not only to have a stabilising influence, but also provided a focal point for 
exploring the experience of making treatment choices, which was less personal than 
asking direct questions of the clinician. I therefore reworded the interview scripts and 
questionnaires, to focus upon the TCG rather than clinician, and proceeded through 
ethics approval.  
 
The addition of the TCG enabled me to gain a sample (n=10), which was consistent 
with the research protocol. All interviews were conducted, transcribed, and analysed, 
using the IPA framework. This is not a framework I was familiar with, therefore I 
spent time with other researchers, both in my organisation and also the university, 
who had used this method previously, to enhance my skills and confidence.  
 
The results, analysis, and discussion sections are presented in a narrative format, 
generating 5 superordinate themes related to the research question. These themes 
concerned: Boundary Management, Diagnostic Stigma, Focus on Time, Meta-
cognitive Processing, and the potential for Iatrogenic Harm. The themes were 
confirmed, with framing and language revised through the support of a second 
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researcher, who validated the findings from the transcript. This support was 
essential, as it not only alleviated my anxiety concerning using a new way of 
researching, but also in reflecting upon whether themes had been generated 
anchored in my own subjective opinion, or whether this accurately represented the 
experience of the clinicians conducting the encounter, and the supervisors providing 
support and clinical direction. I was pleased that very little change was made from 
my original super-ordinate themes, however significant time was spent on prioritising 
and contextualising themes.  
 
8.3: Patient Questionnaires 
Alongside of the interviews, patient questionnaires were collected. There was an 
issue in terms of the data collection which related partly to the literature results, and 
partly to the topics underpinning the TCG. In discussion with clinicians and the 
validation group, certain factors were generated concerning the lack of patient 
response. The reasons concerned the amount of questionnaires that patients gain 
concerning exploring and explaining their experience, and also related to personal 
diagnostic stigma that some patients held concerning their diagnosis.  
 
I relied on the support of the validation group, clinical supervisors, and clinical 
discussions, to decide whether I should return to ethics board to explore another way 
of gaining data. On reflection, my preoccupation with gaining patient data to make 
the research complete (in my mind), biased my reasons for conducting the research. 
After discussion, it was clear that patient data was not required to answer the 
research question, and although it would be preferable to gain perspectives from all 
in the encounter, a result is also interpretable with a low response rate, considering 
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the process issues raised. I therefore agreed with the validation group not to return 
to ethics board to explore additional data gathering.  
 
8.4: Recommendations 
In gaining the results from the literature review, validation groups, interview data, 
patient questionnaires, and through reflection on the research process, nine 
recommendations were made concerning how mental health care staff can be 
supported to make treatment choice decisions with PD patients: (1) a systemic 
boundary management training package being delivered to all staff involved with PD 
services; (2) Stigma reduction strategies (with patient, clinician and through public 
health initiatives); (3) local protocol changes, resulting in a formalised increase in the 
engagement time allocated to make treatment choices; (4) Multi-professional support 
with decision-making; (5) a need to use a tool to focus the formulation of consistent 
treatment decisions (such as the TCG, however this requires further research, prior 
to validation). (6) Further research considering the effect of austerity measures upon 
clinician meta-cognitive processing when making treatment choices, (7) the need to 
consider indirect or iatrogenic harm that may occur with some treatments, requiring a 
long and short-term focus upon treatments; (8) targeted training concerning the 
provision of assertive yet compassionate feedback upon treatment decisions; and (9) 
the recommendation for future PD research, concerning patients who reject their 
diagnosis and evidence-based treatment strategies, yet present for help. 
 
The outcomes of the research study are complicated, and demonstrate how there 
are a number of variables which require consideration in such an encounter. Figure 
28 provides a concluding diagrammatic to represent the complexity of the Treatment 
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Choice Encounter, summarising the phenomenological analysis conducted through 
this research, including the recommended outcomes which may assist a clinician, 
from the data gained.  
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Section 9: Dissemination 
Due to the size of this study and the different strands of the research, and the nature 
of the AR research process, I felt that it has been important to disseminate results as 
the study progresses, rather than wait until the end. Dissemination has been 
conducted through various methods, and further dissemination activities are 
planned. I have summarised the dissemination strategies below:  
 
9.1: Practice change 
Various components of the study have resulted in practice change within my 
organisation. This has particularly pertained to the analysis of staff support 
measures, the delivery of focused staff training, and the need to update clinical 
policies in the trust.  
 
As a part of the doctorate research process, I have applied and been nominated for  
forums and networks, that have enabled me to have a wider influence upon policy 
and practice change. I have been nominated and elected on to the NHS 
Confederation’s Mental Health Network Board. I have also been awarded the title of 
Queen’s Nurse and been nominated and accepted into the Phi Mu Chapter 
(England) of Sigma Theta Tau International (STTI), Honour Society of Nursing, 
which enables me to widen my contacts concerning leadership, and attend forums to 
present this research and enable peer-scrutiny. My roles with the NHS 
Confederation, Nursing Honour Society and Queen's Nursing Institute inform clinical 
practice change. 
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9.2: Publication 
I have refined the literature review conducted in the first year of the doctorate, which 
contributed to the generation of ‘treatment choices’ being the focus topic area. The 
paper was published:  
Graham. J. (2012). Cognitive Behavioural Therapy for occupational trauma: a 
systematic literature review exploring the effects of occupational trauma and 
the existing CBT support pathways and interventions for staff working within 
mental healthcare, including allied professions. The Cognitive Behaviour 
Therapist. Vol 5(1): 24-45.  
 
 
I am currently in the process of preparing two other papers which will be submitted 
for consideration for publication, concerning the findings of this research. I feel that 
publishing the findings of my research is important, to share the new insights that 
have been raised concerning engaging PD patients.  
 
Research results have been disseminated through validation groups, and also local 
mental health meetings, and service user and carer forums. Each of the interviewees 
that participated within the research has received a letter of gratitude concerning 
their participation, and also a summary of the research findings and 
recommendations. 
 
Certain findings have resulted in smaller practice change initiatives as a part of the 
Action Research process (i.e. the design and commencement of multi-level 
‘Professional Boundaries Training’ – detailed in Appendix 28).  
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9.3: Conferences and Presentations 
I have presented at psychotherapy, nursing, and health and social care conferences 
to disseminate this research at different stages. Appendix 29 details the 7 local, 
national, and international conference presentations at which I have presented my 
research, and a further two I have yet to present at, but I have had my abstract peer-
reviewed and accepted.  
 
9.4: Original Contribution  
Practice reformations and refinements connected with economic reforms are 
affecting mental health and social care provision locally, nationally, and 
internationally. Specialist mental health services are providing increased group-
based intervention and also training, consultation, multi-disciplinary team working, 
and supervision, to other (non-psychotherapeutically trained) team members, aimed 
at increasingly cost-effective treatment delivery. This research examines one such 
practice change, aimed at developing a sustainable practice initiative for clinicians 
working with patients with PD.  
 
Within the literature reviewed, I have not been able to source any information to 
suggest that a specific model or heuristic has been developed concerning making 
treatment choices with PD patients. Although my work draws on a substantial body 
of knowledge concerning therapeutic encounters with PD patients, it focused upon 
the systemic and individual experience of making treatment decisions, which I have 
found to be lacking in the current research. I feel that my interpretation of a clinical 
heuristic to aid formulation, in the form of the TCG, is unique, and adds to the body 
of knowledge. Though it is recognised that the aim of this study is not to validate the 
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tool, it has been rated by stakeholders as having local clinical benefit, and so post-
doctoral research will focus upon researching its efficacy and targeted use.  
 
Finally, I feel that through my work being accepted for peer-reviewed publication and 
a wide range of conferences, this is indicative that my area of study is contributing to 
research regarding PD. With the delayed publication of the NICE Guidance for 
Borderline Personality Disorder, and the focus of the BABCP 2015 Spring 
Conference being solely devoted to expanding mental health and psychotherapeutic 
practice for people with Personality Disorders, I feel that my research focus is in line 
with contemporaneous issues being raised in my clinical practice field.  
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Appendix 2 – Table presented to demonstrate the journal source breakdown for the 
literature review conducted within the study exploring treatment choices for people with 
Personality Disorder. 
Journal Title No  Journal Title No 
Psychodynamic Psychology 1  Psychological Medicine 1 
Psychoanalytic Psychotherapy 3 European Psychiatry 1 
The European Journal of 
Psychological assessment  
3  Counselling Psychology Journal: 
practice and research 
1 
Psychology and Psychotherapy: 
Theory, Research & Practice 
2 Journal  of Theoretical and Philosophical 
Psychology 
1 
Psychiatry 1 Social Work in Mental Health 1 
Psychotherapy Research 2  Clinical Psychology Review 2 
Personality Disorders: Theory, 
Research and Treatment 
8  Journal of Counselling & Clinical 
Psychology 
6 
Journal of Abnormal Psychology 7  Journal of Psychotherapy Integration 10 
Journal of Psychiatric and Mental 
Health Nursing 
3  Professional Psychology: research and 
practice. 
13 
Psychotherapy 6  Psychology: Practice, Policy and Law 1 
The American Journal of 
Psychoanalysis 
1  Journal of Trauma and Dissociation 1 
Developmental Psychology 1 
Journal of Counselling Psychology 2  British Journal of Psychiatry 1 
Psychiatry Research 2  Emotion 1 
Peace and Conflict: Journal of Peace 
Psychology 
1  Psychotherapy: Theory, Research, 
Practice and Training 
9 
Psychiatry Quarterly 1  American Psychologist  2 
Forensic Psychiatry and Psychology 3  Bipolar Disorders  1 
Psychological Services 1  Rehabilitation Psychology 1 
Pain 1  Psychology Bulletin 4 
Journal of Contemporary 
Psychotherapy 
1  Psychological Trauma: Theory, 
Research, Practice and Policy 
1 
Nordic Psychology 3  Canadian Psychology 2 
Group Analysis 1  Psychology of Addictive Behaviours 3 
The American Journal of 
Orthopsychiatry 
4  International Journal of Forensic MH  2 
Journal of Personality & Social 
Psychology 
1  The Psychology Manager Journal  1 
Social Studies of Science 1 
Personality and Individual Differences 1  Journal of Clinical Nursing 1 
Psychological Assessment 11  Law and Human Behaviour 2 
The Lancet 1  Psychiatric Bulletin 2 
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Appendix 3 - Table presented to demonstrate the age range of the literature sourced 
for the literature review conducted within the study exploring treatment choices for 
people with Personality Disorder. 
Age Range Number 
 
Under 2 years since the publication date N = 50 
 
Between 2 and 5 years since the publication date N = 41 
 
Between 5 and 10 years since the publication date N = 42 
 
Older than 10 years since the publication date N = 11 
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Appendix 4 - Table presented to demonstrate the diagnostic focus of the papers 
sourced for the literature review conducted within the study exploring treatment 
choices for people with Personality Disorder. 
Diagnosis Number(N) 
Borderline Personality Traits/Disorder N = 24 
Narcissistic Personality Traits/Disorder N = 2 
Paranoid Personality Traits/Disorder N = 1 
Dependant Personality Traits/Disorder N = 3 
Antisocial Personality Traits/Disorder (Psychopathic) N = 10 
Avoidant Personality Traits/Disorder  N = 3 
Obsessive-Compulsive Personality Traits/Disorder N = 2 
Personality Disorder (unspecified/all) N = 58 
Psychotic Disorder (including Schizophrenia) N = 2 
Mood or Affective Disorders (including depression) N = 4 
Anxiety Disorders  N = 5 
Eating Disorder  N = 2 
Alcohol or Illicit Substance Misuse N = 2 
Self-Harming & Suicidal Behaviours N = 6 
Hypochondriacal and/or somatoform disorder N = 2 
Attachment Disorder N = 1 
Trauma (including PTSD) N = 4 
Multiple mental health disorders N = 28 
Not related to any diagnosis  N = 11 
*NB: the total number for this section exceeds the total number of papers reviewed (n=144) as 
certain papers referred to more than one diagnosis or related problem. 
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Appendix 5: Table presented to demonstrate the country of origin for the papers 
sourced for the literature review conducted within the study exploring treatment 
choices for people with Personality Disorder. 
Country of origin Number 
 
United States of America N = 82 
United Kingdom N = 25 
Canada N = 8 
Sweden N = 4 
Norway N = 4 
Netherlands N = 4 
Germany N = 2 
Denmark N = 2 
Switzerland N = 2 
China N = 1 
Greece N = 1 
Italy N = 1 
Austria N = 1 
Spain N = 1 
Finland N = 1 
Australia N = 1 
Israel N = 1 
Multicentre N = 3 
   
Student Number: 100104045 
324 
 
 Appendix 6 – Personality Disorder Diagnostic Categorisation 
 
 
DSM-IV-TR (APA, 2000;287-297) 
 
ICD-10 (WHO, 1992;36) 
 
 
Personality Disorder 
 
Cluster A Personality Disorder 
   301.0   Paranoid Personality Disorder 
   301.20 Schizoid Personality Disorder 
   301.22Schizotypal Personality Disorder 
 
Cluster B Personality Disorder 
   301.7   Antisocial Personality Disorder 
   301.83 Borderline Personality Disorder 
   301.50 Histrionic Personality Disorder 
   301.81Narcissistic Personality Disorder 
 
Cluster C Personality Disorder 
   301.82 Avoidant Personality Disorder 
   301.6  Dependant Personality Disorder 
   301.4 Obsessive-Compulsive   
             Personality Disorder 
 
 
F60 Specific Personality Disorders 
 
   F60.0 Paranoid Personality Disorder  
   F60.1 Schizoid Personality Disorder  
   F60.2 Dissocial Personality Disorder  
   F60.3 Emotionally unstable personality       
             disorder  
         .30 Impulsive type  
         .31 Borderline type  
   F60.4 Histrionic Personality Disorder  
   F60.5 Anankastic Personality Disorder  
   F60.6 Anxious [avoidant] personality  
             disorder  
   F60.7 Dependent Personality Disorder  
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Appendix 7 - A brief overview of Objectivism and Objectivists 
 
Objectivists propose that ‘reality’ exists independent of consciousness and so can be 
perceived and conceptualised objectively, the aim of their research is therefore to 
conduct research in a way that is ‘value-free’ (Bryman, 2012). They often take a 
‘nomothetic approach’ to study, meaning that they typically conduct research with 
large groups of people, in an attempt to produce ‘generalisable’ laws or principles 
concerning objective phenomena (Bowling, 2002).  
 
This approach is typically conceptualised as using the positivist paradigm, where-by 
the hypothetico-deductive method is employed to problem conceptualisation 
(Popper, 2002), and problem-solving usually favours quantitative methodology 
(Bishop, 2002). This means that research focuses on either falsification or 
verification of a specified variable or hypothesis (Hume, 1978). This approach aims 
to quantify ‘generalisable’ results (Hughes, 1990b).  
 
There are many criticisms of the objectivist and positivist stand-points. The main 
concerns are that it may ‘over-simplify’ complex health and social phenomena, and 
in doing so, the subjectivity of experiences which provide context and conceptual 
relativity may be lost (Cruickshank, 2011).  
 
The aim of this proposed research study is to explore treatment choices and the 
effects the interpersonal interaction and value based judgements may have upon 
treatment choices, affecting care delivery and outcome. It is proposed that an 
objective analysis of this encounter would be difficult at this stage, as in reviewing 
the literature, multiple variables are cited as posing difficulty in making treatment 
decisions. This generates the current need to explore the contextual interaction of 
these variables, rather than test a hypothesis to produce a generalizable result 
concerning the variables, which means, at this stage in understanding the 
phenomena of treatment choices with people with personality disorder and 
objectivist, quantitative approach would not seem practical, realistic or achievable.  
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Appendix 8 - A brief overview of Subjectivism and Subjectivists 
 
The origins of subjectivism are attributed to Descartes, specifically concerning his 
work upon ‘methodological doubt’ (Stroud, 2002). Subjectivists are proposed to 
reject the notion of objectivity and external truth, proposing that humans are unique 
and their subjective perceptions and experiences are of value (Hanley et al, 2001). 
Subjectivists are posited to take an ‘ideographic approach’ to research in social 
science, which Kant described as the tendency to ‘specify’ as opposed to 
‘generalise’ in nomothetic approaches (Bowling, 2002). This means that they may 
use an ‘interpretivist’ paradigm to understand a problem by submersing themselves 
in the experience and subjectively translating their findings (Gray, 2004).  
 
Subjectivists are suggested as using a ‘nominalist ontology’ and ‘anti-positivist’ 
epistemology, which is ontologically different from an objectivist (Burrell and Morgan, 
1979). What this means is that the concept of ‘objectivity’ is felt not to be possible in 
a situation with so many variables, (Denzin, and Lincoln, 2000).  
 
The Subjectivist epistemological stand-point has critics due to the subjective nature 
of research results, these critics typically prize ‘generalisability’, therefore place less 
value in subjectivity and uniqueness (Raven, 2013). Historically, UK Policy favoured 
research conducted from more of an objective or Positivist standpoint, meaning that 
subjectivists were deemed as less ‘politically powerful’ (Jordan et al, 1998). 
However, over the past 10-15 years there has been a paradigm shift, and value 
placed upon subjectivist and interpretevist research has increased, evident by the 
inclusion of subjectivist and constructivist research within change agendas (Pope 
and Mays, 2006). 
 
Subjectivists typically favour qualitative research methods, as these approaches 
place value upon ‘contextualism’ as opposed to ‘generalisability’. A pure subjectivist 
approach to this proposed research would be difficult. This is because the treatment 
choices encounter exists within a structured health care system. This means that 
there is a non-subjective reality concerning resource allocation, policy, and 
procedure which governs the potential outcomes for the treatment choices 
encounter.  
 
This means that the individuals within the encounter (the clinician and the patient) 
have the ability to subjectively affect the encounter, however are also influenced by 
the reality of governance frameworks. A true subjectivist may reject the fact of 
‘conceptual realism’ (Paul et al, 2008), meaning that should the research question be 
explored from a solely subjectivist viewpoint, the results may be of little practice 
value, because they may utterly conflict with the resource provision in the current UK 
healthcare climate.  
 
  
Student Number: 100104045 
327 
 
Appendix 9 – Semi-structured interviews as the exemplary method for IPA 
 
Semi-structured interviews as the exemplary method for IPA (the structure is summerised 
from the description provided by Smith et al, 2014:55-80) 
 
1. Construct a research question. 
 
2. Decide upon the sample. 
 
3. Develop semi-structured interview schedules focussed on the research question and 
subject matter. Consider whether a coding value is attached to each question. 
 
4. Construct questions and prompts that encourage the participant to disclose their 
perception, without leading them to or from a particular response. 
 
5. Conduct the semi-structured interviews (typically lasting approximately 1 hour).  
 
6. Tape-record and then transcribe each interview.  
 
7. Analyse the transcripts, looking for themes, in the first case initially. Annotation will 
be placed in the left hand margin concerning interesting or significant details of the 
participant’s response. Make comment on themes, association, connections, and 
preliminary interpretation. Particularly exploring the use of metaphors and emotive 
language and references to: ‘me’ and ‘not me’. 
 
8. Return to the beginning of the transcript and use the right hand margin to document 
emergent theme titles.  
 
9. Connect the themes raised throughout the transcript, using analytical and theoretical 
ordering, identifying themed clusters and subordinate themes. 
 
10. Continue the IPA transcript analysis with the other cases. 
 
11. Look for convergence and divergence in each case. 
 
12. Once each case has been analysed by the interpretative process, a final table of 
subordinate themes is constructed.  
 
The resulting analysis should respect both theoretical convergence and within that, individual 
idiosyncrasy in how that convergence is manifest, consistent with the constructivist theory.  
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Appendix 10 - Table presented to detail the professional background of interviewee’s 
participating in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
Profession 
 
Number 
 
 
Psychiatrist 
 
 
2 
 
 
Nurse 
 
 
5 
 
 
Occupational Therapist 
 
 
1 
 
 
Nurse Consultant 
 
 
1 
 
 
Clinical Psychologist 
 
 
1 
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Appendix 11 - Table presented to detail the age range of interviewee’s participating 
in the study exploring treatment choices for people with Personality Disorder. 
 
Age Number 
 
 
25 - 35 years old 
 
 
2 
 
 
36 – 45 years old 
 
 
2 
 
 
46 – 55 years old 
 
 
5 
 
 
56 – 65 years old 
 
 
1 
 
 
65 years old and above 
 
 
0 
 
 
* Please note that the mean age of the team members in the locality is 43 years old.   
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Appendix 12 - Table presented to detail the gender distribution of interviewee’s 
participating in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
Gender 
 
 
Number 
 
 
Female 
 
 
6 
 
 
Male 
 
 
4 
 
 
Not stated 
 
 
0 
 
 
* Please note that the locality gender distribution 70% female 30% male at the time of the study, 
meaning this sample is slightly over representative in terms of males.   
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Appendix 13: Table presented to detail the first language of interviewee’s 
participating in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
 
Language 
 
 
Number 
 
 
English as a first language 
 
 
8 
 
 
English not a first language 
 
 
2 
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Appendix 14: Table presented to detail the qualification level of interviewee’s 
participating in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
 
 (**certain participants have more than one qualification, which is why the numbers detailed are above the 
numbers of participants interviewed) 
 
 
Qualifications 
 
 
Number 
 
 
Diploma 
 
 
4 
 
 
Batchelor’s Degree 
 
 
6 
 
 
Master’s Degree 
 
 
4 
 
 
Doctorate Level Qualification 
 
 
3 
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Appendix 15 – Table presented to detail the number of years each interview 
participant has worked in mental health care, for interviewees participating in the 
study exploring treatment choices for people with Personality Disorder. 
 
Interviewee experience in mental health care 
 
 
Interviewee  
 
 
Number of Years 
 
Interviewee 1 (clinician) 10 years 
 
Interviewee 2 (clinician) 17 years 
 
Interviewee 3 (clinician) 28 years 
 
Interviewee 4 (clinician) 27 years 
 
Interviewee 5 (clinician) 8.5 years 
 
Interviewee 6 (clinician) 15 years 
 
Interviewee 7 (clinician/supervisor) 27 years 
 
Interviewee 8 (clinician/supervisor) 36 years 
 
Interviewee 9 (clinician/supervisor) 13 years 
 
Interviewee 10 (clinician/supervisor) 20 years 
 
Average / Mean 20 years (averaged to the nearest year) 
 
 
Total 
 
201.5 year 
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Appendix 16 – Table presented to detail the number hours worked for each interview 
participant in the study exploring treatment choices for people with Personality Disorder. 
 
Interviewee Hours worked 
 
Interviewee 1 (clinician) 37.5 Hours per week 
 
Interviewee 2 (clinician) 37.5  Hours per week 
 
Interviewee 3 (clinician) 37.5 Hours per week 
 
Interviewee 4 (clinician) 37.5 Hours per week 
 
Interviewee 5 (clinician) 37.5 Hours per week 
 
Interviewee 6 (clinician) 37.5 Hours per week 
 
Interviewee 7 (clinician/supervisor) 30 hours per week 
 
Interviewee 8 (clinician/supervisor) 37.5 Hours per week 
 
Interviewee 9 (clinician/supervisor) 37.5 Hours per week 
 
Interviewee 10 (clinician/supervisor) 37.5 Hours per week 
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Appendix 17 – Table presented detailing the total patient case load size for each 
interview participant in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
Participant Total number of patients on current caseload 
 
Participant 1 (clinician) 100 patients 
 
Participant 2 (clinician) 80 patients 
 
Participant 3 (clinician) 30 patients 
 
Participant 4 (clinician) 280 patients 
 
Participant 5 (clinician) Not stated 
 
Participant 6 (clinician) 20 patients 
 
Participant 7 (clinician/supervisor) 15 patients 
 
Participant 8 (clinician/supervisor) 24 patients 
 
Participant 9 (clinician/supervisor) 700 patients 
 
Participant 10 (clinician/supervisor) 40 patients 
 
Average 143 Patients  
(based on 9 participants as one did not state their caseload) 
 
 
Total 
 
1289 patients 
 
 
 
(*please note that interview participants did not state what proportion of these patients had a 
diagnosis of Personality Disorder – they did however state  their caseload predominantly consisted of 
people either diagnosed with PD or with traits of PD) 
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Appendix 18 – Table presented to detail the diagnostic range that each interview 
participant in the study exploring treatment choices for people with Personality Disorder 
works with. 
 
Participants working with patients presented with diagnostic co-morbidities alongside 
of the diagnosis of Personality Disorder. 
 
Mental Health Problems 
 
 
Number of interviewees 
 
 
Personality Disorder 
 
 
10 
 
 
Trauma 
 
 
9 
 
 
Depression 
 
 
10 
 
 
Anxiety 
 
 
10 
 
 
Psychosis 
 
 
7 
 
 
Bipolar Affective Disorder 
 
 
7 
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Appendix 19 – Table presented detailing transcript information for each participant in 
the study exploring treatment choices for people with Personality Disorder. 
 
 
Participant Interview Length Transcript Length 
 
Participant 1 (clinician) 49 minute 40 seconds 409 lines 
 
Participant 2 (clinician) 51 minute 38 seconds 469 lines 
 
Participant 3 (clinician) 54 minute 09 seconds 427 lines 
 
Participant 4 (clinician) 66 minutes 41 seconds 728 lines 
 
Participant 5 (clinician) 51 minute 41 seconds 364 lines 
 
Participant 6 (clinician) 58 minute 23 seconds 595 lines 
 
Participant 7 (clinician/supervisor) 55 minutes 27 seconds 689 lines 
 
Participant 8 (clinician/supervisor) 63 minutes 38 seconds 600 lines 
 
Participant 9 (clinician/supervisor) 61 minutes 35 seconds 778 lines 
 
Participant 10 (clinician/supervisor) 79 minutes 14 seconds 1246 lines 
 
Average 59 minutes 
(to the nearest minute) 
630 lines 
(averaged to each whole line) 
 
 
Total 
 
9 hours 52 min 6 seconds 
 
6305 
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Appendix 20:  Table presented detailing the gender distribution of the questionnaire 
respondents in the study exploring treatment choices for people with Personality 
Disorder. 
 
Gender Number 
 
Female 12 
 
Male 3 
 
Not stated 0 
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Appendix 21: Table presented detailing the age range of the questionnaire 
respondents in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
Age Number 
 
18 - 30 years old 4 
 
31 – 40 years old 5 
 
41 – 50 years old 5 
 
51 – 60 years old 1 
 
61 years old and above 0 
 
Not stated 0 
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Appendix 22:  Table presented detailing the diagnosis of the questionnaire 
respondents in the study exploring treatment choices for people with Personality 
Disorder. 
 
 
Diagnosis Number 
 
Personality Disorder (Unspecified) 7 
 
Borderline Personality Disorder 7 
 
Bipolar Affective Disorder – Type II 1 
 
Depression 3 
 
Complex PTSD 2 
 
No disorder stated 1 
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Appendix 23: Table presented detailing the mental health service experience of the 
questionnaire respondents in the study exploring treatment choices for people with 
Personality Disorder. 
 
 
 Number 
 
New to service 3 
 
Previously received mental health services 11 
 
Not stated 1 
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Appendix 24: Table presented detailing the outcome of the questionnaires received 
in the study exploring treatment choices for people with Personality Disorder. 
 
Question Strongly 
Disagree 
Disagree Neither 
Agree or 
Disagree 
Agree Strongly 
Agree 
I found the ‘treatment 
choices grid’ helpful 
 
1(7%) 0 1(7%) 9(60%) 4 (26%) 
I understood why the specific 
intervention had been 
offered to me, at this time. 
 
1(7%) 0 1(7%) 9(60%) 4(26%) 
I understood why certain 
treatment was not suggested 
for me at this time. 
 
1(7%) 0 1(7%) 10(66%) 3(20%) 
By using the ‘treatment 
choices grid’ I understood 
that as my needs change so 
will the treatment choices 
available to me. 
 
1(7%) 0 1(7%) 10(66%) 3(20%) 
I found the wording used in 
the ‘treatment choices grid’ 
easy to understand. 
 
1(7%) 0 2(14%) 8(53%) 4(26%) 
The ‘treatment choices grid’ 
helped me to structure my 
care plan with my worker. 
 
1(7%) 0 2(13%) 9(60%) 3(20%) 
I would recommend that this 
‘treatment choices grid’ is 
used with other people 
entering this service. 
 
1(7%) 0 1(7%) 8(53%) 5(33%) 
% figures provided are rounded to the nearest whole percent. 
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Appendix 25:  Table presented detailing the outcome for Q1 upon the questionnaires 
received in the study exploring treatment choices for people with Personality Disorder. 
 
Q1 - What did you most like about the ‘treatment choices grid’ and/or the way 
it was used in your session? 
 
“it is sensible” 
 
“I liked it because I can see how I can work towards getting help” 
 
“easy to understand” 
 
“I can see where I am on the grid and why I am having the groups in ICT” 
 
“It is easy to understand and I can see where I am on the grid. I can still get help 
even when I can’t talk to staff” 
 
“It is very easy to understand” 
 
“I can see how thing will work” 
 
“Easy to understand and cross reference within the ‘boxed’ structure. Similar to, but 
better than the arrow type of grids. The clear indications of treatment choices and 
how/ when they would be used would be used usefully for treatment.” 
 
“Well presented and laid out. Easy to understand, helps me to understand my 
problems” 
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Appendix 26:  Table presented detailing the outcome for Q2 upon the questionnaires 
received in the study exploring treatment choices for people with Personality Disorder. 
 
Q2 - What did you least like about the ‘treatment choices grid’ and/or the way it 
was used in your session? 
 
“I want to get better but I don’t want to go to a unit” 
 
“nothing” 
 
“Nothing that I do not like” 
 
“I liked it at the beginning of treatment” 
 
“Rather cold and clinical in its presentation. Giving factual guidance as to treatment 
choices but lacking in the human touch of verbal interactions.” 
 
“If anyone has any difficulty then they can easily ask for things to be clarified, but it 
might be made simpler with less writing.” 
 
“I didn’t like it” 
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Appendix 27: Table presented detailing the outcome for Q3 upon the questionnaires 
received in the study exploring treatment choices for people with Personality Disorder. 
 
Q3 - Do you have any suggestions about the way in which your treatment 
choices could be explored with you? 
 
“No” 
 
“It’s all explanatory” 
 
“When I can trust people, trust is a big issue for me” 
 
“My honest opinions about this questionnaire that the ‘treatment choices’ are laid out 
as ‘belonging to me’ and yet they are choices that ultimately made for me by 
availability of treatment at the centre I attend for such sessions. Certain treatment 
choices are either too expensive, not practiced at the centre or severely time limited 
and thus in my experience, the tantalising options for treatment as laid out within the 
said grid are usually just a disappointment. Before treatment choices can be 
explored they need to increase in availability and scope” 
 
“It could help the staff to understand other people’s problems and how to help” 
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Appendix 28 – Boundary management training summary report. 
 
Professional Boundaries Training 
Summary Report 
Introduction: 
 
Professional Boundaries Training has been identified as a key area which benefits any professional 
working within an organisation who provides services for people with Personality Disorder. 
However, when NHS Trusts, local Universities and Social Care Employers have been contacted, it has 
been a subject that is absent from many local induction and mandatory training schedules, and also 
professional CPD courses. This has triggered locality exploration concerning the potential to create 
an adapted locality training package to support all in the organisation.  
 
In order to support the development of a whole system training package, a generic Boundary 
Management Session was sourced and attended produced by an independent trainer who provided 
consent for the training package to be used and adapted concerning the issue of systemic 
approaches to supporting people with Personality Disorder. 
 
This introductory session provided a baseline package, that was then adapted by a locality 
trainer/researcher to focus and develop a specific Boundary Management Package for Personality 
Disorder Service Providers, that was not just aimed at clinicians, but different members 
organisations which may be involved with boundary management issues. These staff groups 
included: administrators, human resources departments, senior managers, and directors. The 
rationale for this adaption and expansion is focussed on the notion of “One Team Working”, which 
promotes internal consistency in working practices, as well as consistency with external providers, 
and is key to notions of “Board to Ward” communication and consistent working practices.  
 
The aim and objectives of the training are: 
 
Aim: To explore the personal and systemic impact of boundary crossing in health and social care 
when working with people who have a diagnosis of Personality Disorder.  
 
Objectives: 
1. To explore the types of abuse that can occur and the definition of vulnerability, and 
relate this to the topic of boundary violations. 
2. To explore the continuum of boundary issues that may occur within a relationship 
with a person in a position of responsibility.  
3. To explore the differences between personal and professional relationships. 
4. To explore boundary issues that may occur at different levels, specifically: between 
patients; between patients and staff; between patients and organisations; between staff 
groups, and between staff members and employing or allied organisations. 
5. To explore a clinical example of a boundary management challenge. 
6. To explore personal and professional obligations of all staff in terms of boundary 
management.  
 
The training is also anchored in research and regulation, and is specifically related to increasing 
whole-system working when referring to the following themes: 
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 The Frances Report - Mid-Staffordshire Enquiry – learning lessons regarding whole-
system working.  
 ‘Raising Concerns at Work’ (whistleblowing) – derived from: ‘Freedom to Speak up 
Review’, ‘Speaking-Up Charter’, and the ‘Enterprise and Regulatory Reform Act’.  
 Building upon local initiatives focused upon the: ‘Having a difficult Conversation’ 
campaign introduced by Trust Nursing and Partnerships division in 2013. 
 This builds upon specific research conducted pertaining to making treatment choices 
with people who have a Personality Disorder appreciating the local pressures, when 
supporting patient groups considering the 6 C’s framework.  
 It provides a framework to enable the exploration of “proactive risk-management 
decisions”, specifically focused upon enabling safe and consistent discharge 
processes. 
 It is also a re-enforcing strategy, to ensure all staff are aware of specific policies 
related to specific boundary management issues, including; Bullying and Harassment 
Policy, Personal Responsibility Framework, Complaints Procedures, Safeguarding 
and Risk Management Policies, Raising Concerns policy, and other Human Resources 
Policies concerning boundaried working practices (i.e. Social Media Policy). 
The Boundary Management Training package has been launched and 104 staff have completed the 
training. The course evaluation for the first attendees is presented below: 
 
Session Attendance: 
 
Date / Time of Session Number of attendees Number of feedback forms  received 
2nd July 2015 – PM 18 17 (94%) 
10th July 2015 – AM 8 8 (100%) 
10th July 2015 – PM 9 9 (100%) 
21st July 2015 – AM 13 12 (92%) 
21st July 2015 – PM 2 2 (100%) 
31st July 2015 – AM 15 14 (93%) 
31st July 2015 – PM 10 10 (100%) 
14th August 2015 – AM 15 15 (100%) 
14
th
 August 2015 – PM 7 7 (100%) 
17th August 2015 - AM 7 6 (85%)  
Total: 104 100 (96%) 
 
Multi-professional learning is considered as a core requirement for this training, in order to 
promote interprofessional learning and multiple system engagement. Due to this, each of 
the 10 sessions conducted included a wide range of professions, rather than being 
profession-specific. A breakdown of the different professions groups who attended the 
training is shown below: 
 
Profession Number 
Lead Consultant Psychiatrist 1 
Consultant Psychiatrist 1 
Inpatient Nurse 6 
Occupational Therapist 5 
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Nurse Consultant 2 
Psychotherapy Lead 2 
Psychotherapist 2 
CPN 12 
Social Worker 10 
Team Manager 8 
Service Manager / Modern Matron 3 
MHO 14 
Nursing Assistant  18 
STR Worker 2 
Psychotherapy Trainee 1 
Human Resources  3 
Assistant Director 1 
Ward Sister 2 
OT Assistant 1 
Nurse-Led Clinic Coordinator 1 
Student Nurse 1 
IAPT 1 
MHA Administrator 1 
Secretary 3 
Administrator 3 
Total: 104 
 
The gender breakdown of attendees is presented in the following table, no results are drawn from 
this, except to state that it is reflective of the current employment in locality teams: 
 
Gender Number 
Female 83 
Male 21 
 
 
Attendee Feedback 
 
Each attendee was provided with a feedback form to complete at the end of each training session. 
The response rate for completion was good, with an average of 96% feedback for the 10 sessions 
conducted. The feedback form consisted of 5 specific questions, which attendees could rate using a 
Likert Scale (1-5 – 1 being the least positive, and 5 being the most positive rating). The feedback for 
each question is presented below: 
 
Question 1– Did trainers demonstrate subject knowledge, and create interest for the course subject? 
Score 5 (trainers demonstrated exceptional knowledge) 93% 
Score 4 7% 
Score 3 0 
Score 2 0 
Score 1 (trainers failed to demonstrate knowledge or generate interest) 0 
 
 
Question 2 – I had opportunities to participate and ask questions? 
Score 5 (I had a good opportunity to ask questions) 96% 
Score 4 4% 
Score 3 0 
Score 2 0 
Score 1 (I was not provided  with the opportunity to ask questions) 0 
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Question 3 – Did the training have an appropriate balance of theoretical and practical activity? 
Score 5 (There was a good balance of theory and practice activity) 82% 
Score 4 17% 
Score 3 0 
Score 2 0 
Score 1 (The training had too much of either: theory and practice activity) 0 
Not rated 1% 
 
Question 4 – Did the training content meet the stated learning outcomes? 
Score 5 (The training met all stated learning outcomes) 92% 
Score 4 8% 
Score 3 0 
Score 2 0 
Score 1 (The training provided differed from the learning outcomes set) 0 
 
Question 5 -Was the training facilitated and presented in such a way that you can use it in your work? 
Score 5 (I can apply what I have learned to my work) 95% 
Score 4 4% 
Score 3 0 
Score 2 0 
Score 1 (I cannot apply what I have learned to my work) 0 
Not Rated 1% 
 
 
Alongside of the Likert ratings, attendees were requested to provide free text feedback concerning 
their experience of the training. A summary of the responses are provided below: 
 
Free-text responses by attendees concerning: - their experience of the ‘Professional Boundaries Training’ 
“Very good delivery, prompted discussion and reflections”. 
“Maybe could highlight the main recommendations concerning compassion”. 
“Open and fluid feel to the session”. 
“More explanation about how Personality Disorders develop may help”. 
“Group work and case studies generated good thinking and reflections”. 
“More group work please, the discussions were very interesting and informative”. 
“It was good to talk about cases, but with some distance, making it feel safe”. 
“It was great that people could bring their personal experiences, and this was explored in a supportive way” 
“Examples were clear, and related to my workplace”. 
“Very interactive and reality-based”. 
“Excellent training, enables me to reflect”. 
“Opportunities to discuss personal experiences was helpful and supportive”. 
“This course was helpful, because I thought I was aware of my own boundaries, but this helped me reflect 
upon issues that I had not thought of as boundary issues in the past (i.e. providing too much time for people 
with Personality Disorder)”. 
“Good course, it helps me reflect upon my personal and professional responsibilities”.  
“This course makes you think more carefully about your practice, and where you may be crossing 
boundaries, even though you have good intentions”. 
“As a student, this has enabled me to reflect upon my practice, and prepare for qualification”. 
 
 
Secondly, attendees were requested to provide feedback concerning how they will used the learning 
from the training to influence their future practice. A summary of the responses are provided below: 
Free-text responses by attendees concerning: - how they will apply the learning from the ‘Professional 
Boundaries Training’ in their future practice. 
“I need to consider the issue of organisational boundary issues more in my day to day practice”. 
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“It is useful to reflect upon dynamic formulations, where we find ourselves doing things without realising it, 
and how we got there, something about being vigilant and self-protective”. 
“Awareness of what signs to observe for before boundaries get breached”. 
“In ensuring that my practice not only meets my high standards, but the standards of the organisation, and 
regulatory bodies”. 
“Awareness about needing to be open about what decisions are being made, which could be seen by others 
as “crossing boundaries”. 
“To use the training in clinical and managerial supervision to explore and challenge boundary management 
issues”. 
“This has made me think clearly about boundaries” 
“I will use this training when supervising others”. 
“I will use this in MDT discussions, group supervision, care planning, and clinical reviews”. 
“Via self-reflection, team briefings, supervision, and general work discussion”. 
“Reflection on these areas will help me with my re-validation”. 
“Will use the learning when conducting investigations”. 
“I will be more mindful of potential boundary breaches in my clinical practice”. 
“I will find it more comfortable to discuss difficult boundary issues if they arise”. 
“I will use this daily in my day to day work with people with Personality Disorder”. 
“Increased awareness of boundary issues that can occur between service users and also colleagues”. 
“This training is very relevant to my role in HR, I will use it in all aspects of my work with different 
business divisions”.  
“I will reflect more about boundary issues in my everyday role, and feel more confident to raise concerns if 
they arise”. 
“I feel that I am more aware of the need to support colleagues who may be experiencing difficulties”. 
“I know better how to raise concerns, and also who to approach, if I feel that there are boundary issues in 
my practice area”. 
“Increased awareness of my own practice and how to support my colleagues”. 
“I will be less worried about raising concerns, and understand that they will be taken seriously”. 
“I will use this on a daily basis with service users and colleagues”. 
“I will use this information in my role as a nursing assistant”. 
“It enables me to understand more about potential bullying and harassment and how it can start”. 
 
Summary and Conclusions 
 
The adapted professional boundaries training has been well-received from all attendees. The 
feedback that is presented above demonstrates that the way the training has been developed and 
delivered appears to be beneficial for multi-professional learning and development.  
 
Attendees have provided feedback concerning the method of delivery, they have explained that the 
combination of group work and case vignettes has allowed them to explore issues together, and 
they have explained that it has helped that senior members of the team both delivered and used 
self-disclosure within the training itself, as this allowed honesty and feelings of safety to explore 
difficult practice issue. 
 
Due to the positive nature of the evaluation, the locality have decided to provide training sessions 
throughout the division, and add the training to the list of the services mandatory training 
requirements.  
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Trust Policies: 
 Bullying and Harassment Policy 
 Personal Responsibility Framework 
 Complaints Procedures 
 Safeguarding Policy  
 Risk Management Policies 
 Raising Concerns Policy  
 
Also related to other Human Resources Policies concerning boundaried working practices (i.e. Social 
Media Policy). 
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Appendix 29 – Conference presentations in dissemination strategy 
 
 
Type of presentation: Poster Presentation. 
Topic: The experience of vicarious trauma in 
acute mental health care.  
Venue: University of Derby.  
Conference Topic: Health and Social Care 
Research 
Date: September 2012. 
Status: Completed 
 
Type of presentation: Oral and Poster 
Presentation  
Topic: Treatment Choices for People with 
Personality Disorder. 
Venue: COHEHRE Conference, 
Semmelweis University Faculty of Health 
Sciences, Budapest, Hungary. 
Conference Topic: Health and Social Care 
Perspectives for a Sustainable Future 
Date: 22nd- 24th April, 2015. 
Status: Presentation completed in April 
2015. 
 
Type of presentation: Poster Presentation 
and short workshop.  
Topic: Occupational Trauma in Mental 
Health Care.  
Venue: Regional Research Conference, 
Castle Park Conference Centre, Doncaster.  
Conference Topic: Mental Health Research 
Date: December 2012. 
Status: Completed 
 
 
Type of presentation: Oral and Poster 
Presentation  
Topic: Splitting as a concept: supporting 
people with Personality Disorder in an 
inpatient mental health setting. 
Venue: Sigma Theta Tau International: Phi 
Mu Chapter. 2nd   Biennial Nursing 
Scholarship Conference, Weetwood Hall 
Conference Centre, Leeds.   
Conference Topic: Caring Leadership in a 
Politicised Nursing Arena  
Date: 19th June, 2015. 
Status: Completed 
 
Type of presentation: Oral Presentation (3 
Workshops with 40-50 delegates per 
workshop) 
Topic: Advancing Mental Health Nursing 
Practice: New Ways of Working. 
Venue: Regional Health Education 
Conference, Cedar Court Hotel, Wakefield. 
Conference Topic: Advanced Practice 
Date: June 2013. 
Status: Completed 
Type of presentation: Oral and Poster 
Presentation  
Topic: Demystifying treatment choices 
when working with people who have 
Personality Disorder. 
Venue: Keepmoat Stadium, Doncaster.   
Conference Topic: Grounded Research  
Date: 15th October, 2015. 
Status: Abstract reviewed and accepted, 
awaiting to present. 
 
 
 
Type of presentation: Oral Presentation 
and Workshop 
Topic: Nurse Consultancy: Targeting 
interventions in Mental Health Care. 
Venue: Healthcare Conference UK, Nurse 
Clinics Conference, London 
Conference Topic: Nurse Led Clinics 
Date: 19th November, 2015. 
Status: Abstract peer reviewed and 
accepted, confirmed Speaker, however yet 
to complete the event 
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Appendix 30 - Patient Questionnaire used in the research study exploring treatment 
choices for people with Personality Disorder.  
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Appendix 31 - Clinician/ Supervisor consent and confidentiality form used in the 
research study exploring treatment choices for people with Personality Disorder. 
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Appendix 32 - Clinician/ Supervisor demographics form used in the research study 
exploring treatment choices for people with Personality Disorder. 
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Appendix 33 - Clinician/ Supervisor advice letters used in the research study 
exploring treatment choices for people with Personality Disorder. 
  
Student Number: 100104045 
358 
 
  
Student Number: 100104045 
359 
 
Appendix 34 - Ethics Approval letter – NHS Research Ethics Committee 
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Appendix 35 - Ethics Approval letter – University of Derby  
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Appendix 36 - Ethics Approval letter – NHS Trust Research & Development Service 
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Appendix 37 – Example excerpt from transcript, to demonstrate the left and right 
hermeneutic analysis. 
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